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Abstract 
Over centuries of co-existence with their hosts, microbes that are exclusively 
vertebrate pathogens have evolved mechanisms for manipulation of host cells and 
evasion of the immune system. Some pathogens dodge the immune response by altering 
the functions of and hiding within the very cells that should be consuming and digesting 
them: macrophages. The aim of these studies was to explore the dynamic interactions of 
the host with two microbes that opt to live within the macrophage phagosome: 
Mycobacterium tuberculosis (Mtb) and Salmonella typhimurium. In order to identify 
bacterial genes that provide protection against specific host immune pathways, we have 
developed the strategy of "differential" signature-tagged transposon mutagenesis (STM). 
By evaluating bacterial mutants for differential virulence in strains of immuno-deficient 
mice, we identified five enzymes required for in vivo survival in the face of specific 
immune stresses: four Mtb enzymes essential for growth and rapid lethality in NOS2-
deficient mice but not in IFN-y-deficient mice, and one S. typhimurium enzyme that 
participates in resistance to phagocyte oxidase. The Mtb enzymes suggest novel 
pathways for countering IFN-y-dependent immune mechanisms other than NOS2. 
Analysis of the sequence of the S. typhimurium enzyme suggests the existence in 
prokaryotes of an alternative signaling pathway that complements classical phospho-relay 
2-component regulatory systems. 
Preface 
Although this doctoral thesis is intended for approval by a committee of 
prominent researchers in the fields of immunology and microbiology, I feel strongly that 
the information included herein should be accessible to non-scientist and scientist alike. 
Not only is it important for me share these accomplishments with my family and friends, 
but, additionally, I subscribe to the belief that science is too often discussed only by the 
few and not disseminated to the population at large. Especially as technology has 
advanced, science has become unapproachable to the layperson. This preface serves as 
my first attempt as a scientist to make one small but complex piece of science 
comprehensible, and hopefully interesting as well, to a wider audience. 
The vertebrate immune system, an introduction 
The cells of the vertebrate immune system, also known as white blood cells, can 
be divided into two subsets: innate and adaptive (Janeway and Medzhitov, 2002). The 
innate immune system is evolutionarily the original mechanism of host defense, and all 
organisms that can be said to possess immune systems contain variations of the innate 
immune system. The adaptive immune system is more recently evolved, and is unique to 
vertebrates. The two arms of the vertebrate immune system work together, 
complementing each other's function. 
Some basic distinctions can be made between innate and adaptive immunity. The 
receptors of the innate immune system that recognize pathogens are fixed in the genome, 
and therefore they are present on all cells of one class. These receptors recognize 
molecular patterns that are present in many pathogens, or PAMPs (pathogen-associated 
molecular patterns). Over evolutionary time, these P A M P receptors have been selected 
for recognition of foreign molecules, so that cells of the innate immune system are 
experts at distinguishing between self and non-self PAMP receptor-bearing cells include 
macrophages, neutrophils, eosinophils, mast cells, dendritic cells (DCs), and natural killer 
(NK) cells. Triggering of these cells through PAMP receptors results in rapid anti-
microbial responses, including production of toxic micromolecules and anti-microbial 
peptides, secretion of cytokines and chemokines, and upregulation of co-stimulatory 
molecules on their surfaces. 
Cells of the adaptive immune system, which include B cells and T cells, rearrange 
segments of their genomic DNA to create sequences encoding unique receptors. Thus, 
no two naive B cells or T cells share receptor specificity, and clonal expansion must 
occur to generate an army of cells with the same receptor. Because the process of 
constructing B and T cell receptors involves the generation of almost infinite diversity, 
receptors are inevitably produced that recognize self-molecules, and cells bearing these 
receptors are deleted. Detection is not perfect, however, and some cells B and T cells 
with auto-reactive receptors escape the deletion process. 
B and T cells generally require activation by the innate immune system, and this 
interaction provides a second tier of protection against auto-reactive immune cells. 
Activation results through innate cell production of cytokines and chemokines, but also 
through the action of antigen presenting cells (APCs) that include macrophages and DCs. 
The T cell receptor (TCR) does not recognize intact proteins, but rather digested protein 
epitopes displayed as peptides in the context of major histocompatibility (MHC) 
molecules found on APCs. APCs constantly sample the extracellular milieu by 
phagocytosing and digesting particles that are then presented in M H C class II molecules. 
Intracellular proteins are also broken down and presented to T cells, but in the context of 
class I MHC molecules. T cells come in two different flavors corresponding to the two 
classes on MHC molecules. TCRs on CD4T cells recognize peptides presented in MHC 
class II molecules exclusively, whereas CD8+ T cells respond only to peptides in the 
context of MHC class I molecules. Unlike the TCR, the B cell receptor, also known as 
immunoglobulin (Ig), recognizes unprocessed antigens in blood and tissues, but B cells 
generally also require co-stimulation by T cells to become activated. However, even this 
safeguard of requiring two cells to agree that a protein is foreign is not always sufficient, 
and thus one consequence of having an adaptive immune system is the possibility of 
developing auto-immune disease. 
Once activated, B and T cells undergo clonal expansion, generating effector cells 
and long-lived memory cells. Memory, or the ability to mount a rapid and specific 
immune response to antigens previously encountered by the immune system, is one of the 
main hallmarks and benefits of adaptive immunity. The other substantial advantage of 
adaptive immunity is the ability to amplify anti-microbial responses without 
indiscriminately destroying host tissues. As the innate immune response gets more 
intense, non-specific tissue damage occurs. Because B and T cells focus their cytotoxic 
mechanisms against distinct epitopes, clonal expansion results in targeted killing. 
Activated B cells secrete Ig molecules that bind directly to foreign particles and target the 
particles for destruction by the innate immune system. Activation of CD4+ T, or helper T 
cells, results in upregulation of costimulatory molecules and secretion of cytokines. 
CD4+ T cells can mature into one of two classes of helper cells: Thl cells that secrete the 
cytokine interferon-y (IFN-y) and promote immune responses to intracellular pathogens 
(cellular immunity), or Th2 cells that secrete the cytokine interleukin-4 (IL-4) and 
promote B cell development and other immune responses to extra-cellular pathogens 
(humoral immunity). Thl cells potentiate the cytotoxic mechanisms of innate cells as 
well those of CD8+ T cells, also referred to as killer T cells or cytotoxic T cells (CTLs). 
Once activated, CD8+ T cells lyse any cell bearing an MHC-peptide combination 
recognized by the T cell's TCR. Unlike MHC class II molecules, which are only found 
on APCs, class I molecules are present on virtually every cell in the body; thus, CD8+ T 
cells are responsible for destruction of infected cells. Like CD4+ T cells, CD8+ T cells 
also produce cytokines that can feedback on the innate immune system. 
Being the primordial, and in many species the only, immune system, the innate 
immune system not only triggers the adaptive response, but also possesses its own arsenal 
of anti-microbial mechanisms. Some phagocytic cells, including neutrophils and 
macrophages, are bona fide killing machines, which bombard phagocytosed microbes 
with an array of toxic substances. NK cells act as the innate version of CD8+ T cells: 
they kill aberrant host cells, although, unlike T cells, NK cells destroy cells that lack 
MHC molecules. Yet PAMP receptor-bearing cells are only part of the story. The 
sentinel activity as well as the microbicidal activity of the innate immune system extends 
beyond white blood cells. Other cells, including skin cells and the epithelial cells lining 
the lungs and gut, play key roles in defense against invading microbes, both by acting as 
barriers and also by secreting inflammatory mediators. In addition, the liver produces a 
number of acute-phase proteins during early infection that serve to opsonize microbes 
(bind microbes and label them for destruction). Acute phase proteins are effectively 
soluble P A M P recognition molecules, and they include mannan-binding lectin (MBL), C-
reactive protein (CRP) and serum amyloid protein (SAP). Another set of proteins, the 
complement system, consists of at least 20 serum proteins that interact in a highly 
regulated enzymatic cascade and participate in both recognition and destruction of many 
pathogens. Complement components can bind bacteria directly or indirectly via Ig 
molecules bound to bacterial surface antigens. Once complement components are bound, 
a proteolytic cascade is activated, resulting in the insertion of pores in the bacterial 
membrane followed by lysis of the cell. Complement also serves to facilitate ingestion of 
microbes by phagocytes. Phagocytes express complement receptors (CR) and receptors 
(FcR) that bind the non-variable regions of Ig molecules (the Fc region). Thus, the more 
a microbe is decorated with complement and Ig molecules, the more likely that 
phagocytes will ingest it. The interplay between innate and adaptive immunity truly 
works in both directions: innate cells act to activate B and T cells, and Ig molecules and T 
cell cytokines function to improve the killing mechanisms of the innate immune system. 
Classification of microbes 
At the most basic level microbes, or microorganisms, can be categorized as either 
prokaryotes or eukaryotes. Prokaryotes are bacteria: single cells containing protein, 
DNA and RNA within one membrane. Bacteria sometimes contain a rigid cell wall 
outside the plasma membrane, but bacteria never contain membrane bound organelles. 
Bacteria can be subdivided into eubacteria and archea; however, because archea live in 
extreme environments and do not infect animals, this discussion will pertain to eubacteria 
only. All other cellular forms of life are eukaryotic, whether single-celled like protozoa, 
or multi-cellular like plants and animals. (Viruses, which will not be discussed, are 
considered by some to be forms of life, but they are not cells; rather, they invade cells 
and hijack their replicative machinery. Thus, because they cannot survive independently 
of cells, many people do not consider them true "living" things.) Eukaryotic cells contain 
membrane bound organelles that segregate cellular components: the nucleus contains 
DNA; mitochondria contain the enzymes required for producing stockpiles of ATP, the 
molecule cells use to store energy; the endoplasmic reticulum and the Golgi apparatus 
prepare and modify proteins that are targeted for secretion or export to the plasma 
membrane. Organelles allow the cell to regulate events more rapidly and with finer 
precision, as well as to perform more complex functions. Additionally, eukaryotic cells 
possess a cytoskeleton composed of microtubules and actin filaments that permit the cell 
to change its shape. 
Bacteria can be further subdivided based on their shape and on the structure of 
their outer cell layers. Spherical bacteria are referred to as "cocci", and rod-shaped 
bacteria are described as "bacilli", although some bacteria have complicated structures 
that defy either category. Additionally, most bacteria can be classified as either Gram 
positive or Gram negative depending on whether they retain or exclude Gram's Stain (the 
dye crystal violet). Gram positive cells have an inner membrane surrounded by a thick 
wall of peptidoglycan (PGN), which does not allow crystal violet to diffuse out once it 
has penetrated inside the cell. Gram negative cells have both an inner and an outer 
membrane, which are separated by the periplasmic space (Denyer and Maillard, 2002). 
The PGN layer that lies external to the inner membrane is much thinner than the PGN 
found in Gram positive bacteria, and thus Gram negative bacteria are unable to retain 
crystal violet. Another key distinction between these two classes of bacteria is that the 
external leaflet of the outer membrane of Gram negative bacteria is composed of 
lipopolysaccharides (LPS). As discussed previously, LPS is highly immunostimulatory 
and can initiate endotoxic shock. Gram positive bacteria do not make LPS; however, 
they do make lipoteichoic acid and other immunostimulatory molecules. 
Some bacteria have envelopes or capsules that make them resistant to the stains 
used to determine Gram designations. For example, the very waxy outer layer of 
mycobacterial species interferes with crystal violet staining, and thus a special dye, 
Carbol fuschin is used instead. Most bacteria will stain with Carbol fuschin; however, 
only mycobacteria retain this dye well enough to resist destaining with acidic alcohol. 
Thus, mycobacteria are often referred to as "acid-fast bacilli." 
C h a p t e r 1 
Introduction 
Microbial pathogenesis combines the fields of immunology, microbiology, and 
cell biology in order to understand the complex molecular interactions between host cells, 
microbes and microbial products (Cossart et al., 1996; Finlay and Falkow, 1997). The 
bacteria Mycobacterium tuberculosis and Salmonella typhimurium preferentially reside in 
vivo within the macrophage, a host cell that normally destroys invading microbes. 
Comparison of these two bacteria reveals that evolution has generated multiple elegant 
solutions to the problems faced by microbes living inside one of the host's most effective 
killing machines. 
I. Macrophages 
Phagocytes and phagocytosis 
Macrophages, neutrophils and DCs are the only mammalian cells that perform the 
specialized process of phagocytosis. This is in contrast to the process of endocytosis, 
which is used by most cells for the uptake of nutrients. Endocytosis is usually triggered 
by binding of receptors to their cognate ligands, and does not involve rearrangement of 
the actin cytoskeleton. Rather, small molecules including clathrin facilitate membrane 
invaginations and subsequent budding (Mousavi et al., 2004). Phagocytosis involves the 
ingestion of large particles, such as whole cells, and requires actin polymerization at the 
plasma membrane and the activity of myosin, kinases, and GTPases (Amer and Swanson, 
2002). Once a particle is enclosed inside the phagocyte, the phagosome matures through 
the endocytic pathway, a series of steps used by the cell to sequentially degrade ingested 
particles. Vesicles are recruited to the phagosome that contain degradative enzymes such 
as proteases and hydrolases as well as the proton ATPases, which acidify the phagosome. 
The order of fusion of these vesicles with the phagosome appears to be regulated by the 
Rab family of GTPases. Phagosomes start as early endosomes, evolve into late 
endosomes as vesicles fuse, and mature finally into lysosomes, in which the pH drops as 
low as 4.0 and degradation of ingested material is completed. 
The three types of phagocytes serve different purposes in the host. DCs are 
professional APCs that ingest particles and migrate to lymph nodes where they initiate 
adaptive immune responses. Neutrophils, or polymorphonuclear cells (PMNs), are short-
lived effector cells that ingest pathogens and bombard them with granules filled with 
anti-microbial peptides and toxic micromolecules. PMNs also release both cytokines and 
granular contents into the surrounding tissues, thus contributing to the inflammatory 
responses. Macrophages also ingest microbes and destroy them with toxic molecules; 
however, unlike PMNs, macrophages participate in physiologic as well as pathologic 
processes. In addition to phagocytosing invading pathogens, macrophages also scavenge 
dead and damaged host cells. If the macrophage determines that the ingested body 
represents danger, cytokines and chemokines are released to alert other immune cells. 
Receptors for recognition of pathogens 
Capture of microbes by macrophages occurs through an array of receptors 
including complement receptors and Fc receptors, as well as direct binding of microbes 
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by P A M P receptors, of which the macrophage expresses many types (Janeway and 
Medzhitov, 2002). The macrophage mannose receptor (MMR) binds bacteria and fungal 
pathogens and targets them for destruction in the lysosome. MARCO (macrophage 
receptor with collagenous structure), which is found only on macrophages, binds to 
bacterial cell walls and mediates bacterial phagocytosis. The macrophage scavenger 
receptor (MSR) binds a broad range of polyanionic ligands including double stranded 
RNA (dsRNA), which is found in some viruses, and the bacterial products 
lipopolysaccharide (LPS) and lipoteichoic acid (LTA). LPS, also known as endotoxin, 
causes endotoxic shock by over-stimulating the innate immune system, which results in a 
toxic systemic inflammatory response. In addition to binding pathogens for ingestion, 
MSR is thought to protect against endotoxic shock by scavenging free LPS. 
Macrophages possess other PAMP receptors that serve not to capture microbes, 
but rather to recognize the presence of microbes and initiate appropriate immune 
activation. Toll-like receptors (TLRs) are a family of receptors that recognize different 
microbial products, but utilize common signaling pathways to alter cytokine expression 
and macrophage functions (Janeway and Medzhitov, 2002). Signals from these receptors 
are passed to an adaptor molecule, MyD88 or one of its homologs, which then triggers a 
signaling cascade culminating in the activation of the transcription factor NF-kB. NF-kB 
mediates the expression of numerous immune and inflammatory cytokines (May and 
Ghosh, 1998). 
Currently, ten TLRs have been identified in mice and humans, although ligands 
have been established for only half of them. TLR2 recognizes the largest number of 
known ligands, in part because it forms heterodimers with either TLR1 or TLR6 to make 
11 
functional receptors with different specificities. TLR2 ligands include bacterial 
peptidoglycan and lipoproteins, LPS from some bacterial species, a surface antigen from 
the protozoan Trypanosoma cruzi, a component of yeast cell walls, as well as other 
bacterial factors. TLR4 recognizes LPS, LTA, the host heat shock protein hsp60, and the 
fusion protein of respiratory syncytial virus. The sole known ligand for TLR5 is 
flagellin, the protein subunit that makes up flagella, which are the tail-like structures 
bacteria use for swimming motility. TLR9 recognizes unmethylated CpG DNA. 
Although mammalian DNA also contains CpG sequences, they are almost always 
methylated. Thus unmethylated CpG DNA is a hallmark pathogenic microbes, many of 
which do not have methylating enzymes. 
It should be noted that TLR4 is not the only receptor for LPS. Prior to the 
discovery of TLR4, the then yet-to-be-identified LPS receptor was one of the Holy Grails 
of innate immunity. Two proteins had been identified that bound to LPS, but neither 
appeared to have any capacity to convey a signal across the plasma membrane into the 
cell. LPS, which is very hydrophobic, aggregates in micelles in the serum. LPS-binding 
protein (LPB) extracts monomers of LPS from micelles and transports them to host cells 
where monomers are transferred to the surface protein CD14. CD14, however, is not a 
membrane-spanning protein, but rather is held in the plasma membrane by a 
glycosylphosphatidylinositol (GPI) anchor, and by itself cannot transmit information to 
the inside of the cell. The discovery of TLR4 appeared to provide the answer to the 
riddle for how cells relay the LPS signal. Yet, there have been no definitive experiments 
demonstrating direct binding of LPS to any domain of TLR4. It is postulated that a 
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complex of TLR4, C D 14, and a third protein, M D 2 , together bind LPS and induce the 
signaling cascade that results in inflammatory gene expression. 
Several intracellular pathogen recognition systems exist as well. The cytosolic 
protein kinase PKR and the OAS/RNaseL pathway are activated by viral dsRNA. The 
recently identified NOD family of proteins appears to be involved in intracellular 
microbe detection as well. NOD proteins show similar domain architecture to plant 
resistance genes (R genes), which are triggered by microbial products to activate the 
hypersensitivity response, a major plant defense pathway. The range of ligands for the 
NOD proteins has yet to be identified; however, several distinct muropeptides from 
peptidoglycan, a component of both Gram positive and Gram negative bacterial cell 
walls, have been shown to bind NODI and NOD2 (Girardin etal., 2003; Royet and 
Reichhart, 2003), and both NODI and NOD2 have been shown to activate NF-kB. 
Macrophage anti-microbial mechanisms 
The macrophage is equipped with a variety of anti-microbial mechanisms for 
destruction of ingested pathogens (Shiloh and Nathan, 1999). Generation of reactive 
oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) accounts for much 
of the microbicidal activity of macrophages (Nathan and Shiloh, 2000), but other 
mechanisms also contribute to pathogen destruction (Shiloh et al., 1999). 
1. ROI and RNI 
Phagocyte oxidase (phox) is triggered to produce ROI in macrophages and PMN 
that have been activated by cytokine signaling or recognition of microbes. The subunits 
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of the inactive enzyme are located in both the cytosol and in vesicular membranes. When 
phagocytosis occurs, the vesicles fuse with the phagosome, and the cytoplasmic subuits 
are recruited to form a functional enzyme. This process can also occur at the plasma 
membrane at the site of pathogen recognition. Generation of ROI occurs within minutes 
of pathogen recognition. Activated phox transfers electrons from NADPH to molecular 
oxygen to form superoxide ("02"). Superoxide is converted spontaneously or by 
superoxide dismutase (SOD) into hydrogen peroxide, which can be converted by 
transition metal chemistry into hydroxyl radical. Hydroxyl radical is highly reactive, and 
thus does not diffuse far. Hydrogen peroxide, which is toxic, diffuses readily through 
membranes and can reach the cytosol of microbes. In PMNs, the enzyme 
myeloperoxidase (MPO) is responsible for the generation of hypochlorite (HOC1, 
commonly known as bleach) from hydrogen peroxide. Activation of macrophages by 
IFN-y enhances production of ROI by phox (Nathan et al, 1983). 
Macrophages and PMNs use inducible nitric oxide synthase (iNOS or NOS2) to 
generate RNI. Unlike phox, whose subunits are constitutively synthesized as inactive 
precursors, NOS2 is expressed only when macrophages are activated by cytokines such 
as IFN-y. In the cytosol, two NOS2 monomers combine with the cofactors FAD, FMN, 
calmodulin, and tetrahydrobiopterin to form an enzyme that uses electrons from NADPH 
to convert L-arginine into L-citrulline and nitric oxide (NO). Soluble nitric oxide 
diffuses into the phagosome where it reacts with microbial proteins as well as nucleic 
acids. Nitric oxide can also auto-oxidize into other toxic RNIs. When synthesized 
simultaneously, superoxide and nitric oxide can combine to make peroxynitrite, which 
gives rise to sodium nitrite and hydroxyl radical. Hydroxyl radical is perhaps the most 
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reactive of all the RNIs and ROIs. The toxicity of ROI and RNI results from 
modification of protein side chains, disruption of heme and Fe-S clusters, and damage to 
DNA. 
2. Nutrient limitation 
Macrophages can deprive ingested pathogens of nutrients, including divalent 
cations, amino acids, and possibly also carbohydrates. The exact mechanisms by which 
cation restriction occurs remain unclear, but studies of bacterial and protozoal mutants 
indicate that iron (Shiloh and Nathan, 1999) and magnesium (Buchmeier et al., 2000) 
both appear to be limited in the phagosome. Efforts to identify a cation transporter have 
focused on the membrane proteins Nrampl and Nramp2. Nrampl (natural-resistance 
associated macrophage protein 1) was initially identified by cloning of the allele that 
make some inbred strains of mice more susceptible to Salmonella typhimurium, 
Leishmania donovani, and Mycobacterium bovis var. BCG (Govoni et al., 1996). These 
organisms represent three widely differing groups of pathogens, but all three reside 
within the phagosome of the macrophage during infection. Mutations in a yeast Nrampl 
homolog rendered the yeast Saccharomyces cerevisiae sensitive to low manganese. 
Nramp2 controls iron uptake in the intestine, and mutation of the Nramp2 gene leads to 
iron-deficiency anemia in mice and rats. Nramp2 has also been reported to be required 
for iron transport in endosomes. Thus, although there is no direct evidence, Nrampl, 
which is expressed predominantly in phagocytes, is considered a strong candidate for 
mediating iron and/or magnesium restriction in the phagosome. It has also been 
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suggested that Nrampl exchanges metal cations for protons, thus participating in the 
acidification of the phagosome while restricting the nutrient content (Russell, 2001). 
Activated macrophages, like some other mammalian cells, can express 
indoleamine 2,3-dioxygenase (IDO), which catalyzes oxidative cleavage of the indole 
ring of the amino acid L-tryptophan. IDO is upregulated by IFN-y, and TNFa can act 
synergistically with IFN-y to enhance IDO activity in some cell types. L-tryptophan is an 
essential amino acid for many pathogens, and thus IDO's depletion of intracellular L-
tryptophan pools has crippling effects on some intracellular microbes, including 
Toxoplasma and Chlamydia species, as well as some extracellular bacteria, including 
Gram positive cocci (MacKenzie et al., 1999). Bacterial DNA also triggers induction of 
IDO, and stimulation of macrophages with a synthetic DNA analog was found to inhibit 
Mycobacterium avium growth in an IDO-dependent manner (Hayashi et al., 2001b). 
IDO-mediated depletion of L-tryptophan by APCs can also serve to restrict host cell 
activity, specifically T cell responses (Swanson et al., 2003). 
Recently, a number of pathogens that can survive in the macrophage phagosome 
have been shown to rely upon metabolism of fatty acids for survival in vivo. 
Mycobacterium tuberculosis, Cryptococcus neoformans, and Candida albicans all infect 
their hosts via inhalation, and thus one of the first cells encountered by these pathogens is 
the alveolar macrophage. Studies have demonstrated that full virulence of each microbe 
is dependent on expression of isocitrate lyase, an enzyme required to produce 
carbohydrates from fatty acids without using ATP when glucose is not available (Lorenz 
and Fink, 2001; McKinney et al, 2000; Rude et al, 2002). The importance of isocitrate 
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lyase for pathogenesis suggests that the macrophage may attempt to starve ingested 
microbes by restricting carbohydrate in the phagosome. 
3. Acidification 
The ability to acidify vesicles is not unique to phagocytes. Acidification is 
necessary for the activity of lysosomes, and lysosomes are responsible for two important 
functions in nucleated cells: the degradation of macromolecules retrieved from the 
external environment by endocytosis, and the process of autophagy, or digestion of 
organelles that have become dysfunctional or obsolete. Approximately 40 enzymes, 
referred to as acid hydrolases, mediate degradation that occurs in lysosomes, including 
lipases, phosphatases, glycosidases, nucleases, sulfatases, phospholipases and proteases. 
These acid hydrolases are optimally active at low pH, and thus acidification is essential 
for lysosomal functions. All cells that contain lysosomes also contain proton ATPases, 
which pump hydrogen ions into vacuoles targeted for fusion with lysosomes. The 
dependence of lysosomal hydrolases on acidity protects the host cell: if a lysosome were 
to rupture, the degradative enzymes would be non-functional in the neutral pH of the 
cytosol. 
In phagocytes, lysosomes serve an additional function: digestion of pathogens for 
presentation of antigens on MHC class II molecules. When the ingested pathogen is still 
alive, phagosome-lysosome fusion, accompanied by acidification of the phagosome, acts 
as a potential killing mechanism. In the absence of acid hydrolases, it is not clear 
whether acidification alone kills microbes ingested by the macrophage. Many microbes 
that infect their host by the oral route have evolved acid-tolerance mechanisms for 
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surviving the low p H of the stomach, and are thus resistant to acid. Although some 
microbes are susceptible to killing by acid in vitro, acidification in the macrophage 
usually occurs simultaneously with phagosome-lysosome fusion. It is therefore difficult 
to determine if dependence on acid for cytotoxicity in vivo is due to acidity itself or due 
to activation of acid hydrolases. Moreover, acidic conditions render RNI toxic. Nitric 
oxide oxidizes to form nitrite, and, at acidic pH, nitrite is protonated to form nitrous acid 
(Stuehr and Nathan, 1989). Thus, the precise contributions of acidification to killing of 
pathogens by macrophages are difficult to dissect. At the least, acidification contributes 
to macrophage anti-microbial activity by activating other cytotoxic mechanisms. 
Another complication to understanding how acidification participates in host 
defense arises from studies that use bafilomycin Al to inhibit the V-ATPase. Inhibition 
of acidification by treatment of macrophages with bafilomycin Al prevents killing of 
some pathogens (Philippe et al, 2003; Schneider et al., 2000). However, bafilomycin 
has been shown to affect macrophage functions in addition to inhibiting the V-ATPase, 
including maturation of the endocytic pathway (Xu et al., 2003) and the production of 
ROI by phox (Bidani et al, 2000). Thus, the results of experiments that use bafilomycin 
to inhibit macrophage killing are difficult to interpret, and may not actually reflect a role 
for acidification in the specific pathogen-host interactions examined. 
4. Phospholipases 
Phospholipases cleave and release fatty acids from membrane phospholipids. 
Phospholipase A2 (PLA2) contributes to inflammation by releasing arachadonic acid, 
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which can be modified by lipoxygenase to produce leukotrienes or by cyclooxygenase to 
generate prostaglandins, prostacyclins, and thromboxanes. These bioactive lipids have 
both pro- and anti-inflammatory effects (Yoshikai, 2001). PLA2 also appears to 
participate directly in the anti-microbial immune response. Arachidonate and other free 
fatty acids (FFA) have bactericidal activity against various pathogens (Giamarellos-
Bourboulis et al, 2003; Saito and Tomioka, 1988). PLA2 can also directly kill bacteria 
by hydrolysis of bacterial cell membranes (Beers et al, 2002; Buckland and Wilton, 
2000; Gronroos et al, 2001; O'Callaghan et al, 2003). 
Multiple types of PLA2 are found in macrophages, including both secretory forms, 
which might be targeted to the phagosome, as well as cytosolic forms (Dennis, 1994). 
Additional evidence that PLA2 activity may be important for macrophage killing of 
intracellular pathogens comes from a recent report that compared expression profiles of 
bacteria undergoing different stresses. Bacteria experiencing membrane damage due to 
incubation in the detergent SDS exhibit transcriptional responses that are similar to those 
of bacteria ingested by macrophages (Schnappinger et al, 2003). These data suggest that 
bacteria in the macrophage phagosome confront membrane injury, possibly as result of 
phospholipase activity. 
5. Apoptosis 
Apoptosis is a highly regulated, physiologic process by which mammalian cells 
that have been damaged beyond repair or that have become unnecessary can involute and 
die without generating inflammation (Hetts, 1998). Apoptosis can occur as a result of 
endogenous signals, such as mitochondrial damage, or as a result of signaling through 
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surface receptors that contain intracellular death domains (Bhardwaj and Aggarwal, 
2003). The best described of these receptors are Fas and the TNF receptor, both of which 
have the capacity to trigger apoptosis, although they can relay signals for other responses 
as well. Apoptosis of infected cells can be either a physiologic or a pathologic response 
to infection. Some intracellular microbes promote apoptosis and thereby exit host cells 
without triggering an inflammatory response (Navarre and Zychlinsky, 2000). This kind 
of pathologic induction of apoptosis will be discussed later. Contributions of apoptosis to 
the immune system's ability to control and destroy intracellular pathogens will be 
highlighted here. 
When an infected cell dies as a result of microbial proliferation and membrane 
lysis, pathogens are released to infect more cells, and an inflammatory response is 
provoked. However, when infected cells undergo apoptosis, intracellular microbes are 
sequestered in apoptotic bodies, preventing the spread of infection. These apoptotic 
bodies are cleared by phagocytic cells with little effect on the surrounding tissues (Fadok 
and Chimini, 2001). Despite these theoretical benefits, macrophage apoptosis is not 
frequently found as contributing factor in control of intracellular infection. In a mouse 
model of resolving pulmonary infection, one of only a few in vivo examples, apoptosis of 
alveolar macrophages is required for clearance of low dose Streptococcus pneumoniae 
without features of pneumonia (Dockrell et al, 2003). A number of pathogens have been 
shown to block the apoptotic pathways of macrophages in vitro, suggesting that 
macrophages attempt to control infection by inducing programmed cell death. T. gondii 
has been shown to interfere with apoptotic pathways (Denkers, 2003), and attenuated 
strains of Mycobacteria induce macrophage apoptosis, whereas virulent strains inhibit 
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apoptosis (Fratazzi et al, 1999). Apoptosis resulting from Mycobacteria infection 
appears to depend on macrophage production of TNFa and subsequent signaling through 
macropahge TNF receptors (Rojas et al, 1997). 
Although virulent M. tuberculosis blocks macrophage induction of apoptosis, 
both mouse and human antigen specific CD4+ T cells can kill M. tuberculosis-infected 
macrophages by signaling through Fas ligand (FasL) (Lewinsohn et al, 1998; Silva and 
Lowrie, 2000). Fas-mediated apoptosis results in decreased viability of intracellular M. 
tuberculosis within the dying macrophage (Oddo et al, 1998). Fas-mediated apoptosis of 
macrophages also contributes to control of cutaneous Leishmania infections: mice 
deficient in either Fas or FasL are unable to heal skin lesions caused by Leishmania 
major (Conceicao-Silva et al, 1998), and this appears to be due to persistence of infected 
macrophages in these mice. 
II. Macrophages and Intracellular Pathogens 
Despite the macrophage's efforts to convert the phagosomal milieu into a hostile 
environment, many pathogens colonize the macrophage and replicate within this cell. 
These pathogens represent a large phylogenetic range of single-celled organisms that 
include Gram positive and Gram negative bacteria, as well as protozoa and single-celled 
fungi. Although the species of pathogens that invade macrophages are diverse, the tactics 
for survival inside the cell fall within a limited set of known templates (Russell, 2000). 
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Strategies for avoiding degradation in the lysosome: localization within the cell 
Macrophage phagosome maturation is a highly regulated process, and each step 
along the way represents a potential target for microbial disruption. Several families of 
GTPases are involved in the trafficking of vesicles within the endocytic pathway. The 
Rabs are small GTPases belonging to the Ras superfamily (Fratti et al, 2001). (The Ras 
superfamily derives its name from the founding member, viral ras, an oncogene that was 
originally identified for its role in triggering a rat sarcoma). Each Rab is associated with 
trafficking of a specific compartment within the cell: Rab5 associates with maturing early 
endosomes, Rab 7 associates with maturing late endosomes, Rabs 4 and 11 mediate 
recycling of vesicles from early endosomes to the plasma membrane, and Rab 9 is 
associated with trafficking of vesicles from the trans Golgi network (TGN) to late 
endosomes. The ability of microbes to block phagosome-lysosome fusion has been 
correlated with retention and exclusion of specific Rab molecules, although the exact 
mechanisms by which this occurs are generally not well understood. 
Rab GTPases function in both activated and unactivated macrophages. In IFN-y 
activated macrophages, two other families of GTPases appear to participate in regulation 
of vesicular trafficking: a 47-kilodalton family and a 65-kilodalton family (Boehm et al, 
1998). Studies have shown that the 47-kilodalton family GTPases, which includes IGTP, 
LRG-47 and IRG-47, are important for control of phagosomal pathogens (Collazo et al, 
2001; MacMicking et al, 2003; Taylor et al, 2000), although the mechanism of 
regulation is not clear. Is has yet to be demonstrated whether pathogens dysregulate 
phagosome maturation by inhibiting either the 47-kilodalton family or the 65-kilodalton 
family of GTPases. 
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There are four basic strategies for avoiding degradation in the macrophage 
lysosome as a result of phagosome maturation: creation of a novel vacuole outside the 
endocytic network, inhibition of phagosome-lysosome fusion, expression of genes that 
allow survival within the fully mature phago-lysosome, and escape from the phagosome 
into the cytosol (Table I). 
1. A unique vacuole 
Microbes need first to get into the macrophage. A number of pathogens sneak in 
the back door, so to speak, by mediating their own uptake and thus avoiding recognition 
resulting from binding to macrophage phagocytic receptors. Members of the protist class 
Apicomplexa have evolved a set of organelles (micronemes, rhoptries, and dense 
granules) specially designed for initiating vacuolization in the macrophage (Hoff and 
Carruthers, 2002). Through the action of motors and secreted proteins and lipids, 
apicomplexan organisms force their way into host cells by causing invaginations of the 
host cell membrane. The resultant compartment, referred to as the parasitophorous 
vacuole, interacts with the host cell cytoskeleton, but does not fuse with endosomes or 
lysosomes. Toxoplasma gondii uses this mechanism to invade a variety host cell, 
including macrophages. In macrophages, residence in the parasitophorous vacuole 
enables T. gondii to manipulate the host immune response by interfering with 
macrophage cytokine expression while remaining protected from many of the 
macrophage's anti-microbial mechanisms (Denkers etal, 2003). 
Most pathogens enter macrophages through the front door: they are ingested by 
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microbe, but it places the microbe within the endocytic pathway and alerts the 
macrophage to the presence of danger. The Gram negative bacterium Legionella 
pneumophila has evolved mechanisms that delay fusion with lysosomes long enough to 
convert the phagosome into a compartment that no longer resemble any component of the 
endocytic network (Roy and Tilney, 2002). Not exactly a novel vacuole, the 
compartment created by L. pneumophila appears to be an extension of the endoplasmic 
reticulum (ER). L. pneumophila uses the Dot/Icm apparatus, a type IV secretion system, 
to inject effectors into the host cytosol, some of which act to recruit ER-derived vesicles 
to the phagosome, while others prevent normal endocytic maturation. Another Gram 
negative bacterium, Brucella abortus, also uses a type IV secretion system (the VirB 
system) to mediate recruitment of ER vesicles to the phagosome after ingestion by 
macrophage (Celli et al, 2003). 
2. Developmental arrest of the phagosome 
Unlike B. abortus and L. pneumophila, which convert the early phagosome into a 
vacuole with no similarity to endocytic vesicles, Salmonella typhimurium and 
Mycobacterium tuberculosis arrest the maturation of the phagosome such that the 
modified vacuoles containing S. typhimurium and M. tuberculosis resemble stages of 
normal endosome development. M. tuberculosis arrests the phagosome almost 
immediately after ingestion, whereas S. typhimurium allows some maturation processes 
to occur but not others. Because several features of the S. typhimurium vacuole are 
reflective of early endosomes, while others are representative of lysosomes, there is some 
disagreement about whether or not phagosome-lysosome fusion occurs (Buchmeier and 
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Heffron, 1991; Oh et al., 1996). S. typhimurium, a Gram negative bacterium like B. 
abortus and L. pneumophila, shares the strategy of injecting factors into the host cytosol 
to manipulate the fate of the phagosome; however, in the case of S. typhimurium, a type 
III secretion system is used to deliver the effector molecules. Discussion of disruption of 
trafficking in the macrophage by S. typhimurium and M. tuberculosis will be continued 
later in this document. 
3. Survival despite full phagolysosome maturation 
Most pathogens that replicate within the phagosome of the macrophage modify 
the vacuole to some extent. The distinction between microbes that survive by arresting 
endocytic development and microbes that survive within a fully mature phagolysosome is 
determined by the presence or absence of acid hydolases in the replicative niche. A few 
pathogens have evolved to resist killing in the fully mature, hydrolase-containing 
lysosome. The protozoa of the Leishmania genus and the Gram negative bacterium 
Coxiella burnetii both localize to and replicate within lysosomes that are fully acidified to 
a pH between 4.5 and 5.0. Leishmania vacuoles contain active cathepsins B, L, and D, 
and stain positively for the lysosomal membrane components LAMP-1 and LAMP-2 but 
not for the transferrin receptor, which associates only with early endosomes (Courret et 
al., 2002). Leishmania resists damage from acid hydrolases by covering its surface with 
GIPLs, short lipidoglycans that are relatively impervious to attack. Additionally, 
endocytosis and exocytosis occur only at a small area of protected membrane called the 
flagellar pocket, thus protecting endocytic receptors from degradation by hydrolases. 
The mechanisms by which C. burnetii copes with acid hydrolases remain unknown (Baca 
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et al., 1994). Another mystery is how these two pathogens prevent destruction of their 
host cell by antigen-specific T cells, since antigen presentation machinery is functionally 
active within the pathogen-containing lysosomes. One possibility is that the pathogen 
actively degrades MHC molecules (Courret et al, 2001). A second theory postulates that 
processing and presentation of microbial antigens occurs, but the resulting peptide-MHC 
complexes trigger an inappropriate Th2-type immune response that is unable to eradicate 
intracellular infection (Maekawa et al, 1998). 
4. Escape from the phagosome 
Another strategy for avoiding the anti-microbial mechanisms associated with the 
endocytic network is to escape from the phagosome into the cytosol. Among the 
microbes that can lyse the phagosomal membrane after ingestion are the Gram positive 
bacterium Listeria monocytogenes (Cossart and Lecuit, 1998), and the Gram negative 
bacterium Shigella flexneri (Zychlinsky et al, 1994). Macrophages are not the primary 
targets of these pathogens. Both bacteria invade epithelial cells, and in the process create 
vacuoles in these non-phagocytic cells that the bacteria lyse in order to access the cytosol. 
The factors used by S. flexneri to lyse the phagosome have yet to be identified, although a 
lowered pH is required for activation of the required mechanism. L. monocytogenes' 
escape is mediated by listeriolysion O (LLO), a thiol-activated cytolysin similar to 
exotoxins found in other Gram positive bacteria. Although the process of bacterial 
uptake is different with macrophages than with epithelial cells, phagosome lysis has been 
observed for L. monocytogenes and S. flexneri after ingestion by macrophages. 
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Escape to the cytosol prevents degradation by lysosomal acid hydrolases, but the 
cytosol is not a wholly safe environment either, and not all microbes can survive in this 
niche. Brucella engineered to express LLO are unable to replicate within macrophages 
(Kohler et al, 2001), suggesting that cytosolic factors are toxic to Brucella. Recruitment 
of E.R. membrane by B. abortus may be important not only to deviate the phagosome 
from the endocytic network, but also to expand the size of the vacuole as replication 
proceeds and thus prevent phagosome rupture. A study in which intracellular pathogens 
were microinjected directly into the host cell cytoplasm found that only cyptoplasmic 
pathogens could survive in this niche, while microbes that normally reside within the 
vacuole were killed (Goetz et al, 2001). As will be discussed later, S. typhimurium also 
recruits membrane to its vacuole inside the macrophage, and mutants that are not 
maintained in the phagosome are killed by yet-to-be defined factors in the cytosol 
(Holden, 2002). 
Strategies for coping with host production of RNI and ROI 
Regardless of where pathogens localize inside the macrophage, host production of 
toxic micromolecules is a danger that must be confronted by all intracellular pathogens. 
Virulence factors described as anti-oxidant or anti-RNI defenses encompass a range of 
different activities that interfere with ROFs and RNFs ability to cause damage. Some 
pathogens attempt to avoid toxic micromolecules by inhibiting phox or NOS2, thus 
preventing production of ROI and RNI. Examples of this strategy include secretion by 
Bordetella pertussis of an adenylyl cyclase that elevates macrophage cytosolic cAMP and 
stalls the activity of phox (Confer and Eaton, 1982), the tyrosine phosphatase YopH 
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from Yersinia enterocolitica that inhibits the respiratory burst (Green et al, 1995), and an 
unknown mechanism of the yeast Candida albicans that inhibits NOS2 enzyme activity 
in macrophages (Schroppel et al., 2001). A variant of this strategy is the diversion of 
phox or NOS2 away from the pathogen-containing phagosome. S. typhimurium injects 
unknown factors into its host macrophage that cause redistribution of phox from the 
phagosome to the plasma membrane (Gallois et al, 2001). A similar effect on NOS2 
localization has been reported during S. typhimurium infection of macrophages as well 
(Chakravortty et al, 2002). 
For microbes that cannot turn off the enzymatic sources of RNI and ROI, the next 
best defense is catabolism these molecules before they cause damage. Aerobic microbes 
express enzymes, which may include superoxide dismutases (SODs), catalases, 
peroxiredoxins, and glutathione reductases, for detoxification of endogenously generated 
superoxide and peroxides (Dukan and Nystrom, 1999; McCord et al, 1971). These 
enzymes also protect against host-generated ROI (Faguy and Doolittle, 2000). Systems 
specifically expressed to detoxify exogenous ROI and RNI, but not endogenous ROI, are 
also common in the world of intracellular pathogens. In Gram negative bacteria, 
periplasmic SODs act as the first line of defense against exogenous ROI and play little to 
no role in detoxification of endogenous superoxide (Korshunov and Imlay, 2002). S. 
typhimurium mutants deficient in periplasmic SOD also demonstrate increased 
susceptibility to RNI in vivo (De Groote et al, 1997), suggesting that SOD detoxification 
of superoxide prevents formation of peroxynitrite, thus greatly diminishing the effects of 
RNI as well as ROI. Several other defenses against ROI also double as protection against 
RNI. The peroxiredoxin alkyl hydroperoxide reductase, AhpC, which catalyzes the 
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reduction of organic hydroperoxides, can act in many organisms for defense against RNI 
as well as ROI (Shiloh and Nathan, 1999). AhpC's role in detoxification of RNI appears 
to be due to AhpC's ability to catalytically detoxify peroxynitrite (Bryk et al, 2000). A 
role for homocysteine has been demonstrated in defense specifically against RNI, both as 
a sink to absorb RNI, and as a regulator of the hmp gene, which encodes 
flavohaemoglobin (Poole and Hughes, 2000). Flavohaemoglobin can convert nitric oxide 
to less toxic nitrogen species, and E. coli hmp mutants are hyper-susceptible to RNI. 
Enzymes to repair oxidative and nitrosative damage are another important 
component of microbial defense against ROI and RNI. Some enzymes mend damaged 
DNA resulting from a range of molecular insults that include ROI and RNI. The recBC 
system repairs damage inflicted by RNI and ROI (Buchmeier et al, 1995; Shiloh et al, 
1999), and the Uvr system is an important component of Mycobacterium tuberculosis's 
defense against RNI (Darwin et al, 2003). ROI and RNI (through the formation of 
peroxynitrite) can both cause oxidation of proteins, and the enzyme methionine sulfoxide 
reductase (Msr) has been shown to be important for defense against both stresses in vitro 
(St John etal, 2001). 
When all else fails, a final mechanism to defend against macrophage cytotoxicity 
is invoked by certain pathogens that cause chronic disease: reversion to a semi-dormant 
state until immune pressure subsides. Most infections with M. tuberculosis, T. gondii, S. 
typhi, and L. donovani include a prolonged and indefinite period of latency, during which 
the quiescent pathogens are harbored within host macrophages (Coppin et al, 2003; 
Munoz-Elias and McKinney, 2002). Because many macrophage anti-microbial 
mechanisms are induced or up-regulated by EFN-y, a lapse in cellular immunity, such as 
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CD4+ T cell depletion due to infection with HIV, results in decreased immune pressures 
on the intracellular pathogens. These organisms are then able to awake from dormancy 
and recommence intracellular replication. 
III. Mycobacterium tuberculosis 
Tuberculosis, which is caused by infection with the bacterium Mycobacterium 
tuberculosis, is one of the oldest recognized ailments in human society. Remains of 
mummies from Europe, South America, and Asia, dating as far back as 3000 B.C.E, 
contain traces of DNA from Mycobacterium tuberculosis (Fusegawa et al, 2003; Nerlich 
et al, 1997; Salo et al, 1994). The first written accounts of tuberculosis can been traced 
to the Greek physician Hippocrates, who wrote in 460 B.C.E. about fatalities due to the 
widespread disease "phthisis" (Hippocrates, 400 BCE). The cause of the ubiquitous 
disease would not be revealed until centuries later. In the mid 1800's, Louis Pasteur 
popularized the germ theory of diseases: the concept that microorganisms could be the 
source of illness and pathology. Soon thereafter, Robert Koch identified Mycobacterium 
tuberculosis as the causative agent of tuberculosis. In addition, Koch further advanced 
the nascent field of microbiology by introducing criteria by which scientists could deduce 
whether a specific microorganism produces a specific disease. These criteria became 
known as Koch's postulates, and they are still in use today. To conclude that a certain 
microbe causes a disease, Koch's postulates state that 1) the microbe must be found in 
diseased tissues, but not in healthy ones, 2) the microbe must be able to be isolated from 
the diseased tissue and grown as a pure culture, 3) reintroduced of the isolated microbe 
into a healthy person or animal should induce the originally observed pathology, and 4) 
31 
the microbe must be able to be re-isolated following testing of postulate number 3. In the 
late 1800s, Koch demonstrated that all of these criteria were true for the disease 
tuberculosis and the bacterium we now know as Mycobacterium tuberculosis. 
M. tuberculosis (Mtb) is sometimes categorized as a Gram positive bacterium, but 
Mtb truly cannot be described accurately by the Gram stain designation due to its unusual 
external envelope. Like Gram positive bacteria, Mtb has a single plasma membrane 
surrounded by a layer of PGN. However, external to the PGN, Mtb possesses a thick cell 
wall composed almost entirely of lipids and glycolipids. The main component of the cell 
wall is mycolic acid, a long chain branched |3-hydoxyl fatty acid, which can be found 
either covalently or non-covalently attached to the PGN. Interspersed among the mycolic 
acid molecules are numerous complex lipid and glycolipids that remain associated to the 
cell wall through hydrophobic interactions. The lipid-rich cell wall inteferes with 
absorption of crystal violet, and thus a different chemical test is performed to identify 
Mtb and other mycobacterial species in the laboratory. Retention of Carbol fuschin dye 
in the presence of acidic alcohol is a unique characteristic of the lipid envelope, and thus 
the presence of "acid-fast bacilli" in microscopic preparations is diagnostic for 
mycobacteria. 
Tuberculosis: the disease 
There is no reservoir of Mtb outside of the human population, and thus Mtb is 
distinctly evolved to survive and replicate in the human body. Transmission of disease 
occurs exclusively by aerosol droplets produced when the host coughs. Adaptation of 
Mtb inside the human lung and transmission of Mtb are hugely effective, as evidenced by 
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recent estimates indicating that approximately 2 billion people, or one third of the world's 
population, are infected with Mtb (Dye et al, 1999). Of these 2 billion individuals, 20 
million manifest active disease, and approximately 2 million people die from the disease 
annually. Infection with Mtb results in more deaths every year than any other bacterial 
pathogen, rivaled in lethality only by the rapidly spreading epidemic of HIV. Moreover, 
HIV and Mtb infection exacerbate one another, and tuberculosis is the number one cause 
of death in HIV-positive individuals (Corbett et al, 2003). The recent re-emergence of 
Mtb as a global threat has been attributed to the spread of HIV, continued increases in 
population growth and population density, and the development of multi-drug resistant 
(MDR) strains of Mtb (Corbett et al, 2003; De Cock and Chaisson, 1999; Dye et al, 
1999; Snider and Castro, 1998). 
Mtb's ability to exist latently causing subclinical disease in the human lung 
contributes to the continued prevalence of tuberculosis in the human population. The 
vast majority of people infected with Mtb manages to contain infection and control 
bacterial replication; however, Mtb is not sterilized in the lungs of these individuals. 
Rather, Mtb remains in a dormant state in which it survives despite a vigorous immune 
response. Latently infected individuals have no symptoms of clinical disease, and a 
positive tuberculin skin test (also known as the PPD test, referring to the purified protein 
derivative that is injected) is the only indication these individuals have encountered Mtb. 
Years later, infected individuals can experience reactivation of latent Mtb (Lillebaek et 
al, 2002; Tufariello et al, 2003). Approximately half of all active cases of tuberculosis 
are thought to result from endogenous reactivation of latent Mtb infection (Styblo, 1991). 
Reactivation appears to be the result of immunosuppression, although the cause of 
33 
decreased immunity is not always clear, and the underlying reasons for reactivation in 
some individuals remain a mystery. HIV infection has become the number one risk 
factor for reactivation of tuberculosis, increasing the risk of reactivation from 10%-20% 
per lifetime to 10% per year (Corbett et al, 2003). 
The natural history of disease 
When bacteria are inhaled, they are rapidly ingested by alveolar macrophages, as 
well as resident lung DCs (van Crevel et al, 2002). Many of these bacteria evade being 
killed and begin to replicate, eventually lysing the macrophage. Macrophage 
chemokines, as well as the presence of lysed host cells, attract inflammatory cells to the 
site of infection. As monocytes extravasate into the lung tissue, they mature into 
macrophages that ingest extracellular Mtb. As macrophages accumulate, Mtb continues 
to replicate, but tissue damage does not occur during this stage of infection. Two to three 
weeks after initial infection, T cell clones primed by infected lung DCs migrate to the 
lung where they proliferate and activate macrophages to kill intracellular Mtb. The 
arrival of T cells correlates with growth arrest of Mtb. The accumulation of cells at the 
site of infection is called a granuloma, and this structure is usually sufficient to contain 
infection. An equilibrium is achieved between the pathogen and the immune system, and 
Mtb remains in a latent state, so long as immune pressure does not taper off. 
For unknown reasons, some people do not control initial infection and develop 
local disease, or primary tuberculosis. As bacterial replication persists, the inflammatory 
response amplifies, and clinical symptoms of disease begin to manifest: fever, weight 
loss, cachexia, and cough. If bacterial replication continues to exacerbate the immune 
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system, cavitation can occur, in which the center of the granuloma undergoes liquefactive 
necrosis due to the toxicity of an over-exuberant immune response. Cavitary tuberculosis 
is especially infectious because the liquefied cavities becomes linked to airway passages, 
and patients shed very high numbers of bacteria in their sputa (Munoz-Elias and 
McKinney, 2002). In some extreme cases, dissemination of Mtb from the lungs to other 
organs occurs, resulting in systemic, or miliary, tuberculosis. Interestingly, although 
initial infection is always in the lung, and the lung is the most common site of 
reactivation, reactivation can occur in almost any organ ranging from nervous tissue to 
bones (Glickman and Jacobs, 2001). This suggests that initial infection includes a 
hematogenous dissemination to multiple tissues that is quickly controlled by the immune 
system, although not eradicated. 
Treatment and prevention of tuberculosis 
In addition to reactivation of latent disease, another factor that has led to Mtbs 
continued persistence within the human population is a lack of efficient medical 
interventions. Like most diseases caused by microbes, the strategy to eradicate 
tuberculosis consists of a two-pronged approach: chemotherapeutic agents for the 
treatment of infected individuals, and vaccination of uninfected individuals. 
Unfortunately, in the case of M. tuberculosis, neither approach has yielded an adequate 
solution. 
The same antimicrobials that sterilize an in vitro culture of Mtb in a matter of 
days require months for effective treatment of a patient. Anti-mycobacterial drugs must 
be taken in combination for at least six months to provide a lasting cure (McKinney, 
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2000; Munoz-Elias and McKinney, 2002). Even individuals with latent infection must 
adhere to a six-month treatment regimen to reduce the risk of reactivation later in life. 
Penetration of the drugs into the tissues does not account for the discrepancy between in 
vitro and in vivo killing (Barclay et al, 1953). Moreover, killing of bacteria by anti-
tubercular drugs is not accelerated if either the dose (McCune et al, 1957) or the number 
of drugs administered (Jindani et al., 1980) is increased. An altered metabolic state of the 
bacteria in vivo appears to be the source of Mtb's ability to persist despite high levels of 
multiple chemotherapeutic agents. Mitchison proposed that relative in vivo drug 
resistance results from the fact that latent Mtb are either slowly-dividing or non-
replicating (Mitchison, 1980). 
Because chemotherapy is so cumbersome, patient non-compliance is an over-
whelming problem, frequently resulting in patient relapse and/or the emergence of multi-
drug resistant strains of M. tuberculosis. Multi-drug resistant tuberculosis can be 
unresponsive to all available agents, thus leaving surgical removal of the tuberculous 
lesion as a final treatment option. Although a number of drugs have been added to the 
anti-mycobacterial arsenal over the years since the initial use of Streptomycin, no agent 
has been identified that substantially reduces the duration of medication necessary for 
effective treatment. 
The development of a successful Mtb vaccine has been similarly challenging. 
There is currently only one vaccine in use, the bacillus Calmette Guerin (BCG), a live-
attenuated strain of Mycobacterium bovis. Vaccination with BCG has yielded both 
highly variable and generally poor efficacy in prevention of pulmonary tuberculosis in 
adults, despite eliciting potent antigen-specific immune responses in the majority of 
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vaccinated individuals (Brewer, 2000). B C G does, however, appear to protect against the 
morbidity and mortality of Mtb meningitis and other disseminated forms of tuberculosis 
in infants, and thus it is consistently distributed to newborns throughout much of the 
world (Huebner, 1996). 
Most of the current efforts to create new vaccines are focused on either 
augmentation of BCG with Mtb antigens, or else the development of live attenuated Mtb 
strains. It is possible, though, that a better vaccine for pulmonary tuberculosis may be 
elusive because acquired immunity to Mtb may be only partially effective at best. The 
fact that individuals who initially control infection can experience reactivation of disease 
years later demonstrates that immunity to live, virulent Mtb is not sterilizing (Lillebaek et 
al, 2002; Tufariello et al, 2003). In addition to the phenomenon of reactivation of latent 
Mtb, exogenous re-infection of asymptomatic individuals also appears to be common in 
TB-endemic areas, despite the presence of potent antigen-specific immune responses 
established by the previous infection (Caminero et al, 2001; du Plessis et al, 2001; van 
Rleetal, 1999). 
Pathogen-Host interactions 
1. Interactions with the macrophage 
Macrophages are the cells with which Mtb has the most interactions, and thus Mtb 
has evolved complex mechanisms for remodeling the macrophage into a niche where it 
can replicate in relative protection from the host. Even the first interactions between the 
mycobacterium and the macrophage are carefully orchestrated. Studies have shown that 
Mtb is promiscuous in its use of phagocytic receptors, thus ensuring its uptake by 
37 
macrophages. Mtb also promotes its survival by entering macrophages by routes that 
trigger minimal anti-microbial responses. Uptake of non-opsonized Mtb by complement 
receptors and macrophage mannose receptors (Aderem and Underhill, 1999) does not 
trigger phagocyte oxidase (phox) production of ROI (Astarie-Dequeker et al, 1999; 
Wright and Silverstein, 1983). In the absence of these receptors, the macrophage 
scavenger receptor will also bind Mtb. Binding of lung surfactant protein (SpA) to Mtb 
has been shown to facilitate uptake by macrophages while at the same time suppressing 
macrophage production of RNI (Pasula et al, 1999). Although the significance is not yet 
understood, phagocytosis of Mtb involves the recruitment of cholesterol to the 
phagosome, a phenomenon not usually associated with ingestion of pathogens (Gatfield 
and Pieters, 2000). 
Once ingested, Mtb manipulates the macrophage to alter normal phagosome 
maturation (Deretic and Fratti, 1999; Russell, 2001). It is not clear exactly how Mtb 
disrupts trafficking, but it has been demonstrated that the Mtb phagosome in unactivated 
macrophages fails to advance beyond being the early endosomal stage, with retention of 
Rab5 and exclusion of Rab7 and lysosomal markers such as LAMP-1 and LAMP-2. This 
block in maturation may be due to the inability of Rab5 to bind EEA1 (early endosomal 
antigen 1), which appears to be inhibited after macrophage ingestion of Mtb or latex bead 
coated with Mtb envelope lipids, such as mannose-capped lipoarabinomannin (Man-
LAM) (Fratti et al, 2001). Moreover, like early endosomes, the Mtb phagosome 
maintains communication with the plasma membrane (Sturgill-Koszycki et al, 1994). 
The proton ATPase is not recruited from the phagosome, and thus the pH remains 
relatively neutral. These events are dependent on live Mtb; after phagocytosis of dead 
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bacteria, the phagosome acidifies to a pH of 5.0, whereas phagosomes containing live 
Mtb acidify to a pH of approximately 6.5 (Sturgill-Koszycki et al, 1994). TACO, a 
protein that normally transiently associates with endosomes in the process of maturation 
into lysosomes, is retained on the Mtb phagosome (Ferrari et al, 1999b). The precise 
function of TACO in intracellular trafficking is not currently understood; it is not yet 
clear whether TACO acts to blocks phagolysosome fusion, or whether TACO is simply a 
marker indicating that phagosomal maturation has been arrested. 
In addition to disrupting the endocytic machinery of the macrophage, Mtb also 
interferes with macrophage functions that promote activation of other immune cells. By 
avoiding the lysosome, Mtb prevents not only its own destruction, but also processing of 
Mtb antigens for MHC class II presentation to CD4+ T cells (Pancholi et al, 1993). In 
addition, Mtb has been shown to block antigen presentation by down-regulating 
macrophage expression of both MHC class II and CD1 (Stenger et al, 1998). CD1 is a 
molecule similar to MHC molecules that presents lipid antigen to T cells, as opposed to 
protein antigens. The expression of the costimulatory molecule B7 is also decreased in 
Mtb infected cells (Samandari et al, 2000). 
During infections with most pathogens, macrophages and T cells communicate 
via an elaborate cytokine crosstalk: infected macrophages secrete IL-12, which activates 
naive T cells to become Thl cells and produce IFN-y, which in turn feeds back and 
activates macrophages. Mtb dampens the immune response by interfering with these 
normal cytokine networks. Infection with Mtb inhibits IL-12 expression in macrophages 
(Nau et al, 2002), thus decreasing generation of Thl cells (Hickman et al, 2002). 
Decreased IL-12 may be due to Mtb-induced macrophage production of IL-10 (Redpath 
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et al, 2001), which not only hinders IL-12 expression, but also blocks IFN-y's ability to 
activate macrophages (Murray et al, 1997). T cell activation and proliferation are 
suppressed by IL-6 produced by Mtb-infected macrophages (VanHeyningen et al, 1997). 
Even if T cells manage to become completely functional, T cell cytokines are not fully 
effective because Mtb hinders the macrophage's ability to respond to IFN-y (Kincaid and 
Ernst, 2003). Production of IL-6 contributes to this partial block in responsiveness to 
IFN-y, which occurs in both infected and uninfected macrophages (Nagabhushanam et 
al, 2003). 
As described earlier, there is evidence that macrophages commit suicide in order 
to kill intracellular pathogens. Because the macrophage acts as a safe haven for Mtb, 
apoptosis would be detrimental to the bacterium, and Mtb has evolved mechanisms to 
evade this host defense. Ingestion of mycobacteria can result in macrophage apoptosis; 
however, the fate of the macrophage is dependent on the virulence of the infecting strain. 
Avirulent strains, such as the lab strain M. tuberculosis H37Ra, the attenuated vaccine 
strain M. Bovis BCG, and the non-virulent mycobacterial species M. kansasii, cause more 
apoptosis than virulent strains, including the lab strains M. tuberculosis H37Rv and M. 
tuberculosis Erdman, and various clinical isolates (Keane et al, 2000). Several 
mechanisms for blocking apoptosis during infection with virulent strains have been 
described. Virulent M. tuberculosis H37Rv, but not avirulent H37Ra, induces the anti-
apoptotic Bcl-2 family member Mcl-1 after infection of macrophages (Sly et al, 2003). 
Other reports indicate that Mtb-induced IL-10 stimulates secretion of a soluble receptor 
for the pro-inflammatory and pro-apoptotic cytokine TNFa, thus preventing TNFa from 
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binding receptors on the macrophage and triggering apoptosis (Balcewicz-Sablinska et 
al, 1998; Rojas etal, 1999). 
2. The immune response to M. tuberculosis 
Perhaps because of Mtb's ability to derail so many aspects of cellular immunity, a 
stalemate is reached between the bacterium and the host immune system in most 
individuals, resulting in latent infection. Granulomas form around the invading 
mycobacteria, and replication of bacteria ceases. These granulomas are composed of a 
central core of necrotic tissue (dead macrophages) containing extracellular bacilli, 
surrounded by a mantle of macrophages harboring intracellular bacteria and a sheath of 
CD4+ and CD8+ T cells. The granuloma also includes B cells, DCs, endothelial cells, 
fibroblasts, and probably stromal cells (Gonzalez-Juarrero et al, 2001). 
The most powerful insights into which components of the immune response are 
key for maintaining granulomas have come from studies with mice made deficient in 
specific immune effectors, and from identification of human genetic or pathologic 
immune suppressive conditions. During acute infection, cellular immunity is critical for 
the control of Mtb, with little contribution from B cells or Ig. Studies in T cell-deficient 
mice indicate that T cell production of Thl type cytokines is required for protection 
(Flynn and Chan, 2001), whereas B cell deficient mice show no overt insufficiency in 
controlling Mtb (Johnson et al, 1997). These experiments are reinforced by the findings 
that AIDS patients with low CD4+ T cell counts are predisposed to tuberculosis (Selwyn 
et al, 1989), whereas multiple myeloma patients with defective B cell responses 
demonstrate no increased susceptibility to Mtb (Barnes et al, 1994). 
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Of the two T cell subsets, CD4+ T cells play the dominant role in control of Mtb, 
but CD8+ T cells are also important (Stenger and Modlin, 1999). The role of CD8+ T 
cells in control of Mtb is one area of research in which the immune system of the mouse 
appears to diverge from that of the human. CD8+ T cells can mediate lysis of cells 
presenting Mtb antigens in the context of either MHC class I molecules or CD1 
molecules. There is no mouse homolog for CD lb, the human CD1 molecule shown to 
present Mtb lipid antigens. Moreover, human CTLs appear to lyse macrophages and kill 
intracellular Mtb via the granule protein granulysin. Studies in mice made deficient in 
CTL granule toxins indicate that neither perforin nor granzyme is required for control of 
Mtb (Cooper et al, 1997); however comparable studies cannot be performed to clarify 
the importance of granulysin, because mice do not encode a granulysin homolog. 
Further confusion in the field of CD8+ T cell responses to Mtb infection has arisen 
from the use of (3-2-microglobulin ((32M)-deficient mice as a model for CD8+ T cell 
deficiency. MHC class I molecules are made up of a polymorphic chain that comprises 
the antigen presenting cleft, and an invariant (32M molecule that stabilizes the MHC 
complex in the plasma membrane. In the absence of (32M, class I MHC molecules are 
unstable, and are not expressed on the cell surface. When there are no class I MHC 
molecules, developing CD8+ T cells are deleted prior to maturation into functional cells. 
Thus, |32M-deficient mice have been used to model deficiency in CD8+ T cells. In this 
model, CD8+ T cells were found to play an important role in the control of Mtb (Flynn et 
al, 1992). A later study demonstrated that MHC class I-deficient mice are much less 
susceptible to Mtb than |32M-deficient mice (Rolph et al, 2001). These apparently 
inconsistent data can be explained by the fact that (32M molecules stabilize multiple 
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surface proteins in addition to M H C class I, including the protein HFE, which mediates 
iron uptake. Mutations in HFE result in iron overload. If (32M-deficient mice are treated 
with lactoferrin to chelate some of the extracellular iron, then Mtb infection proceeds 
identically to infection in MHC class I-deficient mice (Schaible et al, 2002). These 
results are consistent with previous studies that found a correlation between iron-overload 
and susceptibility to Mtb (Boelaert et al, 2003). Thus, although CD8+ T cells contribute 
to control of acute infection with Mtb, their role is less important that initially presumed. 
The importance of CD4+ T cells in control of Mtb is well-established. Although 
CD4+ T cells can lyse Mtb infected macrophages using the Fas-Fas Ligand (FasL) 
pathway (Stenger and Modlin, 1999), the CD4+T cell's main role during Mtb infection is 
to produce IFN-y, which activates infected macrophages. IFN-y is essential for control of 
Mtb, as evidenced by infection of IFN-y-deficient mice (Cooper et al, 1993; Flynn et al, 
1993) and IFN-yRl-deficient mice (MacMicking etal, 2003), which are completely 
unable to curb bacterial replication. Naturally occurring mutations in IFN-y-signaling 
pathways in humans result in highly increased susceptibility to mycobacterial infections 
as well (Casanova and Abel, 2002). Activation of macrophages by IFN-y overrides the 
Mycobacteria-induced block in phagosome maturation (Schaible et al, 1998; Via et al, 
1998), and activates mechanisms that result in killing of intracellular Mtb. IFN-y 
activation alters expression of approximately 25% of the macrophage transcriptome (Ehrt 
et al, 2001); however, only a few of these genes have been shown to help control 
replication of Mtb. 
Expression of NOS2 and the production of RNI are induced by IFN-y. Multiple 
studies have demonstrated that mice deficient in NOS2, or mice treated with NOS2-
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inhibitors, are highly susceptible to infection by Mtb (Chan et al, 1995; Flynn et al, 
1998; MacMicking et al, 1997). Additional studies have shown direct toxic effects of 
RNI against Mtb (Chan et al, 1992). The role of NOS2 in control of tuberculosis in 
humans has been more difficult to confirm, largely because there have been no reports of 
human genetic deficiencies in NOS2. However, evidence is accumulating that RNI 
contributes to the human anti-tubercular response (Nathan, 2002; Shiloh and Nathan, 
2000), including multiple studies that have demonstrated that alveolar macrophages from 
the lungs of patients infected with Mtb express NOS2, whereas macrophages from 
uninfected controls do not (Choi et al, 2002; Nicholson et al, 1996). 
Like NOS2, the IFN-y-inducible GTPase LRG-47 is highly induced after 
stimulation of macrophages with IFN-y. Mice disrupted in LRG-47 are also unable to 
control replication of Mtb, and succumb rapidly to infection (MacMicking et al, 2003). 
In the absence of LRG-47, IFN-y is unable to force the maturation of the Mtb-containing 
phagosome, suggesting that LRG-47 acts to regulate vesicular trafficking in activated 
macrophages. Inhibition of both NOS2 and LRG-47 has an additive effect and accounts 
for most of IFN-y's anti-mycobacterial effects, although not all (MacMicking etal, 
2003). 
Despite enhancement of ROI production by IFN-y, induction of phox does not 
appear to be an important macrophage mechanism for the control of Mtb. The human 
condition known as chronic granulomatous disease (CGD) results from a deficiency in 
one or more of the components of phox and the consequent inability to mount a 
respiratory burst (Segal et al, 2000). Patients who suffer from CGD are more susceptible 
to a number of bacterial pathogens (Holland, 2003), and yet there is no definitive 
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evidence that C G D predisposes individuals to mycobacterial infections, although there is 
still some controversy concerning this topic (Lamhamedi-Cherradi et al, 1999). Studies 
using the mouse model of CGD lend further support to the conclusion that phox is not of 
primary importance for control of mycobacterium: phox-deficient mice show little 
(Adams et al, 1997; Cooper et al, 2000) or no (Jung et al, 2002; Ng et al, 2004) 
increase in susceptibility to Mtb. 
Other cytokines with undisputed importance during Mtb infection include IL-12 
and TNFa (Orme and Cooper, 1999). In addition to evidence from animal models, 
human cases have been identified to support the roles of these two cytokines in resistance 
to tuberculosis. Human genetic deficiencies in IL-12 signaling result in increased 
susceptibility to Mtb (Lammas et al, 2002), and treatment of rheumatoid diseases with 
anti-TNF antibodies can result in reactivation of latent Mtb (Gomez-Reino et al, 2003). 
IL-12 is required to promote T cell production of type 1 cytokines including IFN-y, and 
thus IL-12 deficiency results in IFN-y deficiency. The mechanism by which TNFa-
deficiency increases the risk of Mtb appears to be more complex. Like IFN-y, TNFa can 
overcome the block on phagosome-lysosome fusion in infected macrophages. However, 
mice deficient in either one of these two cytokines are extremely susceptible to Mtb, 
indicating that IFN-y and TNFa do not play redundant roles during infection with Mtb 
(Flynn et al, 1995; MacMicking et al, 1997). Some IFN-y effects are mediated 
indirectly through macrophage production of TNFa(Shi et al, 2003); however, the 
difference in pathology in the two strains of immunodeficient mice during infection 
indicates that IFN-y and TNFa play independent roles (Garcia et al, 1997). Mice 
deficient in both IFN-y and TNFa signaling are more susceptible to M. bovis var. BCG 
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than singly deficient mice (Garcia etal, 1997); however, a similar comparison has not 
been performed with Mtb infected mice. 
The correct balance of TNFa is a critical determinant of pathology during 
infection with Mtb. A lack of TNFa results in dysregulation of the immune response to 
Mtb, but excess production of TNFa results in increased lung pathology, and is thought 
to be responsible for many of the clinical symptoms of tuberculosis, including fever and 
cachexia (Tramontana et al, 1995; Tufariello et al, 2003). A recent study found that 
monocytes from patients with active tuberculosis secreted high levels of IL-10 and 
TNFa, but low levels of IL-12, whereas monocytes from asymptomatic infected 
individuals expressed the reverse cytokine profile (Pereira et al, 2004). These data 
suggest that excess TNFa results in clinical symptoms, and that the inability to mount a 
Thl type response during infection with Mtb leads to active disease. 
Our understanding of the immune response to acute infection with Mtb is much 
better than our understanding of the immune factors that are important for maintaining 
latency. This discrepancy is due to a lack of an adequate animal model for latent 
infection as it occurs in humans (Tufariello et al, 2003). Mice, rabbits, and guinea pigs 
are all susceptible to infection with Mtb and provide good models for active disease. In 
the mouse lung, Mtb replicates exponentially for the first 2-3 weeks after infection, at 
which time replication halts as a result of the development of adaptive immunity (Fig. 
1 A). The immune system maintains a constant titer of Mtb in the lungs for months, and 
thus the mouse is often used as a model of chronic infection in which a delicate 
equilibrium has been achieved between the pathogen and the host. However, this model 
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Figure 1. Growth ofM. tuberculosis strains in mice after i.v. infection. C57BL/6 mice 
were infected intravenously with lxlO6 colony-forming units (CFU) of wild-type (WT) 
or mutant bacilli. (A) Growth of wild type M. tuberculosis in the lungs of 
immunocompetent mice. (B) Classification of mutants based on their growth in the 
lungs of immunocompetent mice. 
Modified from Hingley-Wilson et al. (2003) Nature Immunol 4: 949-955 
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bacteria are present. Moreover, during latency in the human lung, there is no progression 
in tissue pathology. Researchers have attempted to improve upon the latency model to 
make it more physiologic. The number of colony forming units (cfu) of Mtb in the 
mouse lung can be reduced to undetectable levels if mice are treated with chemotherapy; 
however, bacteria re-emerge if mice are subsequently immuno-suppressed. This strategy, 
known as the Cornell Model (McCune et al, 1956; McCune and Tompsett, 1956), 
recreates paucibacillary latency in the mouse, but with the caveat that non-physiologic 
reagents need to be imposed. Not surprisingly, studies in the mouse to determine 
immune effectors required for control of latent Mtb have generated varying results 
depending on the model used. Several immune factors, though, are agreed upon to be 
important for control of latent infection. T cells are required for maintenance of latency, 
although the subset of primary importance is debated (Tufariello et al, 2003), and NOS2 
is also important for control of latent Mtb (Flynn et al, 1998). 
3. M. tuberculosis virulence factors 
Although many genes have been described as Mtb virulence factors, there are 
surprisingly few genes for which both an in vivo phenotype and a mechanism of virulence 
have been identified. Disruption of many of the genes originally studied in vitro causes 
no deficit for growth of the resulting mutants in vivo. Conversely, the functions of many 
of the genes identified by screening of random mutants in vivo have not yet been 
determined. Mutants which do manifest in vivo phenotype have been grouped into 
categories based on replicative ability in the lungs of immuno-competent mice (Hingley-
Wilson et al, 2003). Those mutants that demonstrate suboptimal growth during acute 
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infection are referred to as giv mutants, indicating their deficit for "growth in vivo". 
Mutants, such as auxotrophs, that do not replicate at all and are rapidly eliminated from 
the host are called severe giv (sgiv) mutants. Mutants that demonstrate no deficit for 
rapid growth during the acute phase of infection but are unable to maintain high titers 
after adaptive immunity sets in are referred to as per mutants, because they do not persist 
(Fig. IB). 
Because of the important role played by NOS2 in control of Mtb, many studies 
have focused on understanding bacterial factors that have evolved to counter this host 
threat. A number of Mtb genes have been described that have in vitro activities for 
detoxification of RNI or repair of the lesions caused by these species, including ahpC 
(Bryk et al, 2000), msrA (St John et al, 2001), noxRl (Ehrt et al, 1997), noxR3 (Ruan et 
al, 1999), and glbN (Ouellet et al, 2002). However, Mtb mutants deficient in any one of 
these genes demonstrate no phenotype in vivo, suggesting that other RNI counter-immune 
mechanisms may be upregulated in reponse to the in vivo environment. Alternately, it 
may be that Mtb has evolved unconventional methods for coping with the toxicity of 
nitric oxide in vivo. A saturation screen for Mtb mutants that demonstrate increased 
susceptibility to killing by RNI in vitro revealed unexpected candidates: two proteasome-
associated proteins (mpa and pa/), a DNA repair enzyme that responds to a broad range 
of toxic insults (uvrB), and an enzyme required for the synthesis of a flavin cofactor 
(fbiC) (Darwin et al, 2003). When tested in mice, the proteasome-associated protein 
mutants were attenuated for growth in vivo. When evaluated in NOS2~'~ mice, the mpa 
mutant showed a partial restoration in virulence. 
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Thus, in the absence of one single enzyme to effectively detoxify nitric oxide, 
Mtb appears to have evolved a number of mechanisms, both common to other pathogens 
as well as unique to Mtb, which together act to counter RNI. Mtb's susceptibility to 
NOS2 is perhaps the result of Mtb's patchwork defense against RNI. It should be noted, 
however, that evolution might have favored Mtb's limited resistance to RNI. In the 
absence of NOS2, a mouse is unable to control bacterial replication and succumbs to 
disease relatively soon after infection. When RNI is present, Mtb achieves an unstable 
equilibrium with the host: bacterial replication halts, and Mtb persists in the host's lungs 
despite an ongoing immune response. In a human host, persistence of infection coupled 
with continued inflammation results in a chronic productive cough laden with Mtb 
bacilli. Because contagion is via aerosol droplets, Mtb's ability to cause chronic 
infection maximizes its opportunities to spread to other hosts. Evolution of effective 
defenses against all aspects of the host immune response would lead to earlier death of 
the host, and would decrease the distribution of the bacteria. 
Several studies have revealed that phox's apparent lack of contribution to control 
of Mtb is due to efficient bacterial enzymes that have evolved specifically to detoxify 
host-produced ROI. Mtb possesses one catalase for the breakdown of hydrogen 
peroxide: KatG. A katG mutant is attenuated for growth in wild type mice, but grows 
identically to wild type Mtb in phox-deficient mice (Ng et al, 2004). The fact that KatG 
is not required for virulence in the absence of phox suggests that the major, if not only, 
function of KatG in vivo is to defend Mtb against host ROI. Mtb also produces two 
superoxide dismutases (SODs) for the catalytic degradation of superoxide: SodA, which 
is iron-dependent, and SodC, which is copper/zinc-dependent. SodA is the predominant 
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SOD, and disruption of sodC does not alter growth in vivo; however, a sodC mutant is 
attenuated in IFN-y-activated macrophage capable of generating ROI (Piddington et al, 
2001). When tested in phox-deficient macrophages, SodC mutants grow no differently 
than wild type Mtb. SodA appears to be required for defense against both endogenous 
and exogenous (host-generated) ROI. The inability to generate an Mtb mutant with a 
deleted sodA gene suggests that SodA is essential for in vitro growth; however, a mutant 
with reduced expression of SodA is severely attenuated in vivo (Edwards et al, 2001), 
again demonstrating that Mtb has evolved efficient mechanisms for countering ROI. The 
extreme phenotype of the reduced expression SodA mutant suggests that seemingly 
ineffective immune pressures may become exceptionally potent when microbial counter-
immune mechanisms are disrupted. 
The onset of adaptive immunity halts the increase in bacterial titer in the lungs of 
Mtb infected mice, and results in a shift to the chronic phase of infection. The identities 
of genes for which disruption results in per phenotypes shed light on the nature of Mtb's 
environment within the granuloma during the chronic phase of infection. Under 
conditions of nutrient starvation, some bacteria initiate the stringent response, a 
coordinated shutdown of active metabolism that is mediated by production of 
hyperphosphorylated guanine nucleotides ((p)ppGpp). Disruption of the Mtb gene 
relMtb, which mediates the synthesis of (p)ppGpp, results in an inability of Mtb to persist 
in vivo (Dahl et al, 2003), supporting the idea that IFN-y-activated macrophages halt 
bacterial growth by depleting the phagosome of nutrients. Another stress-induced 
response that occurs in many bacteria is the "SOS" response, which leads to an increase 
in the generation of mutations during periods of adverse conditions. DnaE2, one of 
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Mtb's two major D N A polymerases, appears to be responsible for error-prone D N A 
synthesis during the SOS response. The Mtb dnaE2 mutant, like the relMtb mutant, 
replicates like wild type Mtb during acute infection, but is defective in persistence during 
chronic infection (Boshoff et al, 2003). Further evidence that Mtb is confronted with a 
state of starvation during chronic infection is provided by studies indicating that the Mtb 
id mutant is also a pex mutant (McKinney et al, 2000). As mentioned previously, Icl, 
functioning as one of two enzymes in the glyoxylate shunt, allows bacteria to convert 
fatty acids into carbohydrates when glucose is unavailable. The harsh nature of the 
phagosomal environment has also been illustrated by microarray analysis of Mtb genes 
induced in the macrophage. Comparison of Mtb genes expressed inside IFN-y activated 
macrophages with genes expressed when Mtb is subjected to specified in vitro stresses 
suggests that Mtb experiences iron depletion, decreased oxygen, carbohydrate restriction, 
and assault on the lipid membrane within the activated macrophage (Schnappinger et al, 
2003). 
It is becoming increasingly apparent that, in addition to proteins, Mtb lipids and 
glycolipids act as effector molecules to subvert host cell functions (Beatty et al, 2000). 
A large proportion of the Mtb genome is dedicated to lipid biosynthesis and lipid 
degradation genes (Glickman and Jacobs, 2001). Mtb encodes multiple homologs of the 
E. coli p-oxidation genes, enzymes used to break down fatty acids for fuel. However, 
some of the homologs found in Mtb do not participate in catabolism, but rather contribute 
to the synthesis of complex lipids. FadD28, one of 36 FadD genes, is required for the 
production of phthiocerol dimycocerosate (PDIM), a cell wall associated lipid found only 
in pathogenic mycobacteria that is required for replication of Mtb in the lungs (Cox et al, 
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1999). Lipids may act as a barrier for Mtb, but their roles go far beyond that. The 
precise structure of these complex lipids is essential for their contributions to virulence. 
The cyclopropane synthetase PcaA adds a single propane rings to one chain of mycolic 
acid. Mutants disrupted in pcaA have a per phenotype in vivo (Glickman et al, 2000). In 
addition, the pcaA mutant triggers an immune response in the lungs that is altered as 
compared with the response to wild type Mtb, suggesting that mycolic acid may be 
bioactive lipids and cause immune modulation. 
In addition to giv, sgiv, and per, two newer terms were recently introduced to 
describe mutants with complex in vivo phenotypes. Mutants that produce altered 
pathology in the lungs without demonstrating altered bacterial growth in vivo make up 
the class of mutants referred to as pat mutants, short for "pathology". To date, two 
mutants have been identified that fit the pat designation, and both are related to sigma 
factor functions. The putative transcription factor WhiB3 is a binding partner of the 
sigma factor RpoV. WhiB3 is not required for growth in vivo, but a whiB3 mutant causes 
less pathology in the lungs and thus requires significantly longer to kill its host that wild 
type Mtb (Steyn et al, 2002). Disruption of the gene sigH, which encodes an 
extracytoplasmic (ECF) alternative sigma factor, also decreases virulence without 
affecting bacterial replication and persistence in vivo (Kaushal et al, 2002). 
The sigH mutant is another example of the lack of correlation between in vitro 
and in vivo data seen for many Mtb mutants. Mtb sigH was cloned by homology to the 
ECF sigma factor sigE, and was shown to be involved in resistance to heat shock and 
oxidative stress in M. smegmatis (Fernandes et al, 1999). Soon thereafter, sigH was 
identified by SCOTS (selective capture of transcribed sequences) as being expressed in 
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Mtb after phagocytosis by human macrophages (Graham and Clark-Curtiss, 1999). 
Further research demonstrated increased susceptibility to heat shock and oxidative stress 
in an Mtb sigH mutant (Raman et al, 2001). When the Mtb mutant was assayed for 
virulence in mice, it demonstrated no defect for growth and survival within the lungs, but 
still required significantly longer to kill the mice (Kaushal et al, 2002). This attenuation 
was determined to be due to an altered immune response that was capable of controlling 
bacterial replication, but did not produce extensive immunopathology. Therefore, the 
increased susceptibly to oxidative stress seen in vitro did not appear to be the cause of the 
sigH mutant's attenuation in the mouse. 
A fifth mutant classification was created for one mutant for which the phenotype 
was found to depend on route of infection. The hbhA mutant has difficulty disseminating 
from the lungs to other tissues, and therefore manifests a phenotype only when delivered 
by the aerosol route (Pethe et al, 2001). This mutant has been dubbed a dissemination 
(dis) mutant. Like the other four categories of mutants, the term "dis" is descriptive of 
the phenotype, but in this case the phenotype provides a guideline for understanding the 
function of the gene. hbhA encodes heparin-binding hemagglutinin which has been 
shown to bind human complement component 3, as well as heparin and other sulfated 
sugars (Mueller-Ortiz et al., 2002). The hbhA mutant demonstrates no inability to invade 
macrophages, but has altered interactions with epithelial cells (Mueller-Ortiz et al, 2002; 
Pethe et al, 2001). Although it has been thought that Mtb is disseminated from the lungs 
in phagocytes, these data suggest that the ability to bind and interact with epithelial cells 
contributes to Mtb pathogenesis. 
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The unique nature of the strategies used by Mtb for survival in the host 
complicate our ability to deduce the precise mechanisms by which particular Mtb genes 
lead to virulence. FadD28, PcaA, and Mpa were each identified during screens of 
random Mtb mutants for specific phenotypes (Cox et al, 1999; Darwin et al, 2003; 
Glickman et al, 2000). Although mechanisms describing how these enzymes affect 
pathogenesis have yet to be revealed, the clues we do have about their functions steer us 
towards considering original ways in which bacteria may have evolved to interact with 
the host. Limiting the influence of our pre-conceived ideas about virulence may be the 
most productive way to identify new Mtb virulence factors. 
IV. Salmonella typhimurium 
Salmonellae are Gram negative facultative intracellular bacteria that infect a wide 
range of animal hosts. The genus Salmonella is further subdivided into serotypes that can 
be differentiated based on the structure of two surface antigens: LPS and flagella. 
Nomenclature for the different serotypes is commonly confused. There are only two 
Salmonella species, S. bongori and S. enterica, which encompass eight subspecies (Chan 
et al, 2003; McClelland et al, 2001). S. bongori is subspecies V, and the other seven 
subspecies -I, II, Ilia, Illb, IV, VI, and VII- contain over 2200 serotypes that all fall 
within the species S. enterica. Technically, individual serotypes should be referred to as 
serovars of S. enterica; however, in practice, most serotypes are used in place of the name 
of the Salmonella species. For example, S. enterica serovar Typhimurium has become 
known as S. typhimurium. 
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S. typhimurium, one of a small number of Salmonella serotypes that infects 
humans, causes localized inflammation in the human intestine. Although S. enteriditis, 
along with S. virchow, is the main cause of Salmonella infection in chickens, it is not one 
of the main serotypes to infect humans. In addition to S. typhimurium, the serotypes that 
commonly cause enteritis in humans include Heidelberg, Derby and Infantis. S. arizonae 
rarely infects humans, and mostly colonizes reptiles. S. dublin is infective to cows, and S. 
choleraesuis infects pigs. S. bongori does not cause disease in mammals. 
S. typhimurium is categorized in subspecies I of S. enterica, and exhibits 89% 
homology to the serotype Typhi, also in subspecies I (McClelland et al, 2001). S. typhi 
is an exclusively human pathogen that causes the systemic disease typhoid fever. 
Typhoid fever, although not a pandemic like tuberculosis, causes substantial worldwide 
morbidity and mortality every year. Due to overcrowding and poor sanitation, typhoid 
fever affects 16 million people and results in 600,000 deaths each year (Kaufrnann et al, 
2001). Infection of mice with S. typhimurium produces a systemic disease that resembles 
human infection with S. typhi, and thus is used as a model to understand the pathogenesis 
of typhoid fever. 
Salmonella serotypes are highly homologous to several other Gram negative 
species, including Escherichia coli, Yersinia species, and Shigella species. With overall 
genome homology upwards of 70%, these 4 genera would arguably not receive separate 
designations if they were classified today. For this reason, S. typhimurium is frequently 
studied as a model for understanding bacterial genetics and bacterial cell biology. 
Moreover, S. typhimurium infection of mice can serve as a general model for studying 
microbial pathogenesis. 
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The immune response to Salmonella 
The natural route of infection for S. typhi in humans and S. typhimurium in mice 
is oral. Some bacteria manage to survive gastric defenses, chiefly acid and RNI, and 
make their way to the small intestine, where they invade the epithelial lining of the 
terminal ileum to gain access to deeper tissues. Invasion is mediated by the bacteria and 
occurs through M cells (Jepson and Clark, 2001). M cells are specialized epithelial cells 
found in follicle-associated epithelium (FAE) that sample antigenic material from the gut 
lumen and transfer it to gut-associated lyphoid tissue (GALT) found below in the 
mucosa. In the intestine, the FAE overlies lympoid tissue known as Peyer's patches. 
Salmonella destroy the M cell through which they invade, providing a pathway for more 
bacteria to enter the mucosa and colonize Peyer's patches (Carter and Collins, 1974; 
Jones et al, 1994; Kohbata et al, 1986). Alternatively S. typhimurium has also been 
shown to be transported across gut epithelium by CD18+ phagocytes (Vazquez-Torres et 
al, 1999). This phase of infection is associated with recruitment of PMNs to the site of 
invasion, which attack bacteria in Peyer's patches and extravasate into the lumen of gut 
(Cheminay et al, 2004; Gewirtz et al, 2001a). Macrophages in Peyer's patches also 
participate in the initial immune response to S. typhimurium; however, S. typhimurium 
lyses these macrophages and migrates to the lymphatics and bloodstream for transport to 
lymph nodes, the liver and the spleen. 
Within 3 days, most bacteria are found intracellularly within phagocytes. In the 
spleen, the majority of bacteria localize to macrophages of the red pulp and the marginal 
zone (Salcedo et al, 2001). In the liver, S. typhimurium resides in infiltrating PMNs 
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during the first few days of infection, and in infiltrating macrophages at later times 
(Richter-Dahlfors et al, 1997). Resident macrophages of the liver (Kupffer cells) and 
hepatocytes do not appear to be infected, and there is no appreciable infiltration of B or T 
cells (Richter-Dahlfors et al, 1997). In susceptible mice, although replication of bacteria 
is not controlled, death ultimately results from sepsis due to bacterial products, including 
LPS and flagellin (Khan et al, 1998). 
As with Mtb, there are disagreements about the contributions of specific immune 
factors to the control of S. typhimurium. Many of the discrepancies between data can be 
traced to the use of different strains of mice as well as of different strains of bacteria. 
Many laboratories use C57BL/6 or BALB/c mice for experimental infections. These 
strains are homozygous for the susceptible allele of Nrampl (NrampT), a critical locus 
for control of Leishmania, S. typhimurium, and M. bovis wax. BCG (Govoni et al, 1996). 
Thus, even "wild type" C57BL/6 mice are immuno-compromised, as compared to strains 
such as 129Sv or CBA that are NrampT. 
Several laboratory strains of S. typhimurium axe also commonly used as virulent 
"wild type" strains, although genetic differences between the strains have never been 
characterized. Additionally, some laboratories use clinical isolates of varying virulence. 
Virulence is determined by the ability of a bacterial strain to kill mice, generally an 
NrampT strain such as C57BL/6 or BALB/c. Definitions of virulence vary. For non-
oral routes of infection (i.p. or i.v.), some people define virulence as a lethal dose 
required to kill 50% of the mice (LD50) that is less than 100 cfu (Swords et al, 1997). A 
virulent LD50 for oral or gastric infection is usually considered to be between 105 and IO6 
cfu. When comparing mutant bacteria to the parental strain, individual laboratories 
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determine their own definitions of what attenuation means (Bowe et al, 1998). The first 
complete genome to be published for S. typhimurium was sequenced from the LT2 strain, 
an attenuated strain which does not express the alternative sigma factor RpoS (Swords et 
al., 1997). Despite acknowledgement of this genetic insufficiency, there are many 
laboratories that routinely use LT2 as a "wild type" strain. Some laboratories choose to 
use attenuated strains of S. typhimurium to prolong the duration of infection in 
susceptible mice; however, a recent study demonstrated that overlapping yet distinct sets 
of host immune factors are responsible for control of different attenuated S. typhimurium 
mutants with similar virulence phenotypes (Raupach et al, 2003). Thus, infection with 
attenuated strains does not necessarily reflect on the immune response to virulent strains 
of S. typhimurium. 
In addition to the Nrampl locus, the production of ROI by phox is an undisputed 
and critical component of host defense against S. typhimurium, as manifest by 
experiments in mice (Mastroeni et al, 2000; Shiloh et al, 1999), experiments in 
macrophages (Shiloh et al, 1999; Vazquez-Torres etal, 2000a), and by the increased 
susceptibility to Salmonella infections of individuals with chronic granulomatous disease 
(Segal et al, 2000). Because S. typhimurium resides in the macrophage phagosome 
during most of the course of infection, it is not surprising that a macrophage cytotoxic 
mechanism is of primary importance for killing of S. typhimurium. Similarly, cytokines 
known to activate macrophages and promote phox activity are also important mediators 
of the immune response to S. typhimurium (Eckmann and Kagnoff, 2001). A deficiency 
in TNFa or the TNF receptor severely exacerbates disease and prevents localization of 
phox to Salmonella-containing phagosomes (Nauciel and Espinasse-Maes, 1992; 
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Vazquez-Torres et al, 2001). This blockade in vesicle fusion in TNF-unresponsive mice 
cannot be overcome by activation of macrophages with IFN-y. However, a deficiency in 
either IFN-y or IL-12, which stimulates T cells and NK cells to produce IFN-y, also 
increases host susceptibility to S. typhimurium in both mice (Kincy-Cain et al, 1996; 
Nauciel and Espinasse-Maes, 1992) and humans (Jouanguy et al, 1999). As with Mtb, 
mice rendered deficient in both TNFa and IFN-y fare worse after infection with S. 
typhimurium than mice lacking either cytokine alone (Nauciel and Espinasse-Maes, 
1992). 
During S. typhimurium infection, which cells are making the important IFN-y: T 
cells, NK cells, or other cells? Contributions of IFN-y to control of S. typhimurium can be 
seen using resistant mice infected with virulent bacteria (Nauciel and Espinasse-Maes, 
1992), susceptible mice infected with attenuated bacteria (Bao et al, 2000; Kirby et al, 
2002), and susceptible mice infected with virulent bacteria (Gulig et al, 1997), and the 
cells producing IFN-y are not always the same. With attenuated bacteria in susceptible 
mice, macrophages and neutrophils were the chief sources of IFN-y in one study (Kirby 
et al, 2002), while NK cells produced IFN-y in a separate study using the same strain of 
mice but a different attenuated strain of S. typhimurium (Schwacha et al, 1998). 
Splenocytes from resistant mice produce much more IFN-y in response to S. typhimurium 
than splenocytes from susceptible mice, and the big producers in the resistant mice are 
NK cells (Ramarathinam et al, 1993a, b). 
Although Nrampl and phox are both anti-microbial mechanisms found in 
phagocytes, and although the experiments with cytokine-deficient mice support the 
relevance of a Thl response during infection, the roles of specific phagocyte populations 
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for control of S. typhimurium axe also not entirely clear. When macrophages are depleted 
from susceptible mice before infection with virulent bacteria, the mice experience less 
morbidity and mortality than their counterparts with macrophages (Wijburg et al, 2000). 
This result demonstrates how completely S. typhimurium has evolved to survive and 
replicate within the macrophage in vivo. Yet, macrophage production of TNFa is 
required for maximum production of IFN-y by NK cells in the spleen during virulent 
infection of resistant mice (Ramarathinam et al, 1993b). In the absence of Nrampl 
activity, macrophages appear to be relatively impotent to mount a protective immune 
response, and therefore become detrimental to the immune response because they 
function to conceal and protect S. typhimurium. 
PMN also express phox and kill S. typhimurium. Not surprisingly, this difference 
in the role of macrophages in resistant and susceptible mice influences the relative 
importance of PMN during infection. In fact, Fierer has shown that a requirement for 
PMN during S. typhimurium infections depends on two specific factors: the Nrampl 
status of the host, and the presence or absence of the virulence plasmid (spv) in the 
bacterium (Fierer, 2001). NrampT mice are so susceptible to spv+ bacteria that the 
presence or absence of PMN has no effect on disease progression; however, when 
susceptible mice are infected with spv" S. typhimurium, PMN become an important 
component of the immune response. Likewise, PMN-depleted NrampT mice have no 
problem controlling attenuated spv" bacteria, but PMN do a play a role in resistant mice 
infected with fully virulent spv+ S. typhimurium. 
Studies using attenuated strains of Salmonella to infect susceptible mice, as well 
as studies using NrampT xnice, demonstrate that both T cells (Lo et al, 1999; Mittrucker 
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et al, 1999; Weintraub et al, 1997) and B cells (Mittrucker et al, 2000) play a role in 
immunity to S. typhimurium. Because infection of susceptible strains of mice with 
virulent S. typhimurium generally results in murine death before adaptive immunity can 
develop, the role of T and B cells in the control of S. typhimurium is often studied in the 
context of memory and secondary infection. That is to say: mice are immunized with an 
attenuated strain of S. typhimurium, and then later challenged with a virulent one. 
Development of resistance during immunization with attenuated strains is dependent on 
the interactions between B cells and T cells (Mastroeni and Menager, 2003). During 
secondary infection, Thl memory is critical for immunity, and T cells become an 
important source of IFN-y (Kirby et al, 2002). CD4+ T cells specific for an epitope 
found in FliC (flagellin), one of the monomers that comprises flagella, account for much 
of the protective memory response (McSorley et al, 2000). 
One of the biggest controversies regarding the immune response to S. 
typhimurium concerns the relevance of NOS2: some researchers find important 
contributions of NOS2 to control of S. typhimurium (Mastroeni et al, 2000), while others 
do not (Shiloh et al, 1999). A lack of susceptibility of NOS2-deficient mice infected 
with S. typhimurium may be in part due to an insufficiency in NK cell produced IFN-y in 
NrampT strains of mice (Ramarathinam et al, 1993a), and in part due to death of mice 
before the development of an adaptive immune response and T cell production of IFN-y. 
Even with inocula as low as 10 organisms, S. typhimurium kills immuno-competent 
C57BL/6 mice in approximately one week (Shiloh et al, 1999). When experiments are 
performed during which S. typhimurium-infected mice are able to contain infection for at 
least 2 weeks, NOS2 appears to contribute to the immune response late in infection. 
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Several studies have demonstrated a role for N O S 2 and RNI in control of attenuated 
strains of S. typhimurium (Alam et al, 2002; Mastroeni et al, 2000). Not only do 
C57BL/6 mice infected with attenuated strains live long enough for T cell responses to 
develop, but in addition, attenuated strains of S. typhimurium have been show to stimulate 
IFN-y production by NK cells in NrampT mice (Schwacha et al, 1998). NrampT mice, 
which survive a sufficient time to mount a T cell response, also trigger NK cells to 
produce early IFN-y. If NrampT 129Sv mice are infected with high numbers of virulent 
S. typhimurium, the bacteria do not kill the mice; however, NOS2-deficient 129Sv mice 
begin to die 10 days after infection, suggesting that late activation of NOS2 is required 
for continued suppression of infection (Mastroeni et al, 2000). 
Contributions of RNI to the macrophage's ability to kill S. typhimurium have also 
been evaluated by comparing macrophages deficient in NOS2 with immuno-competent 
macrophages. A small impact of NOS2 on killing of virulent S. typhimurium can be seen 
at 20 hours after infection in macrophages from NrampT C57BL/6 mice, and this effect 
is enhanced by activation of macrophages with IFN-y (Vazquez-Torres et al, 2000a). 
When NOS2-deficient mice on a C57BL/6xl29Sv background are evaluated, there is no 
detectable influence of NOS2 on the killing of virulent S. typhimurium by macrophages at 
4 hours after infection (Shiloh et al, 1999). The differences in the mouse strains used, 
the differences in the time points for evaluation, and/or the presence or absence of IFN-y 
to activate macrophages may explain the dissimilar results. Considering how much 
variability in the immune response to S. typhimurium is generated depending on the strain 
of mice and strain of bacteria used, it is not ultimately surprising that researchers disagree 
about the roles of particular immune mediators in the control of S. typhimurium infection. 
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Defense against R O I and R N I 
Many genes have been identified in S. typhimurium that contribute to protection 
against oxidative stress. S. typhimurium encodes both constitutive and inducible 
antioxidant mechanisms. Inducible antioxidant genes are triggered by several stresses 
including hydrogen peroxide, superoxide, and growth into stationary phase. 
Sub-lethal doses of hydrogen peroxide induce about 30 proteins in S. typhimurium 
(Morgan et al, 1986), at least 9 of which are dependent on the transcriptional activator 
OxyR that is active only when oxidized (Janssen et al, 2003; Storz and Imlay, 1999). 
OxyR-dependent genes include the catalase katG, the peroxiredoxin ahpCF, the 
glutathione reductase gorA, the glutaredoxin grxA, the DNA binding protein dps, the 
regulatory DNA oxyS, and the iron regulatory locus fur. Catalases detoxify hydrogen 
peroxide by converting it to water and oxygen. Peroxiredoxins reduce hydrogen peroxide 
as well as organic hydroperxoides. Glutathione (GSH) acts as a hydrogen donor, thus 
maintaining a reducing environment in the cytosol. Glutaredoxins transfer hydrogen ions 
from GSH to disulfide-linked oxidized cysteine residues. This reaction generates 
disulfide-linked glutathione (GSSG), which is converted by glutathione reductase back to 
GSH (Dickinson and Forman, 2002). Fur represses uptake of iron. Because cytoplasmic 
iron can convert hydrogen peroxide by the Fenton reaction to the very reactive hydroxyl 
radical, regulation of cytoplasmic iron levels is an important method for minimizing 
damage resulting from exposure to ROI. The exact mechanism by which Dps prevents 
DNA mutagenesis specifically resulting from ROI and promotes virulence is not well 
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understood; however, it may involve sequestering iron and thus preventing localized 
Fenton reactions (Grant et al, 1998; Halsey et al, 2004). 
The SoxR/S regulon, which contains at least 10 genes, is activated as a result of 
intracellular superoxide (Pomposiello and Demple, 2000; Storz and Imlay, 1999). One of 
the induced genes, sodA, encodes a cytoplasmic, Mn-dependent superoxide dismutase 
that converts superoxide to hydrogen peroxide. In addition to detoxifying endogenous 
superoxide, over-expression of SodA promotes resistance of S. typhimurium to killing by 
the J774.1 macrophage cell line (Tsolis et al, 1995). S. typhimurium possesses two other 
SODS, SodCI and SodCII, which are both Cu, Zn-dependent and localize to the 
periplasm. However, neither sodCI nor sodCII is regulated by SoxR/S (Fang et al, 
1999). The fur locus is also part of the SoxR/S regulon, and is involved in a further level 
of regulation among these genes. When E. coli are grown in iron-rich media, Fur binds 
to the sodA promoter and prevents its expression (Niederhoffer et al, 1990). In S. 
typhimurium, inactivation of the Fur repressor results in increased SodA activity and 
increased resistance to killing by macrophages (Tsolis et al, 1995). 
Bacteria grown to stationary phase are subject to a number of stresses associated 
with high-density cultures, including nutrient deprivation and accumulation of toxic 
waste products. Expression of genes to cope with these stresses is governed by several 
alternative sigma factors including o\ a", and cr5, referred to in S. typhimurium as RpoS, 
RpoH, and RpoE. The best studied of these is RpoS, which regulates at least 30 genes 
upon entry into stationary phase (O'Neal et al, 1994; Talukder et al, 1996), and is active 
when S. typhimurium resides inside host cells (Chen et al, 1996a). RpoS regulates the 
genes encoding KatE and KatN, 2 of the 3 catalses used by S. typhimurium (Robbe-Saule 
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et al, 2001). RpoS exerts control over KatG expression in E. coli, but this relationship 
has not been evaluated in S. typhimurium (Loewen et al, 1998). KatG and KatE both 
require a heme prosthetic group for their catalytic activity, whereas KatN appears to be a 
non-heme catalase, like AhpC. RpoE also contributes to regulation of S. typhimurium''s 
anti-oxidant defense, although the mechanism has not been described. An S. 
typhimurium strain deficient in RpoE is attenuated in mice, but is restored in virulence in 
mice lacking phox (Testerman et al, 2002). RpoS mutants demonstrate a similar pattern 
of differential virulence, although rpoE/rpoS double mutants remain relatively attenuated 
in phox-deficient mice, highlighting the fact that these sigma factors regulate other genes 
in addition to anti-oxidant defenses (Testerman et al, 2002). 
The role of heme catalases in detoxification of ROI is underscored by the 
increased susceptibility to hydrogen peroxide of an S. typhimurium mutant defective in 
hemA, which catalyzes the first committed step in heme biosynthesis (Elgrably-Weiss et 
al., 2002). Heme catalases appear to be important to S. typhimurium when bacterial 
density is high and concentrations of hydrogen peroxide are in the millimolar range. 
However, they may be redundant in vivo, as a katE/katG double mutant is fully virulent 
in both mice and macrophages (Buchmeier et al, 1995). This resistance to ROI may be 
due to residual catalase activity provided by KatN or AhpC, or due to the fact that DNA 
repair enzymes (RecBC) appear to play a more important role in defenses againt ROI 
than catalases during exposure to lower concentrations of hydrogen peroxide (Buchmeier 
etal, 1995). 
A number of regulatory genes have been implicated in resistance to ROI, 
including RamA (van der Straaten et al, 2004), SlyA (Buchmeier et al, 1997), and ArcA 
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(Lu et al, 2002). The ArcA locus is also associated with resistance to RNI (Lu et al., 
2002). Other S. typhimurium genes that protect against both RNI and ROI include sodCI 
(De Groote et al, 1997), msrA (St John et al, 2001), and ahpCF (Chen et al, 1998). 
AhpCF can catalytically detoxify peroxynitrite (Bryk et al, 2000). Resistance to RNI 
mediated by SodCI and MsrA also appears to be the result of interference with 
peroxynitrite's ability to cause damage. It is thought that elimination of superoxide by 
SodCI prevents peroxynitrite from forming, and MsrA, which reduces oxidized 
methionines, appears to repair oxidative lesions caused by peroxynitrite. 
Type III secretion systems 
Virulence of virtually all pathogens relies upon secretion of protein or lipid 
mediators that manipulate host cells. For Gram negative bacteria, secretion is 
complicated by the challenge of two membranes, separated by the periplasmic space, 
across which molecules need to be transported. Evolution has provided Gram negative 
with at least five solutions to this problem (Fig. 2) (Henderson etal, 2000; Hueck, 1998). 
Type I secretion and type III secretion involve direct transport of molecules through 
channels that span both membranes and the periplasmic space. Type II sec-dependent 
secretion is a two-step process. Proteins for export are first transported from the 
cytoplasm into the periplasm by the sec pathway, which is also used to transport proteins 
whose final destination is the periplasm. A second set of transporters then exports 
proteins targeted for secretion across the outer bacterial membrane. Type IV secretion 
can be .sec-dependent or sec-independent, with some substrates initially brought into the 
periplasm, and others exported directly from the cytoplasm. Type V secretion, which 
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Figure 2. Secretion systems of Gram negative bacteria. (A) Schematic overview of 
the type I, II, and III secretion systems as exemplified by alpha-hemolysin secretion 
by E. coli (type I), pullulanase secretion by Klebsiella oxytoca (type II), and Yop 
secretion by Yersinia (type III). OM, outer membrane; PP, periplasm; IM, inner 
membrane; CP, cytoplasm. (B) The secretion pathway of the true autotransporters 
is depicted in the bottom left of the diagram and the 'unlinked' autotransporters in 
the bottom right. The three functional domains of the proteins are shown: the leader 
sequence (black), the passenger domain (red) and the (3-domain (green). The 
autotransporter polyproteins are synthesized and generally exported through the 
cytoplasmic membrane via the Sec machinery (colored ovals). However, some 
autotransporters possess extended signal sequences that make it at least possible 
that alternative pathways are involved. Once through the inner membrane, the 
signal sequence is cleaved and the (3-domain inserts into the outer membrane in a 
biophysically favored (3-barrel structure that forms a pore in the outer membrane. 
After formation of the (3 -barrel, the passenger domain inserts into the pore and is 
translocated to the bacterial cell surface where it might undergo further processing. 
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includes auto-tranporters and two-partner secretion systems, is two-step, sec-dependent 
mechanism. During the second step of Type V secretion, either the protein to be 
secreted, or its partner, forms an outer membrane pore intended solely for the transport of 
the molecule to be secreted. 
Type III and type IV secretion systems required for virulence share two additional 
features: they both demonstrate homology to bacterial macromolecular complexes not 
involved exclusively in pathogenesis, and they are both capable of translocating 
molecules directly into host cells. The type III secretion system (TTSS) appears to be a 
modified flagellar apparatus, a tail-like structure used for motility, and the type IV 
secretion system is derived from the pili used by bacteria to transfer DNA between cells 
during conjugation (Fig. 3). The needle-like projections of these secretion systems allow 
a bacterium to make direct contact with the host cell membrane. The bacterium then 
exports subunits through the secretion apparatus that form a pore, also known as a 
translocon, which inserts in the host cell plasma membrane, providing a continuous 
channel from the cytoplasm of the bacterium into the cytoplasm of the host cell. In this 
way, bacteria can inject molecules directly into the host cells, and thus manipulate 
intracellular signaling in a similar manner to certain secreted exotoxins. The type III 
secretion apparatus, which is often to as referred as the "needle complex" because it both 
physically and functionally resembles a syringe (Kubori et al, 1998), appears to 
translocate only proteins, whereas the type IV apparatus can export both DNA and 
proteins (Hueck, 1998; Nagai and Roy, 2003). There is one report that Gram positive 
bacteria may possess a functionally equivalent system to type III and type IV secretion 














Figure 3. Schematic representation of a bacterial flagellum (a) and a 
conjugative pilus (b) showing their similarity to type III and type IV secretion 
systems, respectively. 
Modified from Covacci, A. and Rappuoli, R. (2000). J. Exp. Med. 191: 587-592. 
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(Madden et al, 2001). Further studies will be required to determine whether this 
phenomenon is widespread, or unique to Streptococcus pyogenes. 
Salmonella pathogenicity islands 
"Virulence factors" can be defined as any gene required for growth of a pathogen 
within its host (Groisman and Ochman, 1997). However, many genes fitting this 
description, such as genes for nutrient synthesis, are also present in strains of commensal 
bacteria that live symbiotically with their hosts. A more rigorous definition of "virulence 
factors" are those genes required for growth in vivo that are not found in related 
nonpathogenic bacteria. Virulence factors clustered on the chromosome are called 
pathogenicity islands (PAIs) (Groisman and Ochman, 1997; Marcus et al, 2000). The 
genes of a PAI often work together to enact a particular virulence function that is relevant 
at a specific time during infection, such as expression of a TTSS. PAIs appear to have 
been obtained by most bacteria through the process of horizontal gene transfer, based on 
their location in the genome (near sites common for insertions such a tRNA genes), their 
G+C content being dissimilar to the rest of the genome, and the fact that PAIs often 
encode all of the components required to enact complex phenotypes. Acquisition of a 
PAI virulence cassette can sometimes be sufficient to convert a nonpathogenic species 
into a virulent one (McDaniel and Kaper, 1997). 
There are five Salmonella pathogenicity islands (SPIs) located on the 
chromosome, two of which encode virulence-related TTSSs. SPI-1 appears to have been 
the older of the two TTSS, acquired earlier in the evolution of S. typhimurium than SPI-2 
(Amavisit et al, 2003). The SPI-1 encoded TTSS confers upon Salmonella the ability to 
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invade epithelial cells, and is homologous to TTSSs in Shigella, Yersinina, Erwinia, and 
Pseudomonas, all with similar roles in pathogenesis (Groisman and Ochman, 1997). The 
SPI-2 TTSS is necessary for growth in macrophages, and appears to be unique to 
Salmonella species, although some of the genes encoding the needle apparatus 
demonstrate mild homology to Yersinina and E. coli genes. Perhaps because it is newer 
to the genus, or perhaps because of the nature of its function, SPI-2 is the most highly 
conserved of the SPIs among Salmonella serotypes (Amavisit etal, 2003) 
The TTSSs encoded by SPI-1 and SPI-2 require four classes of proteins for 
complete function: apparatus proteins, regulatory proteins, secreted effectors, and 
chaperones for the secreted effectors. Although the genes encoding the secretion 
apparati, as well as most of the chaperones and regulators, are located within the PAIs, 
genes encoding secreted effectors are found in the PAI and scattered throughout the 
chromosome. A number of TTSS effectors are clustered together in another PAI: SPI-5 
(Hong and Miller, 1998; Wood et al, 1998). SPI-5 is the most recently identified of the 
SPIs, and includes some genes with homology to Shigella invasion genes. SPI-5 encodes 
effectors secreted by both the SPI-1 and SPI-2 TTSSs (Knodler et al, 2002). The SPI-1 
TTSS effectors found at SPI-5 are required for enteropathogenesis in cattle, but have not 
been shown to play a role in disease in mice (Hapfelmeier et al, 2004), despite 
promoting invasion of cell lines in vitro (Hong and Miller, 1998). The exact functions of 
the SPI-5 encoded SPI-2 effectors are not clear. 
The nucleotide composition of SPI-3 and SPI-4 indicates that they were both 
horizontally acquired by the Salmonella genome; however, unlike the other SPIs, they 
exhibit mosaic structures, and there is no obvious functional relationship between the 
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gene products within each PAI. SPI-3 genes, including the mgtBC encoded magnesium 
transporter, are important for survival in macrophages (Blanc-Potard et al, 1999). The 
function of SPI-4 is less clear, although a locus within the region contributes to 
intramacrophage survival (Wong etal, 1998). 
In addition to these chromosomal virulence cassettes, many Salmonella serotypes 
contain a virulence plasmid, which varies in size between different serotypes. In S. 
typhimurium, pSLT is 95 kb. The spv operon, spvRABCD, is present on all Salmonella 
virulence plasmids, and contributes to virulence in mice by promoting survival in 
macrophages (Gulig et al, 1998). The actions of spvB and spvC axe sufficient to confer 
the survival advantage (Matsui et al, 2001). The exact mechanisms of these virulence 
factors are unknown, although SpvB acts can ADP-ribosylate actin in host cells, thus 
preventing actin polymerization (Lesnick et al, 2001). 
PhoP-PhoQ 
Many prokaryotes use two-component regulatory systems to convert detection of 
environmental changes into transcriptional responses (Stock et al, 2000). The archetypal 
sensor kinase is a transmembrane protein composed of two domains: an N-terminal 
sensor domain that detects changes in the periplasm, and a cytoplasmic kinase domain 
that autophosphorylates a specific C-terminal histidine residue. The activated sensor 
kinase transfers the phosphate to a specific aspartate residue on the cytoplasmic response 
regulator. Phosphorylation causes a conformational change in the response regulator, 
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allowing the protein to mediate a response to the extra-cytoplasmic change. Frequently 
this response consists of the response regulator binding to specific promoters, thus 
activating or repressing genes that will address the altered extra-cytoplasmic environment 
of the bacterium. 
The PhoP-PhoQ system is the first example of a two-component regulatory 
system for which the primary function is to signal changes in extracellular magnesium 
levels (Groisman, 2001). Autophosphorylation of the PhoQ sensor kinase is inhibited by 
millimolar levels of extracellular Mg A Ca2+, or Mn2+, whereas micromolar levels of these 
ions activate the system. PhoP and PhoQ are found in a number of bacterial species, 
including both pathogenic and non-pathogenic strains, and appear to regulate four main 
classes of genes: genes that regulate adaptation to limited environmental magnesium, 
genes that regulate virulence in pathogenic strains, genes that alter the bacterial outer 
envelope, and species-specific genes that confer unique properties to particular 
organisms. 
In S. typhimurium, the PhoP/Q system regulates at least 40 genes, representing 
1% of total ORFS, some of which appear to be ancestral while others appear to have been 
acquired by horizontal transfer (Lejona et al, 2003). PhoP/Q is required for virulence in 
both mice and macrophages (Miller et al, 1989). Two independent studies demonstrated 
that the majority of S. typhimurium genes identified as being induced within macrophages 
are PhoP-dependent (Heithoff et al, 1999; Valdivia and Falkow, 1997). The 
contributions of PhoP/Q to virulence are presumably due to a combination of the multiple 
deficiencies of the phoPQ mutant demonstrated in vitro, including increased 
susceptibility to killing by antimicrobial peptides, bile salts, and low pH. The PhoP-
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regulated genes involved in providing resistance to these host mechanisms can be divided 
into three categories: adaptations to changes in extracellular cations (specifically 
magnesium), resistance to antimicrobial peptides, and activation of virulence factors. 
Adaptation to low extracellular magnesium takes many forms. The mgt genes 
(mgtA, B, and C) axe directly activated by PhoP and encode magnesium transporters. 
mgtC is required for growth in limited magnesium as well as for growth in macrophages, 
suggesting that the intra-phagosomal environment of S. typhimurium is deficient in Mg2+ 
(Blanc-Potard and Groisman, 1997). In addition to the need to cope with nutritional 
deprivation, S. typhimurium must adjust for the change in ionic content of its 
environment. The bacterial surface chelates cations as a method of preventing repulsion 
of adjacent negatively charged LPS molecules. As extracellular magnesium decreases, 
there is less positive charge available to stabilize LPS molecules. PhoP induces the 
transcription of a second two-component regulatory system, PmrA/B, which activates the 
ugd and the pbgPE operon. These genes mediate the incorporation of 4-aminoarabinose 
into Lipid A of LPS, decreasing the overall net negative charge of LPS. This modification 
of Lipid A effectively balances the effects of reduced available magnesium, thus 
stabilizing surface interactions between adjacent LPS molecules to maintain the integrity 
of the bacterial envelope. 
Addition of 4-aminoarabinose to Lipid A also serves to increase S. typhimurium's 
resistance to the antimicrobial peptide polymyxin B. Several other PhoP-activated genes 
have been identified that increase the bacterium's ability to defend against host-derived 
antimicrobial peptides. pagP encodes an enzyme that incorporates palmitate into Lipid 
A, a modification that heightens resistance to some antimicrobial peptides (although not 
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to polymyxin B ) . PgtE is an outer membrane protease that cleaves particular 
antimicrobial peptides. Studies comparing mutant strains of S. typhimurium suggest that 
other PhoP-activated genes involved in defense against antimicrobial peptides remain to 
be identified. 
Beyond these specific PhoP-activated pathways, the PhoP/Q system contributes to 
the repression and activation of S. typhimurium's major virulence mechanisms. 
Consistent with the role in adaptation to limited divalent cations and resistance to 
antimicrobial peptides, the genes influenced by PhoP are critical for survival once S. 
typhimurium has translocated from the intestine into host tissues. PhoP represses SPI-1 
genes required for invasion of gut epithelial cells, but appears to positively regulate the 
spv genes, although this remains controversial. 
Salmonella pathogenicity island -1 (SPI-1) 
SPI-1 was originally identified as a critical locus for S. typhimurium invasion of 
epithelial cells in the intestine (Galan and Curtiss, 1989; Jones and Falkow, 1994; Mills et 
al, 1995). S. typhimurium mutants defective in this locus have a higher LD50 (100-
lOOOx) than wild type strains when infection occurs orally, although SPI-1 mutants 
demonstrate no deficit for survival and growth in vivo after i.p. infection (Galan and 
Curtiss, 1989; Penheiter et al, 1997). Being the first TTSS and the first PAI identified in 
S. typhimurium, the locus was not originally designated "SPI-1", but rather "inv/spa" to 
indicate the contribution of the locus to invasion and the homology of some SPI-1 genes 
to the Shigella spa locus (Groisman and Ochman, 1993). 
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SPI-1 contains genes encoding a TTSS, several secreted effectors, chaperones, 
and regulators for expression of the locus, including invF and hilA. Expression of SPI-1 
genes occurs during late log phase growth at 37°C in vitro. Not surprisingly, optimal 
expression occurs under conditions that approximate the environment in the lumen of the 
intestine, including neutral pH and oxygen-limitation (Bajaj et al, 1996). Initially it was 
thought that secretion of SPI-1 effectors was dependent on bacterial contact with host 
cells; however, a shift in pH from acidic to alkaline, as would be expected to occur as 
bacteria move from the stomach to the intestine, is sufficient to induce SPI-1 secretion 
(Daefler, 1999). 
HilA, the master regulator of SPI-1, activates expression of invF, which in turn 
acts in concert with the SPI-1 chaperone SicA to induce expression of SPI-1 effectors 
encoded both within SPI-1, as well at other loci on the chromosome (Darwin and Miller, 
1999, 2001b). Many regulators have been shown to influence expression of hilA 
including RtsA and RtsB (Ellermeier and Slauch, 2003), HilC, HilD and HUE (Akbar et 
al, 2003; Baxter et al, 2003), Hha (Fahlen et al, 2001), CsrA (Altier et al, 2000), and 
the two component regulatory systems PhoP/PhoQ (Pegues et al, 1995) and BarA/SirA 
(Johnston et al, 1996; Lawhon et al, 2002). The specific environmental signals that lead 
to activation of the individual regulators are not well understood; however, short chain 
fatty acids found in the intestine have been shown to trigger SPI-1 expression by 
signaling through BarA/SirA (Lawhon et al, 2002). 
There are at least 13 effectors known to be secreted by the SPI-1 TTSS (Zhou and 
Galan, 2001). Biochemical function has been established for more than half of the 
effectors, although almost all of the effectors have been characterized according to 
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contributions to virulence. Three of these secreted proteins act together to form the SPI-1 
translocon: SipB, SipC, and SipD (also referred to as SspB, SspC, and SspD). SipA, 
SipC, SopB (also known as SigD), SopE, SopE2, and SptP are involved in actin 
rearrangements and mediate invasion of epithelial cells. SipA, SopA, SopB, SopD, and 
SopE2 are responsible for S. typhimurium-induced enteropathogenesis in cattle (Zhang et 
al, 2002). SspHl, which can be secreted by both SPI-1 and SPI-2, is not found in all 
isolates of S. typhimurium; however, when present, it participates in lethal virulence in 
calves by an unknown mechanism (Miao et al, 1999). SlrP and AvrA were identified as 
SPI-1 effectors based on homology to Yersinia TTSS secreted effectors, but their precise 
role has yet to be determined. Although AvrA is homologous to Yersinia's YopJ, it was 
named based in its homology to the gene AvrRxx, a virulence factor found in the plant 
Xanthomonas (Hardt and Galan, 1997). Like SspHl, SlrP appears to have the unusual 
ability to be secreted by either SPI-1 or SPI-2. 
The mechanism by which SPI-1 effectors mediate invasion of epithelial cells in 
vitro has been well characterized (Gruenheid and Finlay, 2003). The effectors SopE and 
SopE2, which act as guanine-nucleotide-exchange factors (GEFs), are first injected into 
the epithelial cell where they act to activate Cdc42 and Racl. SopB/SigD, found in SPI-5 
but secreted by the SPI-1 TTSS, can also activate these small GTPases indirectly. 
Activated Cdc42 and Racl mediate localized actin polymerization that results in plasma 
membrane ruffling. SipA binds to and stabilizes rearranged actin in the cytosol. SipC, 
which is present at the site of contact between the bacterium and the membrane because it 
functions as part of the translocon, nucleates and bundles actin at the membrane. SipC 
also appears to bind cytokeratins, suggesting that intermediate filaments may also 
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participate in the invasion process. SigD/SopB, which functions as an inositol 
phosphatase, breaks down phosphatidylinositol-4,5-bisphosphate (PIP2), assisting in 
plasma membrane invaginations at the commencement of invasion and in vacuolar 
sealing at the end. Once the bacterium is enclosed in the newly formed SCV, the GAP 
(GTPase-activating protein) function of SptP reverses the actions of SopE and SopE2 by 
turning off Cdc42 and Rac 1. SptP also demonstrates tyrosine phosphatase function, and 
may act to alter vimentin or the architecture of intermediate filaments. Microtubules do 
not appear to be involved. 
The contributions of SPI-1 to penetration of the epithelial barrier in the intestine 
in vivo have recently been further dissected to reveal that, although SPI-1 is required for 
invasion of epithelial cells, SPI-1 is not required for dissemination of bacteria from the 
intestine after oral inoculation (Lostroh and Lee, 2001). S. typhimurium defective in both 
the SPI-1 gene invA and the fimbrial gene IpfC, which targets bacteria to Peyer's patches, 
gain access to the spleen and liver after being transported across the intestinal epithelium 
by CD18+ phagocytes (Vazquez-Torres et al, 1999). Moreover, although hilA mutants 
demonstrate a decreased ability to disseminate from the gut, mutants lacking the entire 
SPI-1 locus, which cannot invade tissue culture cells in vitro, colonize mice as effectively 
as wild type S. typhimurium after gastric inoculation (Murray and Lee, 2000). The ASPI-1 
mutant, however, has a higher LD50 (>100x) than either the hilA mutant or the wild type 
strain. The difference in phenotypes of the two mutants can be explained if both hilA-
dependent and /n/A-independent SPI-1 encoded factors are required for full virulence. In 
a model proposed by Murray and Lee, a SPI-1-dependent, fa7A-independent factor causes 
the recruitment of inflammatory cells to the site of infection. SipB, a /z//A-dependent 
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SPI-1 T T S S effector, has been shown to exert cytotoxic effects on macrophages (Hersh et 
al, 1999). Bacteria with intact hilA thus eliminate infiltrating macrophages, and proceed 
through the lamina propria to the bloodstream. Mutants lacking hilA are unable to induce 
macrophage death after they are ingested due to an inability to express sipB, and 
therefore hilA mutants are killed by macrophages. The results of Murray and Lee suggest 
that mutants lacking all of SPI-1 trigger decreased recruitment of inflammatory cells, and 
thus SPI-1 mutants transverse the epithelium without being deterred by immune cells. 
The attenuation of SPI-1 mutants despite being fully competent to colonize the mouse 
suggests either that SPI-1 mediates additional virulence functions, or that inflammatory 
responses to invasion are required for full virulence of S. typhimurium. 
Salmonella pathogenicity island - 2 (SPI-2) 
Unlike SPI-1, which appears to be dispensable during infection following i.p. or 
i.v. inoculation, the SPI-2 TTSS is required for growth of S. typhimurium in mice and in 
macrophages (Hensel etal, 1995; Ochman et al, 1996; Shea et al, 1996). In vivo 
deficiencies of SPI-2 mutants can be observed starting at 8 hours after infection, at which 
time SPI-2 mutants fail to proliferate in the spleen and liver, in contrast to the more than 
1000-fold increase in cfus of wild type bacteria in these organs during the first 3 days of 
infection (Shea et al, 1999). The failure of SPI-2 mutants to grow in macrophages 
results from the mutants' inability to remodel the phagosome. Wild type S. typhimurium 
manipulates the macrophage's endocytic network to create a hospitable niche in which to 
replicate. Phox is diverted away from the phagosome, and phagosome maturation is 
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halted (Waterman and Holden, 2003). In the absence of these adjustments, SPI-2 mutants 
are unable to proliferate. 
Expression of SPI-2 is induced after phagocytosis of S. typhimurium by the 
macrophage. Environmental signals trigger the membrane protein EnvZ to phosphorylate 
the response regulator OmpR, which in turn activates transcription of ssrAB (Lee et al, 
2000a). SsrA and SsrB act as the master regulators of SPI-2 TTSS expression. These 
two proteins, which function as a two-component regulatory system, are not related to the 
SsrA/tmRNA system that some bacteria use to mark proteins for degradation that have 
stalled during translation (Karzai et al, 2000). Transcription of SPI-2 genes is triggered 
by low extracellular magnesium or calcium or by low extracellular phosphate levels 
(Deiwick et al, 1999), suggesting that these conditions are representative of the 
environment within the macrophage phagosome. In contrast to SPI-1 effectors that are 
secreted when the pH shifts from acid to alkaline, SPI-2 secretion is stimulated by a shift 
to acid pH (Beuzon et al, 1999). Although the ramifications are not known, SsrB exerts 
influence over SPI-1 genes, including hilA, in addition to SPI-2 genes (Deiwick et al, 
1998; Deiwick et al, 1999). 
SPI-2 effectors 
When SPI-2 was identified, many of the genes were recognized to be homologous 
to genes from SPI-1, as well as from the TTSSs in Yersinina and E. coli. Accordingly, 
the SPI-2 genes were designated as ssa (secretion system apparatus), ssr (secretion 
system regulator), sse (secretion system effector) or ssc (secretion system chaperone) 
(Hensel et al, 1997). The secreted effectors were later divided into two categories: true 
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effectors that are injected into host cells and translocon proteins that form a pore in 
eukaryotic cell membranes (Nikolaus et al, 2001; Scherer et al, 2000). The SPI-2 
translocon is encoded by SseB, -C, and -D (Nikolaus et al, 2001). In addition to the 
secretion system genes, the SPI-2 locus contains 12 genes that do not contribute to the 
TTSS, including a tetrathionate reductase complex and several ORFs of unknown 
function (Hensel et al, 1999). 
The precise functions of the at least 23 individual secreted effectors of SPI-2 are 
mostly unknown. The first gene identified to encode a secreted SPI-2 effector was spiC. 
spiC is found between the ssr genes and the ssa genes within SPI-2. Initial studies by 
Groisman's group indicated that a spiC mutant is greatly attenuated for growth in 
macrophages, and that SpiC is secreted into host cells where it disrupted trafficking of 
endosomes, thus potentially explaining how the Salmonella-containing vacuole (SCV) is 
diverted from normal endosome-lysosome fusion (Uchiya et al, 1999). The role of SpiC 
as a secreted effector was later challenged by Freeman et al., who suggested that SpiC in 
fact acts as a chaperone for the translocon proteins SseB and SseC (Freeman et al, 2002). 
In addition to demonstrating that the spiC mutant does not secrete SseB or SseC, the 
authors noted that the extreme attenuation of the spiC mutant resembles that of an 
apparatus mutant, not an effector mutant. Groisman and colleagues recently responded 
by demonstrating that SpiC interacts with the macrophage protein Hook3, and that a 
dominant negative Hook3 affects endosomal trafficking in the same manner as either 
expression of SpiC or infection by S. typhimurium (Shotland et al, 2003). Additionally, 
another group identified the mammalian protein TassC as a SpiC binding partner, and 
depletion of TassC by anti-sense oligonucleotides resulted in enhanced survival of a spiC 
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mutant (Lee et al., 2002). Thus, although it is clear that SPI-2 dysregulates vescicular 
trafficking in macrophages, it is uncertain which effectors are mediating this function. 
Like SPI-1, SPI-2 encodes only a few secreted effectors. Most of the known SPI-
2 effectors located outside SPI-2 were identified by genetic, not functional, strategies. 
Miao and Miller reasoned that, like secreted effectors of other TTSSs, SPI-2 effectors 
should contain a consensus amino acid sequence that targets them for secretion. 
Alignment of the sequences of effectors isolated from culture supernatants (SspHl, 
SspH2, and SlrP) revealed a conserved N-terminal domain that was used to identify five 
new effector genes: ssel, sseJ, sifA, sifB, and sopD2 (Brumell et al., 2003; Miao and 
Miller, 2000). 
Expression of most of the TTSS structural genes within SPI-2 is governed by the 
SsrA/B two-component regulatory system. Considering the possibility that genes outside 
SPI-2 that function with the SPI-2 TTSS might be co-regulated, Worley, et al. 
investigated the scope of the SsrB regulon (Worley et al, 2000). Transcriptional fusions 
revealed that more than 10 genes outside of SPI-2 are are regulated by SsrB. These 
genes, referred to as SsrB regulated factors (srfs), were mostly novel with the exception 
of srfH (ssel). The functions of SrfA-M still remain unknown. 
SPI-2 was originally identified by Holden's group during an STM screen for S. 
typhimurium virulence genes (Hensel et al, 1995). The technique of STM sets bacterial 
mutants to compete in vivo to reveal which mutants are less fit than their virulent 
counterparts. Holden extended this principle to identify secreted effectors of SPI-2: by 
competing single mutants with double mutants, Holden was able to determine whether 
virulence factors function in the same or different pathways. Using competitive 
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infections, Holden's group found that SifA acts in the same virulence mechanism as SPI-
2 (Beuzon et al, 2000). Furthermore, Holden's group demonstrated that SifA is secreted, 
and contributes to remodeling of the SCV membrane. SifA was named for its 
contribution to the formation of Salmonella-induced filaments (sifs), structures that result 
from complex actin and membrane rearrangements triggered by the bacteria. When SifA 
is not secreted, S. typhimurium is unable to maintain the integrity of the vacuolar 
membrane and individual bacteria end up in the cytoplasm of the macrophage where they 
are unable to replicate. SifA appears to be required for recruitment of membrane to the 
expanding SCV, and another SPI-2 effector, SseJ, participates in disassembling or 
remodeling the SCV membrane (Ruiz-Albert et al, 2002). Thus, if both sseJ and sifA axe 
mutated, the double mutant does not lose its vacuolar membrane in the macrophage, 
although it is attenuated in vivo. 
The formation of Sifs can be observed microscopically after infection of epithelial 
cells with wild type but not SPI-2 mutant 5. typhimurium. Using changes in host cell 
morphology as an indicator of SPI-2 effector activity, Guy et al. screened for mutants, 
which, like the sifA mutant, are unable to induce sifs (Guy et al, 2000). spiC and several 
SPI-2 apparatus genes were identified, as well as a locus in the smf-aroE intragenic 
region and a locus on S. typhimurium'?, virulence plasmid. The SPI-2 encoded genes 
sseF and sseG also influence sif formation. Although sseBCD encode the SPI-2 
translocon, sseFG appears to encode true secreted effectors. Secretion of both proteins 
into culture supernatant as well as translocation into host cells and involvement in sif 
formation has been demonstrated (Hansen-Wester et al, 2002; Kuhle and Hensel, 2002). 
85 
Finally, analysis of SPI-5 led to the discovery that, although some SPI-5 gene 
products are secreted by SPI-1, the gene pipB is part of the SPI-2 regulon. Furthermore, 
PipB is translocated by SPI-2 into the macrophage cytosol where it contributes to sif 
formation (Knodler et al, 2002). 
The Salmonella-containing vacuole and intracellular trafficking 
Two separate Salmonella-containing vacuoles (SCVs) are generated during 5. 
typhimurium infection of the mouse: the SCV formed after SPI-1 mediated invasion of 
epithelial cells, and the SCV created out of the phagosome resulting from the actions of 
SPI-2 within the macrophage. Both SCVs differ from the traditional phagosome due to 
manipulation of host cell enzymes and cytoskeletal structures by translocated TTSS 
effectors. 
The process of SPI-1 forced entry into epithelial cells is complete within 90 
minutes (Garcia-del Portillo and Finlay, 1995), at which time the SCV associates with the 
early endosomal markers EEA1 (early endosomal antigen 1) and the transferrin receptor 
(TF-R). Within 15 minutes of internalization, the SCV undergoes rab7-dependent fusion 
with compartments that contain lysosomal glycoproteins (lgps) and lysosomal acid 
phosphatase (LAP). Fusion appears to be controlled by the bacterium and results in 
segregation from the endocytic pathway. The SCV does not follow a conventional 
maturation resulting in the formation of a true lysosome because the SCV does not 
acquire the mannose-6-phosphate receptor or cathepsin D. However, the SCV is also 
isolated from the early endocytic/recycling network, resulting in only limited access to 
the SCV by fluid endocytic markers (Garcia-del Portillo and Finlay, 1995). 
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While SPI-1 enables S. typhimurium to invade normally non-phagocytic epithelial 
cells by inducing a "splash" in the membrane, S. typhimurium takes advantage of the 
phagocytic nature of macrophages to facilitate its uptake by these cells. SPI-2, therefore, 
mediates not the creation of a vacuole, but rather the modification of the phagosome into 
a niche suitable for Salmonella survival and replication (Holden, 2002). However, 
Salmonella does influence the macrophage during phagocytosis, instigating what 
resembles macropinocytosis, rather than traditional receptor-mediated endocytosis. 
Diffuse ruffling occurs at the surface of the macrophage. This is distinct from the 
ruffling mediated by SPI-1, which is localized on epithelial cells at the point of invasion. 
Morphologically, the SCV resembles a macropinosome with space between the 
bacterium and the membrane, rather than a close fitting phagosome (Alpuche-Aranda et 
al, 1994). The spacious vacuole forms around S. typhimurium regardless of the method 
of opsonization, although vacuoles formed after IgG-opsonization are initially small and 
only later enlarge. 
Also independent of the mode of bacterial entry, segregation of the SCV from the 
endocytic pathway can be detected starting at 15 minutes after internalization. The SCV 
prevents the accumulation of the late endosomal markers Rab 7 and Rab 9 and retains the 
early endosomal marker Rab5 (Amer and Swanson, 2002), although the SCV has 
minimal access to extracellular fluid markers. Trafficking of the SCV is controlled by 
the bacterium, as inhibition of bacterial protein synthesis prevents the divergence of the 
SCV from normal phagocytic maturation (Holden, 2002). As in the epithelial cells, the 
SCV in the macrophage contains some lgps including LAMP-1, but does not manifest all 
of the characteristics of a true lysosome, including the presence of degradative enzymes. 
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S. typhimurium's ability to evade destruction in late endosomes and lysosomes is the 
result of undefined actions of the PhoP/Q system. The SCVs of PhoP mutants gradually 
accumulate cathepsin D and other lysosomal markers that are not associated with the 
vacuoles of wild type bacteria (Garvis et al, 2001). 
PhoP/Q allows S. typhimurium to escape from destruction in the lysosome, but 
SPI-2 is required for creation of the niche in which bacteria can replicate. SPI-2 genes 
are up regulated 1-6 hours after entry into the macrophage by activation of the 
OmpR/EnvZ system, presumably due to alterations in the SCV environment. In vitro, 
translocon proteins are secreted only when the pH drops below 5.5, suggesting that 
acidification of the SCV may signal injection of SPI-2 effectors into the macrophage in 
vivo (Beuzon et al., 1999). This usually occurs within the first hour, with the pH in the 
SCV dropping as low as 4.0. Three to six hours after uptake, bacterial replication begins 
and is accompanied by SPI-2 mediated changes in actin polymerization. An F-actin 
meshwork forms around the SCV, and the SCV begins to extend sifs along microtubules. 
Sifs, like the SCV, are enriched in lgps and the proton ATPase, and are formed through 
the coordinated action of multiple SPI-2 effectors, including SifA, SifB, SseJ, SseF, 
SseG, SopD2, and potentially PipB. It is not clear which effectors initiate the formation 
of actin meshwork around sifs; however, SspH2 and Ssel associate with actin and actin-
binding proteins. The virulence plasmid-encoded protein SpvB, which is not thought to 
be secreted by SPI-2, can ADP-ribosylate actin and disrupt actin meshworks, and thus 
may contribute to actin rearrangements formation (Gruenheid and Finlay, 2003). 
As S. typhimurium duplicates within the macrophage, each daughter bacterium 
buds off into its own SCV, and membrane must constantly be recruited to maintain SCV 
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integrity (Beuzon et al, 2000; Meresse etal, 2001). The S. typhimurium effectors that 
act to form sifs mediate both the recruitment of endosomes to supply membrane' to the 
enlarging SCV, as well as the removal of membrane. When certain SPI-2 effectors are 
disrupted, the resulting mutants are unable to maintain their SCVs, and these mutants end 
up in the cytosol where they are killed. The source of the cytosolic killing activity has 
yet to be identified, although it has been postulated to be ubiquicidin, a small cationic 
protein with anti-microbial activity (Hiemstra et al, 1999). The bactericidal mechanism 
appears to be unique to macrophages, as evidenced by the fact that S. typhimurium 
manipulated to lose its vacuolar membrane in epithelial cells replicates better than 
enclosed bacteria (Brumell et al, 2002). 
In addition to sif formation, SPI-2 modifies the SCV in other unusual ways. 
Through the action of an unknown effector, SPI-2 prevents the fusion of vesicles 
containing phox with the SCV (Vazquez-Torres et al, 2000b). In fact, S. typhimurium-
infected macrophages redirect the trafficking of phox-containing vesicles to the plasma 
membrane instead of to the phagosome (Gallois et al, 2001). SPI-2 secreted effectors 
may also exert a similar re-trafficking action on inducible nitric oxide synthase (NOS2) 
(Chakravortty et al, 2002). Despite being originally identified as a cytosolic enzyme, 
studies have shown that NOS2 can associate with intracellular vesicles (Vodovotz et al, 
1995) and the actin cytoskeleton (Webb et al, 2001); however, NOS2 does not appear to 
be targeted to phagosomes (Webb et al, 2001). SPI-2 also appears to mediate 
recruitment of cholesterol and the GPI-anchored protein CD55 to the SCV, although it is 
not clear what role in intracellular survival this might have. 
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Flagellar genes and their overlapping regulation with SPI-1 
Flagella are extracellular appendages used by microbes for motility. The number 
and localization of flagella vary between bacterial species. Salmonella species tend have 
to 6-8 peritrichous (distributed evenly over the surface) flagella, whereas other species, 
such as Caulobacter crescentus, have one polar flagellum. These long, tail-like 
structures are composed of the monomer flagellin, which is exported to the outside of the 
bacterium where it polymerizes to form the flagellum. The apparatus employed by the 
bacteria to secrete flagellin is known as the hook basal body (HBB), which consists of a 
double ringed pore that spans both bacterial membranes and the periplasmic space. This 
method of secretion is functionally and structurally related to secretion by virulence-
related TTSSs. In fact, many of the proteins that make up the secretion apparati of the 
SPI-1 and SPI-2 TTSS have homologs in the flagellar HBB (Fig. 4). 
Flagellin monomers are encoded by two independent genes that are situated at 
separate loci on the chromosome: fliC, which encodes phase-1 flagellin and fljB, which 
encodes phase-2 flagellin. The expression and secretion of these proteins requires more 
than 50 genes, including structural subunits, secretion chaperones, regulators, and 
proteins that provide motive force (Aldridge and Hughes, 2002). Expression of these 
genes follows a complex, three tier regulatory hierarchy. The master regulators in class I 
(FlhD and FllhC) are transcription factors that induce expression at class II promoters. 
Class II genes include structures required during early assembly of the HBB, as well as 
FliA (cf28) and its anti-sigma factor FlgM. FlgM binds FHA until early assembly of the 


































































































































class III promoters, thus activating expression of structures required for the external 
filament of the flagellum, including flagellin. 
Expression from flhDC is repressed by high osmolality via the OmpR protein, and 
activated by cyclic AMP (cAMP) via the CAP-cAMP complex (Francez-Charlot et al, 
2003). A number of regulatory proteins that contribute to control of flhDC expression 
also influence the expression of SPI-1 genes, often via regulation of hilA. Some 
regulators affect similar changes at both loci. The RcsB/C regulatory system represses 
expression of both Sips and flagellin in response to low osmolality (Arricau et al, 1998). 
Other factors have differential effects on expression of flhDC and hilA, causing activation 
of one while repressing the other. The rtsAB operon coordinately regulates flhDC and 
hilA. RtsA binds to the hilA promoter and induces expression of hilA, while RtsB binds 
the flhDC promoter and inhibits expression. The CsrA/B system exerts complex 
regulation over expression of flagellar genes and SPI-1 genes. Activation of BarA/SirA 
results in direct activation of hilA, while indirectly repressing flhDC through upregulation 
of csrB (Teplitski et al, 2003). Although csrA and csrB axe usually expressed together, 
BarA/SirA does not alter expression of csrA. Both over-expression of CsrA as well as 
the lack of it reduces expression of SPI-1 encoded invasion genes (Altier et al, 2000), 
whereas CsrA stabilizes flhDC mRNA, promoting expression of flagellar genes (Wei et 
al, 2001). Further complexity arises from the fact that FlhDC can activate expression of 
hilA, although HilA does not appear to influence flhDC expression (Teplitski et al, 
2003). FlhDC's effects on hilA are mediated by the induction of expression of fliZ, a 
class II flagellar regulator that is located in an operon downstream of fliA (Iyoda et al, 
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2001; Lucas et al, 2000). Thus, disruption of fliA also results in repression of SPI-1 by 
preventing expression of FliZ (Eichelberg and Galan, 2000; Lucas et al, 2000). 
Inflammatory role of flagellin 
Flagellin is the key mediator of S. typhimurium induced inflammation in the 
intestine due to its stimulatory effects on epithelial cells (Zeng et al, 2003). Invasion of 
gut epithelia by S. typhimurium is associated with recruitment of large numbers of PMN 
to the lamina propria, followed by translocation of PMN through the epithelia into the 
lumen of the gut (Fierer, 2001). These two processes are both mediated by the pathogen, 
but appear to be controlled by different bacterial mechanisms. PMN chemotaxis occurs 
as a result of epithelial cell production of IL-8. Epithelial cells are triggered to secrete 
basolateral IL-8 by signaling of bacterial flagellin through toll-like receptor 5 (TLR-5) 
(Gewirtz et al, 2001a; Gewirtz et al, 2001b; Hayashi et al, 2001a). Signaling by TLR-5 
is MyD88-dependent. TLR-5 is expressed on only the basolateral surfaces of the 
epithelial cells; however, 5. typhimurium does not need to migrate across the epithelia to 
induce IL-8 production. Rather, S. typhimurium actively translocates flagellin across the 
epithelia. Salmonella flagellin alone cannot mediate its own translocation, as apical 
flagellin exerts no effect on intestinal epithelia. Moreover, pathogenic S. typhimurium, 
but not flagellated commensal E. coli, axe able to induce IL-8 secretion, suggesting that 
translocation of flagellin is an active process that acts as a virulence determinant. The 
exact mechanism of flagellin translocation is still unknown, but it appears to be SPI-1-
independent, as apically-situated hilA' mutants are still able to trigger basolateral IL-8 
release from epithelial cells (Gewirtz et al, 1999). 
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P M N cross the epithelial layer into the lumen of the gut in response to apical 
secretion of pathogen-elicited epithelial chemoattractant (PEEC) (Gewirtz et al, 1999). 
PEEC secretion is mediated by bacterial SPI-1-dependent secretion of SipA (Lee et al, 
2000b) which results in targeting of epithelial cell ADP-ribosylation factor 6 (ARF6) and 
protein kinase C (PKC) to the apical membrane of the cell (Criss et al, 2001). 
Transmigration of PMN does not require Salmonella uptake by or invasion of epithelial 
cells; however Salmonella. % interaction with the epithelia must occur on the apical side. 
Moreover, recombinant SipA appears to be sufficient to cause PMN transmigration. 
Infiltrating PMNs then halt the pro-inflammatory response by secreting proteases that 
degrade flagellin. Neutrophil elastase and cathepsin G dismantle both soluble and 
bacterial bound flagellin, destroying the bioactive portion and preventing further IL-8 
secretion by epithelial cells (Lopez-Boado et al, 2004). 
Apoptosis and caspases 
The process of eukaryotic cell death is not a single phenomenon. Initially the 
term "necrosis" encompassed all cell death processes, with "oncosis" referring to all non-
organized or non-programmed cell death. Today the vocabulary of cell death is 
dominated by the two terms "apoptosis" and "necrosis", with modified definitions. The 
most simplistic models separate necrosis, or accidental and unorganized cell death, from 
apoptosis, also known as programmed cell death. Classic apoptosis is ATP-dependent 
and involves of chromatin condensation, laddering of chromosomal DNA, and blebbing 
of the plasma membrane with exposure of phosphatidylserine residues, resulting in 
disassembly of the cell into apoptotic bodies (Hetts, 1998). Necrotic death is 
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characterized by cellular swelling, random degradation of chromosomal D N A , and lysis 
of the plasma membrane. In this dualistic model, apoptosis is linked to innocuous 
clearing of dead cell via phagocytosis by neighboring cells, whereas necrosis tends to 
result in activation of inflammatory pathways and often further destruction of the tissue 
(Fadok and Chimini, 2001). In recent years cell death has been more commonly 
described as a continuum ranging from apoptosis to necrosis with specific examples 
demonstrating characteristics of both necrosis and apoptosis (Leist and Jaattela, 2001), 
thus resulting in categories such as apoptosis-like programmed cell death and necrosis-
like programmed cell death. Many researchers acknowledge the limitations of assays to 
differentiate between apoptosis and necrosis (Aigner, 2002). Definitions are descriptive 
and often semantic, and thus the death category assigned to a phenomenon should be 
understood in the context of the assays used by the researchers to evaluate cell death. 
Regulation of classical apoptosis by proteases was first observed in the nematode 
Caenorhabditis elegans (C. elegans) (reviewed in (Ellis et al, 1991). The responsible 
enzymes had been identified based on their homology to the mammalian protease 
interleukin-1 (3 converting enzyme (ICE). This family of enzymes was dubbed "caspases" 
to indicate their function as a cysteine proteases that cut at aspartic acid residues, a 
previously unidentified cleavage site for mammalian proteases (Howard et al, 1991). 
Soon after the C. elegans caspases were recognized to mediate programmed cell death, 
mammalian caspases were identified with corresponding functions (Alnemri et al, 1996). 
There are about a dozen caspases in mammals that promote apoptosis (Los et al, 
1999; Thornberry and Lazebnik, 1998). The caspases are divided into 3 families based 
on gene homology: the ICE-like proteases (Caspl, 4, 5, 13, 14, and murine Caspll and 
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12), the CED-3 family (Casp3, 6, 1, 8, 9, and 10), and Casp2. Each family exhibits a 
substrate preference. Although all of the caspases contain a similar catalytic core 
including of the amino acid sequence QACXG, the 4 or 5 amino acids N-terminal to the 
cleavage-site aspartate determine the particular substrate specificity of individual 
caspases. 
Unactivated caspases exist as zymogens. Proteolytic cleavage results in 
activation of the protease domain, which then autocatalytically releases the enzymes' 3 
domains: the prodomain, the large enzymatic subunit and the small enzymatic subunit. 
The two enzymatic subunits comes together to form a heterodimer with protease activity, 
although structural analysis suggests that active caspases are tetramers composed of 2 
heterodimers (Mittl et al, 1997). Some active caspases proceed to cleave other caspase 
family members, resulting in a proteolytic cascade. Based on their order in the cascade, 
caspases can be separated into initiator and effector caspases, with the initiators starting 
the cascade and effectors cleaving substrates that result in cell death. 
Initiator caspases are activated by binding of the caspase's prodomain to adaptor 
molecules through homotypic association of interaction motifs such as the CARD 
(caspase recruitment domain) or DED (death effector domain). Two main pathways 
initiate adaptor molecule activity. Signaling through transmembrane death receptors, 
such as CD95 and TNF-R1, recruits FADD, which contains a DED, resulting in the 
activation of Casp8. Cytochrome c released from mitochondria as a result of toxins and 
other stresses activates the adaptor Apaf 1 in the presence of ATP. Active Apaf 1 then 
interacts with Casp9 via interaction of CARD domains. Additionally, these two 
pathways can activate each other. Casp9 cleavage of Casp6 can result in cleavage of 
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Casp8. Alternatively, Casp8 can activate Bid, which in turn can cause mitochondrial 
release of cytochrome c. 
Release of mitochondrial cytochrome c can influence apoptosis in multiple ways. 
In addition to participating with Apaf 1 and Casp9 to form the apoptosome, cytochrome c 
can increase intracellular calcium by binding to inositol (1,4,5) phosphate receptors on 
the endoplasmic reticulum and triggering calcium release. Intracellular calcium is 
usually tightly regulated, because sustained elevated cytosolic calcium is toxic and can 
result in cell death. Levels of calcium can reach the toxic threshold as a result of 
organelle membrane damage, hyperactivity of ligand-gated ion channels, or calcium 
dumping from the endoplasmic reticulum. Sustained elevated intracellular calcium is 
thought to promote apoptosis by activating multiple targets, including calcineurin, nitric 
oxide synthase isoforms 1 and 3, Ca++-dependent endonucleases, phospholipase A2 
(PLA2), and Ca++-dependent transglutaminases (Orrenius et al, 2003). Additionally, 
calcium activates a family of proteases called calpains that can independently, and in 
collaboration with caspases, cause cell death (Kim et al., 2002). 
Casp3, 6, and 7 are considered the effector caspases. Effectors participate in three 
main strategies to cause disassembly and death of the cell. Inactivation of apoptosis 
inhibitors such as Bcl-2 proteins and ICAD results in rapid initiation of several degradative 
pathways, including DNA fragmentation by the nuclease CAD (caspase-activated 
deoxyribonuclease). Dysregulation of enzyme activity by cleavage of regulatory 
domains from catalytic domains leads to disruption of cytoskeleton structure and DNA 
repair. Caspases target gelsolin, focal adhesion kinase (FAK), p21-activated kinase 2 
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(PAK2), and DNA-PKCS. Finally, caspases help dismantle cells by destroying structures 
such as nuclear lamina. 
Some researchers have described "caspase-independent apoptosis" (Leist and 
Jaattela, 2001) and "caspase-dependent necrosis" (Wang et al, 2003). The definitions of 
apoptosis and necrosis in these articles are derived from morphologic changes in dying 
cells. Caspase-dependent necrosis, for example, is described for A549 cells undergoing 
hyperoxia-induced death with all the features of necrosis, yet death is dependent on 
Casp8 activation of Bid. Caspase-independent apoptosis involves chromatin 
condensation, but it is less complete than in classical apoptosis. Thus, caspase 
involvement in cell death does not define apoptosis, nor do classical apoptotic features 
necessarily imply the involvement of caspases. 
A few of the caspases play important roles in inflammation in addition to 
regulation of cell death. Caspl, or ICE, was identified as the enzyme that converts the 
IL-1 (3 precursor into an active cytokine. Caspl also processes the precursors of IL-16 
and IL-18. Unlike Casp3-deficient mice, which die either in utero or soon after birth due 
to aberrant neural development, Caspl-deficient mice show no developmental defects. 
Moreover, although over-expression of Caspl promotes apoptosis by suppressing Bcl2, 
Caspl-deficient cells demonstrate no overt problems accomplishing programmed cell 
death. Thus, the role of Caspl in inflammation and immunity is well defined, but the role 
of Caspl in cell death is less clear. 
Recently, Caspl has been implicated in several specific cases of immune cell 
death. Death of microglial cells triggered by ATP signaling through P2Z-receptors 
appears to be partially dependent on Caspl, 3 and 8 (Ferrari et al, 1999a). Apoptotic 
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features, such as chromatin condensation and D N A fragmentation, could be blocked with 
caspase inhibitors; however, inhibitors did not prevent cytoplasmic vacuolization and cell 
lysis. Caspl may also play a role in neuronal cell death as a result of traumatic brain 
injury (TBI) (Sanchez Mejia et al, 2001). This subject is currently open to debate with 
opponents presenting evidence that Casp3, and not Caspl, is required for TBI 
cytotoxicity (Allen et al., 1999; Sullivan et al, 2002). Finally, although a number of 
bacterial pathogens can cause host cell apoptosis, only a few have been demonstrated to 
activate Caspl. Two intracellular bacterial pathogens have been connected with Caspl -
dependent cell death: Shigella flexneri (Edgeworth et al., 2002) and S. typhimurium 
(Knodler and Finlay, 2001; Monack et al, 2001). Additionally, the oral Gram-positive 
species Actinobacillus actinomycetemcomitans, a cause of periodontal disease, produces 
a leukotoxin that lyses neutrophils and monocytes in a Caspl-dependent mechanism 
(Kelk etal, 2003). 
Salmonella-induced macrophage death 
S. typhimurium is one of 3 enteric Gram negative bacteria that induce host cell 
death through the actions of a TTSS (Navarre and Zychlinsky, 2000). Shigella, Yersinia, 
and Salmonella are facultative intracellular pathogens that use pathogenicity island-
encoded TTSSs to mediate invasion of host cells. Some TTSS-secreted effectors hijack 
actin filaments, enabling uptake of the pathogen, while other specific effectors are known 
to bind intracellular proteins, thus dysregulating host cell signaling and resulting in host 
cell death. While invasion effectors are most important for interactions with non-
phagocytic cells such as epithelia, the proteins that mediate cytotoxicity are active 
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primarily in macrophages. Shigella and Salmonella effector proteins appear to cause 
death by directly activating macrophage caspases. Yersinia triggers cytotoxicity by 
triggering toll-like receptors (TLRs) to activate pro-apoptotic pathways, and 
simultaneously translocating YopP/J into the host cell cytosol, which prevents the 
activation of NF-kB that would normally prevent macrophage apoptosis. Shigella and 
Salmonella-induced cytotoxicity results in a large inflammatory response, whereas 
Yersinia-induced death resembles classical apoptosis in that it reduces the inflammatory 
component of the immune response. 
There appear to be potentially four independent cytotoxic mechanisms by which 
S. typhimurium can kill macrophages (Table II). SPI-1-dependent killing accounts for 3 
mechanisms of cytotoxicity, one of which occurs very rapidly (within 1-6 hours) and two 
of which occur late (8-12 hours) after infection of macrophages. SPI-2-dependent killing 
occurs only late after infection (6-14 hours) (van der Velden et al, 2000). SPI-1 and SPI-
2 appear to account for all of S. typhimurium's cytotoxic activity: a double mutant that 
can express neither SPI-2 nor the SPI-1 encoded sipB demonstrates no ability to kill 
macrophages (van der Velden et al, 2000). 
If bacteria are grown to late log phase before infecting macrophages, thus 
inducing expression of SPI-1 and its effectors, macrophage cell death can be observed 
within a few hours. This phenomenon has been observed using bone marrow derived 
macrophages (Chen et al, 1996b; Lundberg et al, 1999; Monack et al, 1996), as well as 
both the J774.1 (Chen et al, 1996b; Lundberg et al, 1999) and RAW264.7 (Hersh et al, 
1999; Monack et al, 1996) macrophage-like cell lines. Death is dependent on 





















































































































































































__f Ov" 2. 
oo On " 
•^ rt -J1 
2 r^ 
-°- "3 ~ 
T3 (U tuO 
§3S 




























































(Hersh et al, 1999; Lundberg et al, 1999). SipB is the homolog of the S. flexneri protein 
IpaB, which is necessary for S. flexneri Anduced macrophage apoptosis (Zychlinsky et 
al, 1992). IpaB binds to caspase-1 while inducing macrophage apoptosis (Guichon et 
al, 2001), and SipB appears to function in the same way to promote macrophage 
cytotoxicity. In fact, microinjection of SipB is sufficient to induce macrophage death 
(Hersh etal, 1999). However, despite the involvement of SipB and Caspl, early 
Salmonella-induced macrophage cell death does not appear to be true apoptosis. Two 
independent investigators have closely examined the phenomenon in both cell lines and 
primary macrophages and concluded that there are no true apoptotic features seen in SPI-
1-dependent macrophage death, and that death more closely resembles necrosis (Brennan 
and Cookson, 2000; Watson et al, 2000). Thus, SPI-1-dependent Salmonella-induced 
macrophage cell death is more properly referred to as caspase-1-dependent necrosis. 
Because caspase-1 is not generally associated with apoptosis and because 
macrophage death appears to be necrotic, not apoptotic, it is unclear whether activation of 
caspase-1 by SipB results in rapid macrophage death. SPI-1-dependent caspase-1 
activation, not unexpectedly, results in release of IL-1 [3 and IL-18, which leads to 
inflammation at the site of infection (Hersh et al, 1999; Monack et al, 2001). However, 
cytokine release does not explain how caspase-1 and SipB induce macrophage death in 
vitro. One report indicates that infection of bone marrow macrophages with Salmonella 
induces degradation of Raf-1 that is both SipB- and caspase-1-dependent, and that c-raf-
l- deficient macrophages are hyper-susceptible to Salmonella-induced death (Jesenberger 
et al, 2001). Raf-1 is considered an entry point to the mitogen activated protein kinase 
(MAPK) cascade (Dhillon and Kolch, 2002); however, death of c-raf-1 -deficient 
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macrophages occurred without disruption of M E K or E R K signaling and without 
increased mitochondrial fragility, suggesting a novel function of Raf-1. Raf-1 
modification is also seen as a result of interactions with S. typhimurium porins and with 
the SPI-1 secreted effector SptP (Galdiero et al, 2002; Lin et al, 2003). 
A second form of Salmonella-induced macrophage death has been described as a 
result of infection with over-night cultures of S. typhimurium. Stationary phase cultures 
of S. typhimurium do not express SPI-1, and J774.1 macrophages as well as bone marrow 
macrophages survive long enough to undergo a delayed, SPI-2 dependent death 
(Lindgren et al, 1996). In addition to mutations in SPI-2, disruption of OmpR/EnvZ, the 
2 component regulatory systems that modulate SPI-2, abrogates killing, suggesting that 
the intracellular environment modulates the bacterial mechanisms that result in 
cytotoxicity. The virulence plasmid spv genes, specifically spvB, are required for SPI-2-
dependent cytotoxicity against human monocytes-derived macrophages (Browne et al, 
2002). The specific SPI-2-secreted effectors that trigger death pathways in the 
macrophage are unknown; however, SpvB, not traditionally considered a SPI-2 effector, 
may be responsible, in part, for the destruction of macrophages. SpvB acts as an ADP-
ribosyl transferase that modifies actin, thus blocking polymerization to F-actin filaments 
(Lesnick et al, 2001), and SPI-2-dependent death is associated with extensive disruption 
of macrophage actin. 
SPI-2-dependent, SipB-independent macrophage death is mediated by Casp2 
(Knodler and Finlay, 2001). The specific role of Casp2 in cell death is not fully 
understood, and there is some debate concerning whether Casp2 is an effector or an 
initiator caspase. Like the Caspl null mouse, the Casp2-deficient mouse does not exhibit 
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a dramatic phenotype; however, Casp2 has been demonstrated to be required for 
apoptosis in several systems including beta-amyloid toxicity and trophic factor 
deprivation (Troy and Shelanski, 2003). 
Although the involvements of SPI-1 and SPI-2 in early and late Salmonella-
induced macrophage death appear to be exclusive, the role of caspases may not be so 
distinct. At least one study indicates that rapid SPI-1-dependent death occurs after 
simultaneous and independent activation of both Caspl and Casp2 (Jesenberger et al, 
2000). Moreover, if macrophages deficient in Caspl are studied, delayed SipB-
dependent killing can be examined. Jesenberger, et al. found that Caspl-deficient bone 
marrow macrophages undergo apoptosis that is Casp2-dependent at 4-6 hour after 
infection, and that cytotoxicity is SipB (SPI-Independent, suggesting a third mechanism 
of Salmonella-induced macrophage death. Unlike Caspl-dependent cytotoxicity, delayed 
SipB-dependent, Casp2-dependent death involves Casp3, 6 and 8, as well as cytochrome 
c translocation from mitochondria, thus resembling classical apoptosis. 
A recent study has characterized a SipB-dependent cytotoxicity which appears to 
be caspase-independent (Hernandez etal, 2003). Caspase-1-deficient bone marrow 
macrophages were killed by wild type Salmonella in a delayed, SipB-dependent manner 
that was not inhibited by the pan-caspase inhibitor Z-VAD. Microscopic examination 
revealed that SipB associates with macrophage mitochondria, resulting in mitochondrial 
remodeling and formation of autophagosomes. Recombinant SipB protein has been 
shown to insert into mammalian cell membranes without perturbing bilayer integrity, and 
to induce heterotypic membrane fusion (Hayward et al, 2000). A SipB mutant that lacks 
the domain required to induce membrane fusions could still associate with mitochondria, 
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but was unable to cause formation of autophagosomes or macrophage death. Thus, 
caspase-independent induction of autophagy by SipB may represent a fourth mechanism 
of Salmonella-induced macrophage death. 
It is difficult to study the relevance of Salmonella-induced macrophage death in 
vivo, but several studies have shed light on the possible role of cytotoxicity in systemic 
pathogenesis. Caspase-1"'" mice and wild type mice control S. typhimurium infection 
similarly after i.p. infection; however, caspase-1'1' mice are lOOOx more resistant to 
infection after oral inoculation (Monack et al, 2000; Monack et al, 2001). Moreover, 
histologic analysis of ligated intestinal loops demonstrated that although membrane 
ruffling and invasion occur in caspase-1"'" mice during S. typhimurium infection, there is 
neither cell death in Peyer's patches nor PMN infiltration at the site of invasion. This 
suggests that Salmonella-induced macrophage death is of primary importance during 
invasion of the gastrointestinal tissue, particularly of cells in Peyer's patches. Because 
SPI-1 genes are upregulated by conditions found in the intestine, and SPI-2 genes are 
turned on within the phagosome, it is likely that rapid SipB-dependent killing occurs in 
the macrophages of the gut, whereas delayed SPI-2-dependent cytotoxicity may occur in 
tissue macrophages, allowing bacteria time to replicate within the phagosome. 
Confocal microscopy of liver sections from Salmonella-infected mice revealed 
that bacteria live within phagocytes, not hepatocytes, in the liver, and are cytotoxic to 
phagocytes in which they reside (Richter-Dahlfors etal, 1997); however, this study did 
not distinguish between dying macrophages and dying PMNs. Activated neutrophils will 
die rapidly independent of the presence of Salmonella, and therefore it is difficult to 
ascertain from this study whether Salmonella directly kill phagocytes during systemic 
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infection. It is possible, though, that phagocyte death seen in the liver results from SPI-2 
dependent delayed cytotoxicity, thus enabling nascent intracellular bacteria to spread to 
new phagocytes. 
Mice depleted of macrophages by injection of liposomes are more resistant to i.v. 
infection with S. typhimurium than control mice (Wijburg et al., 2000), suggesting that 
macrophages function more as safe sites for bacterial survival and replication than they 
do as bactericidal cells. Thus, it would be detrimental to S. typhimurium to destroy all 
macrophages encountered in vivo, and cytotoxicity is presumably regulated to optimize 
both the spread and the proliferation of the bacteria. 
Because gut associated macrophages are probably killed by SPI-1-expressing 
bacteria, some people have postulated that dendritic cells may be responsible for carrying 
Salmonella from the site of infection to the liver and spleen (Rescigno et al, 2001). In 
the absence of SPI-1, intestinal S. typhimurium is transported across the gut epithelia by 
CD18+ mononuclear phagocytes that resemble dendritic cells (Vazquez-Torres et al, 
1999). Yet Salmonella may be cytotoxic to dendritic cells, too. LDH release, 
phosphatidylserine redistribution, and caspase activation all occur rapidly after infection 
of dendritic cells with S. typhimurium (van der Velden et al., 2003). Although 
cytotoxicity is both SipB- and caspase-1-dependent, death occurs with either late log 
phase or stationary phase cultures of S. typhimurium, suggesting that death may be 
occurring by a mechanism different from that seen in macrophages. 
S. typhimurium causes systemic disease in mice that resembles typhoid fever 
caused by S. typhi in humans. SPI-1-dependent macrophage death appears to be largely 
responsible for dissemination of the bacteria from the gut tissue into the internal organs. 
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In humans and cattle, infection with S. typhimurium generally causes localized disease in 
the intestine resulting in diarrhea. Despite this difference in pathogenesis in the larger 
species, S. typhimurium induces SPI-1-dependent macrophage death of both bovine and 
human macrophages (Forsberg et al, 2003; Santos etal, 2001). However, SipB-
dependent macrophage death appears either not to occur during or not to contribute to 
enteritis in calves (Zhang et al, 2003). Thus, the systemic nature of S. typhimurium 
infection in mice may be due to specific conditions in the murine intestine that promote 
bacterial expression of genes required for host cell death, resulting in breach of the 
intestinal wall. 
V. S. typhimurium and M. tuberculosis', some key distinctions 
S. typhimurium and M. tuberculosis axe very different in many ways: one is Gram 
negative, the other is acid-fast; infection with one causes a systemic fever in mice and 
gastroenteritis in humans, infection with the other can result in diffuse pathology, but 
most often presents as infection of the lungs. Yet, once inside the host, both pathogens 
take shelter within the macrophage phagosome and cause dysregulation of phagosome 
maturation. A comparison of some of the basic features of the microbial pathogenesis of 
each bacterium reveals both interesting parallels and differences. 
Although S. tyhphimurium and Mtb both modify the macrophage phagosome as a 
survival strategy, the resulting niches are very different. Mtb's preferred phagosome 
resembles an early endosome. In addition to avoiding lysosomal enzymes, Mtb eschews 
the proton ATPase, and thus the pH in the phagosome does not drop below 
approximately 6.5 in unactivated macrophages. This is important because low pH is 
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required for optimal activity of macrophage acid hydrolases, and acidic pH amplifies and 
prolongs the effects of RNI. Nitrite, which can be formed from nitric oxide, is toxic in 
acidic pH, but loses its reactivity when the pH becomes neutral. The SCV in which S. 
typhimurium resides also resembles an early endosome, insomuch as it retains Rab5 and 
excludes Rab7 and many other lysosomal enzymes; however, unlike the Mtb phagosome, 
the SCV acidifies to a pH of 5.0. S. typhimurium appears to require low pH in order to 
activate its virulence mechanisms. SPI-2 effectors, which are required for S. 
typhimurium survival in the macrophage, are not secreted in vitro unless the pH drops 
below 5.5 (Holden, 2002). Thus, while Mtb has evolved to survive by blocking 
phagosome maturation and avoiding acidic environments, S. typhimurium has evolved to 
take advantage of aspects of phagosomal maturation, and may in fact require a low pH to 
survive in vivo. 
Toxic micromolecules pose a threat to all phagosomal pathogens. Mtb and S. 
typhimurium have evolved similar strategies for confronting ROI produced by phox, and 
yet resist killing with different levels of success. Phox activity is triggered by 
phagocytosis, and does not require activation by the macrophage stimulatory cytokine 
IFN-y. Thus, unlike NOS2, which must be transcribed and translated following 
macrophage activation, phox is an immediate threat to phagosomal pathogens. Mtb and 
S. typhimurium have both evolved mechanisms for hindering the efficacy of phox: Mtb 
directs its own uptake by binding to phagocytic receptors that tend not to stimulate phox, 
and S. typhimurium uses SPI-2 to divert phox away from the phagosomal membrane. 
These bacterial manipulations, however, are not sufficient to eliminate the effects of phox 
entirely, and thus both bacteria possess catalases and peroxidases for the detoxification of 
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ROI. Here is where we see a striking difference between Mtb and S. typhimurium: the 
effectiveness of KatG and SodA make Mtb virtually impervious to the activity of phox, 
whereas, despite an arsenal of anti-oxidant mechanisms, S. typhimurium is highly 
susceptible to killing by ROI. Comparison of disease in phox-deficient mice with 
immuno-competent mice clearly illustrates this point (Ng et al, 2004; Shiloh et al, 
1999). 
The opposite holds true for RNI. NOS2-deficient mice control infection with 
virulent strains of S. typhimurium as well as wild type mice; however, Mtb overwhelms 
NOS2-deficient mice, which die substantially earlier than their infected immuno-
competent counterparts (MacMicking et al, 1997; Shiloh et al, 1999). The two bacteria 
share a number of enzymes that have been shown to be important defenses against RNI in 
vitro, including AhpC and MsrA (Shiloh and Nathan, 2000; St John et al, 2001); 
however, as is the case with ROI, it is not clear why one pathogen appears to be so much 
more susceptible to RNI than the other. In fact, Mtb has been shown to possess RNI 
counter-immune mechanisms that are absent in S. typhimurium. The Mtb proteosome 
provides resistance to RNI in vitro and in vivo by an unknown mechanism; however, 
Gram negative bacteria do not encode proteasomes, and thus this is not counter immune 
strategy available to S. typhimurium. 
As discussed earlier, S. typhimurium'1 s apparent resistance to RNI in vivo may 
reflect the use of NrampT mice as a model for acute systemic typhoid fever. Unlike Mtb, 
which causes a chronic infection in mice during which adaptive immunity plays a critical 
role, NrampT mice do not live long enough to benefit from IFN-y generated by antigen-
specific T cells. When NrampT mice are infected, a role for NOS2 in control of S. 
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typhimurium can be demonstrated (Mastroeni et al, 2000). Typhoid fever resulting from 
S. typhi infection of humans is generally an acute and self-limiting infection; however, 1-
5% of infected individuals become asymptomatic chronic carriers (Munoz-Elias and 
McKinney, 2002). A recent publication describes oral infection of NrampT mice with 
low dose virulent S. typhimurium as a mouse model of chronic typhoid fever (Monack et 
al, 2004). This model does not entirely mimic chronic disease in humans, during which 
bacteria evade immune recognition by colonizing the immune-privileged gall bladder. In 
chronically infected S. typhimurium-infected mice, bacterial populations persist in the 
lymph nodes; however, the model presents a novel opportunity to assess components of 
the adaptive immune response required for maintenance of chronic infection. When IFN-
y is neutralized in these chronically infected mice, there is a rebound in bacterial 
proliferation, and the mice demonstrate signs of illness. It will be interesting to learn 
more about which immune factors contribute to maintenance of chronic Salmonella 
infection, and if NOS2 is among them. 
It is not surprising that Mtb and S. typhimurium encode homologous genes; most 
bacteria contain genes with homology to genes from other bacterial species. More 
interesting, though, is the evolution of analogous strategies by Mtb and S. typhimurium 
for interacting with the immune response. One of the most potent immuno-modulatory 
molecule synthesized by S. typhimurium is the Lipid A component of LPS. The outer 
lipids and glycolipids of Mtb are also immuno-modulatory. The use of lipids for both 
protection as well as manipulation of the immune response is beginning to be appreciated 
as a common strategy among pathogens (van der Kleij and Yazdanbakhsh, 2003). 
Bioactive lipids that have both pro- and anti-inflammatory effects are well characterized 
110 
in the host, including prostaglandins and leukotrienes (Yoshikai, 2001). The discovery of 
TLRs and the appreciation that TLR2 mediates signaling of many microbial lipids has 
revitalized the field of microbial bioactive lipids. Lipids from bacteria, single-celled 
parasites, as well as parasitic worms have all been shown to signal through TLR2, 
resulting in suppression or activation of the immune response. 
The delivery of virulence factors into the macrophage is another strategy common 
to the microbial pathogenesis of both Salmonella and mycobacteria. S. typhimurium uses 
TTSSs to inject proteins across the phagosomal membrane and into the cytoplasm of the 
macrophage. Mtb releases both surface proteins and lipids that are transferred out of the 
phagosome and trafficked through the macrophage. Although the exact functions of 
these released proteins and lipids are not known, lipids released from intracellular BCG 
are able to stimulate macrophage responses (Beatty et al, 2000; Rhoades et al, 2003). It 
has been proposed that the transporters that export lipids, such as PDIM, to the surface of 
the bacterium are Mtb's equivalent of the TTSS (Glickman and Jacobs, 2001), although 
actual injection of lipids into the host has not been demonstrated. The ability to inject 
molecules into host cells where they can act to manipulate host functions at a distance 
may be a shared strategy of intracellular pathogens. 
VI. Differential signature-tagged transposon mutagenesis (STM) 
Although in vitro studies provide a simplified system in which to examine 
specific interaction between pathogens and immune cells, the results may not accurately 
reflect real scenarios that occur in the host. In recent years, a number of clever assays 
have been developed that take advantage of new technologies to reveal microbial genes 
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important for disease. D N A microarray technology permits the evaluation of expression 
of entire microbial genomes, reflecting both which genes are induced inside host cell, as 
well as the nature of the intracellular environment (Eriksson et al, 2003; Schnappinger et 
al, 2003). Differential fluorescence induction (DFI) uses expression of a green 
fluorescent protein (GFP) reporter in combination with fluorescence-activated cell sorting 
(FACS) to identify genes that are upregulated under specific conditions, including 
ingestion by macrophages (Valdivia and Falkow, 1997). IVET and RIVET use a similar 
reporter construct strategy, but rely on expression of antibiotic resistance for identifying 
genes, and thus IVET and RIVET can be used to analyze bacterial genes induced in vivo, 
rather than in cell culture. IVET (in vivo expression technology) creates a bacterial 
library of chromosomal fusions in which a promoter-less antibiotic resistance gene acts as 
the reporter. After infection with the library, animals are treated with antibiotics, and thus 
only clones in which the reporter fusion has inserted in a gene expressed in vivo will be 
recovered (Mahan et al, 1995). RIVET (recombinase-based in vivo expression 
technology) uses reporter constructs that express the TnpR resolvase (Camilli et al, 
1994). When induced, TnpR recognizes res sites, and will excise any DNA contained 
within two res sites. A DNA sequence flanked by res sites is placed immediately 
downstream of the promoter of an antibiotic resistance cassette, thus blocking expression 
of antibiotic resistance until the TnpR resolvase is expressed. If a gene is expressed only 
briefly during infection, antibiotic resistance will continue to be expressed even after the 
gene has been turned off. Thus, RIVET can identify genes that are induced only at 
distinct times during infections. 
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Another strategy for understanding genes required for growth in vivo involves 
disrupting bacterial genes and assessing the bacterial mutants for virulence in an animal 
model. Making large numbers of random marked gene disruptions is easily achievable 
using transposon mutagenesis. However, in order to effectively screen libraries of 
mutants, one must have a method for identifying individual mutants from within a pool of 
mutants. More specifically, one must have a method for identifying the absence of a 
particular mutant that has been depleted from the pool because it was unable to survive in 
vivo. Two strategies have been developed with different to solutions to this problem. In 
signature-tagged transposon mutagenesis (STM), a set of transposons is generated such 
that each transposon bears an unique DNA tag, which acts like a bar code (Hensel et al, 
1995). If there are 48 individual tags, then 48 individual transposon mutants can be 
pooled and simultaneously screened for attenuation in vivo. Using Southern 
hybridization, DNA tags carried by bacteria recovered from animals can be analyzed to 
determine which tags are under-represented after passage in vivo as compared to the input 
pool. TraSH (transposon site hybridization) combines transposon mutagenesis with 
microbial genome microarrays to evaluate much larger pools of transposon mutants 
(Sassetti et al, 2001). Pools of bacterial mutants are subjected to a specific stress, and 
then labeled RNA probes are generated from each surviving mutant by amplifying off the 
transposon into the disrupted gene. These probes are labeled, hybridized to a genome 
microarray, and compared to probes generated from non-stressed bacterial pools. 
Although TraSH permits rapid identification of many genes essential for growth under 
the conditions tests, it does not preserve the individual mutants that are attenuated for 
growth, and specific mutants must be reconstructed for further study. STM pools are 
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assembled from individual clones, and thus a stock of each mutant is available for follow 
up experiments. 
Our interest was not general virulence factors, but rather bacterial mechanisms 
that counter specific immune stresses. S. typhimurium and M. tuberculosis persist within 
the macrophage in vivo despite bombardment with RNI, ROI, and other toxic substances. 
The bacterial genes responsible for the survival of S. typhimurium and M. tuberculosis 
despite these host defenses are only partially characterized. In order to identify bacterial 
genes that are required for growth in the face of distinct components of the host immune 
system, we developed a modified version of STM based on the hypothesis that a bacterial 
gene required for protection against a specific stress should be dispensable for bacterial 
growth in the absence of that stress. During Differential STM, pools of bacterial mutants 
are evaluated for differential virulence in at least two strains of mice with different 
degrees of immune-competency (Fig. 5). For example, mutants that are attenuated in 
wild type mice, but have no difficulty growing in NOS2-deficient mice, contain 
transposon insertions in genes that may provide specific resistance to RNI. This strategy 
enables dissection of bacterial counter immune mechanisms to distinct host stresses in 
vivo. 
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Figure 5. Differential signature-tagged transposon mutagenesis: a strategy to identify 
bacterial mutants deficient in the ability to counter specific immune mechanisms. 
Signature-tagged transposon mutants are arrayed in 48 or 96-well microtiter dishes (1). 
Pooled mutants are inoculated into 2 different strains of mice that differ in immune 
status. Strain 2 mice should either be immunocompetent, or deficient in a subset of the 
functions absent in strain 1 mice. Bacteria are recovered from the appropriate organ by 
plate culture at the indicated times post-infection. Signature tags in the recovered pools 
of bacteria are amplified and radiolabeled and used to probe membranes arrayed with 
the set of 48 or 96 signature tags. Tags that are detected in the input pool (2) but 
reduced or absent in the recovered pools (3,4) indicate mutants that are attenuated in 
vivo. The mutant spotted in column 3 row 5 is under-represented in pools recovered 
from strain 2 mice (4) but not in pools recovered from strain 1 mice (3), indicating that 
the corresponding cim gene is required for progressive bacterial growth in the face of a 
an immune mechanism present in mouse strain 2, but absent in mouse strain 1. 
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Chapter 2 
Material and methods 
M . tuberculosis experiments: 
Bacterial strains and growth conditions 
Wild-type Mtb (strains H37Rv and Erdman) and derivative strains were 
propagated at 37°C in Middlebrook 7H9 broth containing 10% OADC (DifCo), 0.5% 
glycerol, and 0.05% Tween-80, or on Middlebrook 7H10 agar containing 10% OADC 
and 0.5% glycerol. Antibiotics were hygromycin (50 fig/ml) and kanamycin (25 fUg/xnl). 
Frozen stocks were prepared by growing broth cultures to mid-log phase (OD^ ~ 0.5), 
adding glycerol to 15%, and storing in aliquots at -80°C. 
Construction of STM mutant library 
A panel of 48 transposons in the temperature-sensitive mycobacteriophage 
phAE87 was constructed as described (Cox et al, 1999). Each phage contained a unique 
random 40mer signature tag within the 7n5370 transposon, which carries the hygromycin 
resistance marker (hyg). Phages were amplified individually in Mycobacterium 
smegmatis mc2155 to final titers of ~5 x 10" PFU/ml. Cultures of Mtb H37Rv were 
mutagenized with the phage stocks and transposon insertion mutants were selected on 
7H10 agar containing 50 uglxnl hygromycin. Individual colonies were picked and 
inoculated into 7H9 broth containing 50 pglxnl hygromycin dispensed into 48-well 
microtiter plates, such that each of the 48 signature tags was represented by one mutant 
per plate. The microtiter plate cultures were grown to stationary phase at 37°C and 
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aliquots from each well were combined to generate pools of 48 signature-tagged mutants. 
The pools were diluted 1:100 in 7H9 broth containing 50 ^g/ml hygromycin and grown 
at 37°C until the OD^ reached ~ 0.2. The amplified pools were then washed and 
resuspended in PBS containing 0.05% Tween-80 and 15% glycerol as a cryopreservant, 
aliquoted in cryovials, and stored at -80°C 
Mouse infections 
Male and female C57BL/6, IFN-y"'", and NOS2A mice, 6-10 wk of age, were 
purchased from Jackson Laboratories. phoxEp91/"NOS2"/" mice were generated and 
maintained as described (Shiloh et al, 1999). Mtb frozen stocks were thawed, diluted in 
PBS, and sonicated briefly to disperse clumps. Mice were infected by injection of 0.1 ml 
(1 x 105 - 1 x 106 CFU) of the diluted bacterial stock into a lateral tail vein and euthanized 
by C02 exposure at specified time points; n = 4-5 mice per time-point unless otherwise 
noted. Organs were removed aseptically and homogenized in PBS containing 0.05% 
Tween-80 and 100 pig/ml ampicillin to prevent contamination. Bacteria in the lungs, 
spleen, and liver were enumerated by plating diluted organ homogenates on 7H10 agar, 
and counting colonies after 3-4 weeks at 37°C; error bars indicate standard deviations. 
Isolation of Mtb genomic DNA and amplification of signature tags 
The four STM mutants characterized in this study were identified from 2 pools as 
follows. Lung homogenates from mice infected with STM pools were plated at low 
density for enumeration of CFU and at high density for STM analysis. Genomic DNA 
was isolated from -10,000 pooled colonies per lung homogenate (recovered pools) and 
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from colonies generated by plating the inocula that were used to infect the mice (input 
pools). STM tags were PCR amplified from input and recovered pools using primers 
specific for invariant regions on either side of the STM tags (Cox et al, 1999), and PCR 
products were purified using the Qiaex II kit (Qiagen). Amplified tags were labeled with 
32P -dCTP using the Megaprime Labeling System (Amersham), and free 32P -dCTP was 
removed using Probequant G-50 Micro columns (Amersham). 
Southern hybridizations 
The 48 individual signature tags were PCR amplified from purified phage DNA 
and cloned individually into pUC19 using HinDlll. The 48 plasmid DNAs were arrayed 
onto 9 x 12 cm Zeta Probe nylon membranes (Bio-Rad) using a 48 well Bio-Dot SF 
Microfiltration Apparatus (Bio-Rad). Hybridizations using labeled signature tags from 
input and output STM pools were performed at 65°C in Rapid-Hyb solution (Amersham) 
and the hybridized membranes were processed per the manufacturer's instructions. 
Autoradiographic films (Kodak) were exposed to membranes for at least 2 hours and 
developed per the manufacturer's instructions. 
Identification of transposon insertion sites 
Genomic DNA was isolated from individual STM mutants grown in 7H9 broth. 
Transposon insertion sites in the genome were identified by inverse PCR as described 
(Cox et al, 1999). Briefly, .foal-digested genomic DNA was purified using the Qiaex II 
kit (Qiagen), self-ligated, and PCR amplified with primers o84L-F (5' 
GTCATCCGGCTCATCACCAG-3') and o84L-R (5'-AACTGGCGCAGTTCCTCTGG-
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3') to amplify the genomic D N A fragments flanking the ends of the transposon. PCR 
products were separated on agarose gels and purified using the Qiaex II kit (Qiagen). The 
nucleotide sequences of the purified amplicons were determined by the Rockefeller 
University DNA Sequencing facility. In some cases, PCR products were cloned using the 
TopoTA Cloning Kit (Invitrogen) and the plasmid DNA was purified using the Qiagen 
miniprep kit prior to sequencing. 
Statistical analysis 
The Student's r-Test was used to evaluate differences in bacterial CFU in infected 
organs. One-tailed Student's r-Tests were applied to comparisons of CFU from H37Rv-
infected wild type mice with CFU from H37Rv-infected IFN-y"'" mice and NOS2"'" mice in 
Fig. 4A. Two-tailed Student's r-Tests were applied to the data in Fig. 1A-C, and the data 
in Fig. 4B-E. Kaplan-Meier curves were compared using the Mantel-Haenszel test as 
applied by the GraphPad Prism 4.0 program from GraphPad Software, Inc. (Motulsky, 
2003). P values < 0.05 were considered statistically significant. Data are represented as 
means with error bars indicating the standard deviations from the means. 
S. typhimurium experiments: 
Bacterial strains and growth conditions 
The bacterial strains used in this study are listed in Tables III and IV. STM pools 
were a generous gift from David Holden; STM mutants were derived from the parental 
strain 12023, also known as 14028 with spontaneous nalidixic acid resistance (14028R) 
(Hensel et al, 1995). Bacteria were grown in Luria-Bertani (LB) broth or on LB-agar 
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spontaneous mutant (14028R) 
ssrB::mTn5 in 12023 (KanR) 
ssaR::mTN5 in 12023 (KanR) 
ydiV::mTn5 in 12023 (KanR) 
12023+pwks30 
SCN19 + pwks30 
SCN 19 + pKH7 
ydiU::CmR in 12023 
ydiV::CmR in 12023 
ydiV::CmR ssaR::mTn5 in 
12023 (KanR) 
ydiV::CmR-lacZYA/ydiV+ in LT2 
ydiV::CmR-lacZYA/ydiV+ in SCN3 
SCN78 + pKH7 
Mouse virulent, fmr 
fljB/MudS fliC::TnlO in 
SL3201(KanR,TetR) 
sipB::aphT transduced 
into 12023 (KanR) 





ydiV::CmR-lacZYA/ydiV+ in 12023 
rpoS mutant 
flhDC:: CmR-lacZYA/flhDC+ in 12023 
flhDC:: CmR-lacZYA/flhDC+ 
in SCN19 (KanR) 
SL1344 y^V::CmR sipC::Tn5-lacZYA 
(KanR) 
SL1344 sipC::Tn5-lacZYA (KanR) 
flaA66 metA22 trp-2 rpsLxyl-401 
ilv-452 leu hsd mos* 
ahpC:: CmR-lacZYA/ahpC+ inl2023 
ahpC:: CmR-lacZYA/ahpC+ in 
SCN 19 (KanR) 
Source or reference 
Shea etal 1999 
P08H06 in Hensel etal. 1995 
P02A02 in Hensel s 1995 










Hoiseth and Stocker 1981 















Table IV. E. coli strains and plasmids used in this study 





TpR StrR Rec A thi pro hsdR 
RP4::2-Tc::Mu::Km Tn7Xpir 
lysogen 
F-l-fhuA2[lon] ompT lacZ::T7 gene I 
galsulAU D{mcrC-mrx)ll4::IS10 
B(mcr-73::mTn/0)2 
ER2566 + pETV10 
Miller and Mekalanos 1988 
Chong et al. 1997 
This Study 
Plasmids 
pwks30 AmpR, low copy-number cloning vector 
pFUSE MobRP4 on'R6K, polylinker upstream 
of promoterless lacZYA (CmR) 
pKH7 fragment containing ydiV and putative 
promoter in pwks30 (AmpR) 
PKH101 pFUSE containing a 1.2 kb fragment 
fusing 784 bp upstream of y<i.Vto 
lacZYA (CmR) 
pFlac pFUSE containing a 728 bp fragment 
fusing 674 bp upstream of flhD to 
lacZYA (CmR) 
pkamt-less pEP 185.2 containing a 1.7 kb BamHI 
fragment from pUTmtn5Kan2 
(KanR, CmR) 
pKH201 pFUSE containing a Smal fragment 
fusing -800 bp of ahpC and it's 5' 
sequence to lacZYA (CmR) 
pET24b+ Expression vector containing an IPTG-
inducible T7 promoter, a T7-Tag, and 
a C-terminal His-Tag 
pETVIO pET24b+ with the coding sequence 
of ydiV replacing the T7-tag. 
pAJD107 AmpR; medium copy-number cloning 
vector 
Wang and Kushner 1991 
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plates. When necessary, growth medium was supplemented with carbenicillin (100 
pg/ml), kanamicin (100 pg/ml), chloramphenicol (25 pg/ml for established strains, 12.5 
pg/ml for selection after transduction or transformation), or tetracycline (15 pg/ml). 
Unless otherwise noted, "late log phase" refers to 20 u.1 of an overnight culture diluted 
1:100 into 2 ml LB media +/- antibiotics in a 14 ml tube, and shaken at 250 rpm and 37°C 
for 5.5 hr, with a final culture density of A600 -3.0. "Stationary phase" refers to an 
overnight culture. 
Mice 
Wild-type and NOS2"'" C57BL/6 mice were purchased from Charles River 
Laboratories, Taconic, or Jackson Laboratories. Additional NOS2"'" mice (MacMicking 
et al, 1995), phoxgp91"'" mice (Pollock et al, 1995), and phoxsp91"'"NOS2"' mice (Shiloh et 
al, 1999) were bred in the Weill Cornell Medical College animal facility after 
backcrossing to C57BL/6 mice for at least 6 generations. MyD88"'~ mice and 
corresponding wild-type C57BL/6 x 129/SvJ were also bred in the Weill Cornell Medical 
College animal facility. 
S. typhimurium targeted gene disruptions 
Targeted mutations were made using the one-step inactivation protocol described 
by Datsenko and Wanner (Datsenko and Wanner, 2000). Briefly: 60-mer primers were 
constructed that contained 40 nucleotides of the gene to be disrupted and 20 nucleotides 
corresponding to regions on the plasmids pKD3 and pKD4. Amplification from pKD3 or 
pKD4 using these primers generated fragments containing either a kanamicin resistance 
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cassette or a chloramphenicol resistance cassette flanked by regions of homology to the 
gene to be disrupted. The plasmid pKD46, containing the X Red recombinase under the 
control of the arabinose-inducible ParaB promoter, was electroporated into S. typhimurium 
LB5000 to create the strain SCN35. Purified PCR products were electroporated into 
SCN35 grown in 0.8% arabinose to express the A. Red recombinase, and plated on LB 
containing either kanamicin or chloramphenicol. Phage lysates were made from 
transformants containing the antibiotic resistance cassette in the correct location, and 
lysates were used to transduce the mutations into 12023 S. typhimurium. 
Methods bracketed by the asterisks were written by Michael Shiloh, and pertain to 
experiments performed by Michael Shiloh. 
Mouse infection with STM pools and recovery of bacteria 
Transposon-tagged S. typhimurium pools in sterile 96-well microtiter plates 
(provided by David Holden) were grown in LB (kanamycin 50 uglxnl, nalidixic acid 15 
}iglml) with gentle shaking at 37°C overnight. Following overnight growth, bacteria were 
reinoculated with a sterilized metal replicator into a fresh plate and grown with shaking at 
37°C to early log phase (OD580~0.2), pooled and collected by centrifugation at 1,000 x g 
for 10 min. Pooled cells were diluted to 5 x 10 CFU/ml in sterile saline, and mice were 
injected intraperitoneally with 200 pi (1 x 105 CFU/mouse). Two C57BL/6 mice were 
injected per pool in the first round. The remainder of the pooled cells was used for 
genomic DNA preparation (input pool). Three days after infection, mice were sacrificed 
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by C02 inhalation, their spleens were removed and homogenized, and serial dilutions 
were plated on LB-kanamicin-nalidixic acid plates (3 plates per dilution). Bacteria were 
harvested from plates containing approximately 1000 colonies such that approximately 
4000 total colonies were collected. Pooled cells were pelleted and resuspended in 10 mM 
Tris-EDTA (TE). 
When pools enriched for attenuated mutants were used as inocula, 4 mice per pool 
were injected. phoxgp91"'" and phoxgp91"'"NOS2"'were injected with 1 x 10 CFU/mouse, and 
were sacrificed after two days, because a higher inoculum (10 CFU/mouse) caused rapid 
death in the mice, and because despite the lower inoculum, the phox-deficient mice did 
not survive for 3 days after infection (data not shown). 
Salmonella genomic DNA preparation 
Salmonella pools resuspended in TE were lysed by the addition of SDS (0.5% 
final cone.) and proteinase K (100 ptg/ml final cone.) and incubated at 37°C for 1 h. 
DNA was separated from lipids and proteins by precipitation with 
cetyltrimethylammonium bromide (CTAB). Proteinase K was inactivated at 65°C for 10 
min. DNA was extracted with choloroformrisoamyl alcohol (24:1), 
phenol:chloroform:isoamyl alcohol (25:24:1) and subsequently precipitated by 
isopropanol (0.7 volume). Genomic DNA was washed with 70% ethanol, resuspended in 
TE, and adjusted to a concentration of 1 mg/ml. 
Colony blots 
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Bacteria were grown overnight in 96-well plates as described above. Nylon 
membranes (NEN) were placed on pre-dried 15 cm square (Greiner) LB plates 
(kanamycin, nalidixic acid) and the membranes were inoculated with a 96-prong 
replicator. Multiple membranes were inoculated for each pool depending on need. 
Bacteria were grown upside-down at 37°C for 8-10 h. Membranes were removed from 
the agar and dried on Whatman paper. Bacteria were lysed by placing the membranes on 
Whatman paper soaked with 0.4 M NaOH for 8 min. Membranes were neutralized in 0.5 
N Tris, pH 7.0 followed by 4 washes in 2X SSC with vigorous shaking to remove 
bacterial debris. After washing, the membranes were dried and the DNA cross-linked to 
the membrane by UV irradiation. Membranes were stored at room temperature until 
needed. 
Generation of probes and membrane hybridization 
Probes were generated by first amplifying the tag region in a non-radioactive 
amplification. In a 100 pi volume, 5 pg of genomic template DNA was mixed with 770 
ng of primer P2 5' TACCTACAACCTCAAgCT-3' and P4 5' 
TACCCATTCTAACCAAgC-3' in a PCR mixture containing 20 mM Tris-Cl, pH 8.3; 50 
mM KCI: 2 mM MgCl2; 0.1% Tween 20; 200 fiM each of dNTP; 2.5 U Taq polymerase 
(AmpliTaq). Amplification was by the following cycle: 95°C, 4'; 20 cycles [50°C, 45"; 
72°C, 10"; 95°C, 30"]. The resulting 80 bp DNA fragments were purified by agarose gel 
electrophoresis, extracted (Qiaquick gel extraction kit), and used as templates for a 
second round of PCR. For the generation of radioactive probes, 20 ng template DNA was 
amplified in a 20 pi volume according to the protocol described above, except that each 
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reaction utilized 100 //Ci 32P-a-dCTP instead of non-radioactive dCTP. The invariable 
PCR arms were removed by Hindlll (New England Biolabs) digestion for 1 h at 37°C. 
Probes were then denatured by boiling for 5 min, and placed immediately on ice. 
Membranes were hybridized with radioactive probes in a solution of Na HPO , pH 7.2, 
0.25 M; NaCl, 0.25 M; EDTA, pH 8.0, 1 mM; SDS, 7%; Formamide, 50%; PEG 8,000, 
10% w/v, in a rotating hybridization oven at 42°C for 16 h. Hybridization solution was 
removed, and the membranes washed twice with 2x SSC, followed by two washes in 2x 
SSC, 0.1% SDS at 65°C for 1 h. Colony hybridization was detected by autoradiography. 
Identification of transposon insertion sites 
Colonies selected for sequencing were grown overnight in liquid culture and 
genomic DNA prepared as described above. Genomic DNA was then digested with 
restriction enzymes having a known site within the mini-Tn5 transposon multiple cloning 
site (de Lorenzo et al., 1990; Herrero et al, 1990). Restriction fragments were 
precipitated and used for ligation into pBluescript SK(+) vector. The products of the 
ligation reaction were precipitated, resuspended in water, and used for electroporation of 
competent E. coli (XL-10 Gold). Transformed cells were grown on LB plates containing 
ampicillin and kanamycin, which allowed for selection of plasmids with inserts 
containing the kanamycin cassette and flanking DNA. Depending on the restriction 
enzyme chosen (either at the I or O end of the transposon), the adjacent DNA was 
sequenced on an ABI automated fluorescence sequencer (Applied Biosystems) using 
primers P6 (5'-CCTAGGCGGCCAGATCTGAT-3') when the DNA was digested at the 
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O end or P7 (5'-GCACTTGTGTATAAGAGTCAG-3') when the D N A was digested at 
the I end. Sequences were compared to Genbank sequences by the BLASTX algorithm. 
Alternatively, overnight liquid cultures of clones were mated with overnight 
liquid cultures of S17-lXpir E. coli (Nals) containing the plasmid pkamt-less (KanrCmr). 
Briefly, small volumes of both cultures were mixed and spotted on an LB plate, and 
mating was allowed to proceed for at least 2 hours. The bacteria were then recovered and 
plated on LB containing both chloramphenicol, kanamicin, and nalidixic acid to select for 
clones in which pkamt-less from S17-iXpir had homologously recombined with the 
kanamicin cassette of the mini-Tn5 transposon in the S. typhimurium STM mutant. 
Genomic DNA was prepared from these clones and digested with SacII. Digests were 
self-ligated and transformed into electrocompetent sl7-lXpir. Plasmid minipreps were 
performed using transformants that had been selected on LB containing chloramphenicol 
and kanamicin. DNA was sequenced using primer P6 as described above. 
In vivo bacterial virulence assays 
To compare in vivo survival, S. typhimurium 12023 and S. typhimurium STM 
mutants were inoculated from fresh overnights into LB at a dilution of 1:100 and grown 
for 1.5-2 hours to early log phase (A^ - 0.2-0.4). For monotypic infections, bacteria 
were pelleted, resuspended in 0.9% sterile saline, and diluted to IO4 CFU/ml. Mice were 
injected intravenously with 100 //l (1 x 103 CFU/mouse). At various time points, mice 
were sacrificed, their spleens were harvested and homogenized in 0.9% NaCl, and serial 
dilutions were plated on LB to determine colony forming units (cfu) per spleen. Colonies 
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were counted the following day. For competition experiments (Beuzon and Holden, 
2001), bacteria were pelleted, resuspended in 0.9% sterile saline and diluted to 5 x 103 
CFU/ml. S. typhimurium 12023 and individual STM mutant strains were mixed in a 1:1 
ration for a final concentration of 1 x IO4 CFU/ml. Mice were injected intravenously 
with 100 pi (1 x 103 CFU/mouse). Spleen homogenates prepared at indicated timepoints 
were plated on LB containing nalidixic acid and kanamicin (to determine numbers of 
STM mutants) and LB containing nalidixic acid (to determine the total number of 
bacteria). Competitive index was determined by the following formula: 
(mutantou/12023out)/(mutantjn/12023in). 
In vitro fitness 
Overnight cultures of STM mutants and 12023 S. typhimurium were diluted 1:100 
into fresh LB. 50 pi 12023 + 50 pi mutant strain were combined with 900 pi LB 
containing 20 pg/ml nalidixic acid in a 14 ml culture tube. Aliquots of the mixed cultures 
were diluted and plated on LB +/- kanamicin to determine the starting ratio of 
mutant: 12023. Cultures were grown at 37°C, 250 rpm for 4-5 hr, then diluted and plated 
on LB +/- kanamicin. Competitive index was determined as before 
[(mutantout/12023out)/(mutantin/12023in)]. 
Isolation and infection of macrophages 
Mice were injected intraperitoneally with 1 ml of freshly prepared, filter-sterilized 
5 mM sodium periodate (NaI04) in 0.9% saline. Four days later mice were sacrificed by 
C02 inhalation. When serum was needed, cardiac puncture was performed to acquire 
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blood, which was allowed to clot at room temperature, and then centrifuged to separate 
the serum. Serum was heated at 56°C for 30 min to inactivate complement MAC 
components. Peritoneal cells were harvested from the same mice by lavage with 10 ml 
cold DMEM. Red blood cells were lysed with hypotonic saline, and leukocytes were 
resuspended in DMEM containing 10% heat-inactivated fetal calf serum (FCS), 1 mM 
sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin-G, and 100 pg/ml 
streptomycin. Cells were plated at a density of 5xl05 cells/well in 96 well microtiter 
plates unless otherwise specified. The following day, nonadherent cells and antibiotic-
containing media were removed by washing cells twice with pre-warmed lxPBS. Wells 
were replenished with DMEM containing 1% heat-inactivated FCS and 1 mM sodium 
pyruvate. Assays were performed on the second day after harvesting cells. Immediately 
prior to infection, cells were washed twice with pre-warmed lxPBS, and wells were 
replenished with either 100 (0,1 DMEM containing 1% heat-inactivated FCS and 1 mM 
sodium pyruvate for bactericidal assays, or with 200 pi Krebs Ringer phosphate plus 
glucose (KRPG) formulated as previously described (De la Harpe and Nathan, 1985) for 
cytotoxicity assays. Bacterial strains for infections were inoculated from fresh overnight 
cultures into LB at a dilution of 1:100 and grown for 5.5 hours to late log phase (A600 - 3-
4.) Late log cultures were resuspended in 0.9% saline, diluted 1:50, and opsonized in 
10% heat-inactivated murine serum for 30 min at 37°C with end-over-end rotation. 
Opsonized bacteria were resuspended in 0.9% saline, and 10 pi of opsonized bacteria was 
added per well of macrophages. Approximately 106 bacteria were added per well for an 
MOI of 2:1, unless otherwise specified. Plates were centrifuged at 250xg for 5 min at 
room temperature and then incubated at 37°C. 
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Salmonella-induced macrophage cytotoxicity assay 
Immediately after centrifugation, samples for the -10 minute time point were 
harvested by removing 100 u,l of supernatant from each well. All other plates were 
incubated 10 minutes at 37°C to allow phagocytosis of bacteria by macrophages, after 
which time the 0 minute time point was harvested, and gentamicin was added to wells in 
all other plates for a final concentration of 10 pg/ml. At indicated time points during 
infection, 100 pi of supernatant from each well was removed. Cytotoxicty was 
determined by amount of LDH released into supernatants using the Cytotoxicity 
Detection Kit (Roche Molecular Biochemicals) according to the equation: %cytotoxicity 
= (experimental LDH release uninfected LDH release) / (Maximum LDH release 
uninfected LDH release) x 100. Remaining medium was removed from the wells prior to 
microscopic examination and photography. Alternately, the Lowry protein assay was 
used to determine total protein per well as an estimate of macrophages remaining. At 
each time point, medium was removed, and wells were washed two times in lxPBS to 
wash away excess serum protein. Macrophages were lysed in 100 mM NaOH for 30 
min, and then 100 pi of Lowry reagent (0.5% CuS045H20 + 1.0% Na3-citrate + 4% 
NaC03) was added per well. Reactions were developed using 10 pi of Folin and 
Ciocalteu's Phenol reagent (Sigma), and plates were evaluated at A650. 
Bactericidal assays 
After centrifugation, plates were incubated at 37°C, 5% C02 for 10 min to allow 
for phagocytosis. At time 0, wells were washed 3x with prewarmed lx PBS. The 
130 
macrophages in one plate were then lysed with 0.1% Triton X-100, and 10 ul of lysates 
were transferred via multichannel pipette to wells containing 100 .ul LB broth + 10% 
Alamar blue in a read-out plate. Wells in the unlysed plates were replenished with 100 \xl 
DMEM containing 1% heat-inactivated FCS, 1 mM soduium pyruvate, and 10 [ig/ml 
gentamicin, and plates were incubated at 37°C, 5% C02. At indicated time points, 
macrophages in one 96-well plate were lysed, and 10 pi of lysates was transferred to the 
read-out plate. Read-out plates were stored overnight at 4°C, and evaluated the following 
day (Shiloh etal, 1997). 
In vitro stress susceptibility assays 
Overnight cultures of S. typhimurium were diluted 1:100 in LB broth +/-
carbenicillin 100 jig/ml in 14 ml tubes, and outgrown for 5.5 hour at 37°C, 250 rpm to an 
A600 of approximately 3.5. 5.5 hour cultures were diluted 1:100 into LB broth containing 
the specified stress. Samples were cultured at 37°C in 96-well microtiter plates with 
agitation. Unless indicated, starting pH of the cultures was approximately 7.0. Assays 
using sodium nitrite were performed at pH 5.5 in LB media +100 mM MES. Growth 
and/or killing of bacteria were evaluated by assessing A600 of the culture, plating for cfus, 
or the Alamar Blue assay (Shiloh et al, 1997). 
Production of recombinant YdiV and Antiserum 
Primers were generated to PCR amplify ydiVfxom S. typhimurium chromosomal 
DNA such that the product would contain a 5' Ndel site around the start site and a 3' 
Xhol site: forward (5'-CATGGGACTGGCCATATGATTGCTTCACTTGATGAGCTT) 
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and reverse ( 5 ' - C G G C A A A C A G A A C T C G A G T C G C T G A A C G A G T T T A A T G A G ) . The 
product was cloned into pET24b+, cut with Ndel and Xhol, and the resulting plasmid 
(pETVIO) was used to transform E. coli ER2566. The hexahistidine fusion protein was 
over-expressed by induction with 1 mM IPTG for 3.5 hours. Sonication was used to 
disrupt E. coli, and His-tagged protein was purified on Ni-NTA agarose beads under 
native conditions. A portion of the purified protein was subjected to SDS-PAGE, and the 
Coomassie blue-stained band running at approximately 25 kDa was cut from the gel and 
sent to Covance (Denver, PA) for production of antisera. Rabbit were injected with a 
primary boost of purified protein in Freund's complete adjuvant, followed by 4 boosts in 
Freund's incomplete adjuvant. Rabbit sera was purified by adsorption with acetone 
powders made from S. typhimurium SCN 19 and E. coli ER2566. 
Protein analysis: Silver stained SDS-PAGE gels and Western Blots 
Bacterial lysates were prepared by sonicating on ice in 50 mM Tris, pH 7.5. 
Cytosolic fractions were recovered by centrifugation to separate membrane fraction. 
Secreted and shed proteins were prepared by tricholoroacetic acid (TCA)-precipitation of 
bacterial supernatants. Briefly, supernatants were filtered through 0.45 u.M syringe 
filters. 100% TCA (4°C) was added per sample for a final concentration of 10% TCA, 
and proteins were pelleted by spinning at 18K x g, 4°C for 10 min. Precipitated proteins 
were washed with cold acetone and re-pelleted. Remaining acetone was evaporated 
before resuspending supernatant proteins. Protein samples were separated by SDS-
PAGE. 8% polyacrylamide was used when evaluating YdiV, and 15% polyacrylamide 
was used for all other assays. Silver staining was performed as described (Blum et al, 
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1987). Briefly, polyacrylamide gels were fixed overnight in methanol (50%), acetic acid 
(12%) and 0.185% formaldehyde. Gels were pretreated in sodium thiosulfate, 
impregnated with silver nitrate, and developed with sodium carbonate. Developing 
reaction was stopped with methanol and acetic acid, and gels were equilibrated with 
glycerol. For immnoblots, proteins were transferred from polyacrylamide gels to 
nitrocellulose membranes and reacted with antiserum or anti-flagellin monoclonal 
antibody (Virostat) in (pH 7.5) Tris-buffered saline with 0.1% Tween-20 (TBST) 
containing 5% nonfat milk. Anti-rMsrA and rMsrB antisera were prepared as described 
(St John et al, 2001). Bound antibody was detected by enhanced chemiluminescence 
(Pierce). 
Motility assays 
Bacterial motility was assessed by spotting 2 pi of culture on the surface of agar 
plates containing 0.32% agar for swimming motility and 0.6% agar for swarming 
motility. Media in the plates contained 1% Tryptone and 0.5% yeast extract (with no 
added NaCl.) Plates were analyzed after either 5 hr incubation at 37°C or overnight 
incubation at room temperature. 
Congo Red Agar 
Bacterial production of exopolysaccharide was evaluated by plating liquid 
cultures of S. typhimurium on Congo Red agar plates. Congo red plates were made as 
follows: 5 g tryptone, 2.5 g yeast extract, and 7.5 g agar were dissolved in 500 ml water 
and autoclaved. When media was sufficiently cool, Congo Red was added to a final 
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concentration of 40 pg/ml, and Coomasie Brilliant Blue was added to a final 
concentration of 10 pg/ml. Plated bacterial cultures were incubated at 30°C or room 
temperature overnight (Romling et al, 1998; Zogaj et al, 2001). 
Transcriptional fusion constructs and analysis of gene expression 
Chromosomal lacZYA fusion reporters were constructed using the plasmid pFUSE 
(Baumler et al, 1996). In order to include full promoter sequences, segments of 
chromosomal DNA selected for insertion into pFUSE included part of the upstream gene, 
the intervening region, and a portion of the 5' region of the gene to be evaluated. 
Restriction fragments of genomic DNA were subcloned into the multiple cloning site of 
pAJD107, and then recovered using Xbal and Smal for ligation into pFUSE. Ligations 
were transformed into E. coli S17-lXpir. Clones generated by this method include 
pKHlOl (784 bp of DNA upstream of ydiV fused to lacZYA), pFlac (728 bp of DNA 
upstream of flhD fused to lacZYA), and pKH201 (-800 bp of DNA upstream of ahpC 
fused to lacZYA). Fusion constructs were transferred by conjugation into SCN14 (NalR) 
or SCN19 (NalR,KanR), and integrants into the S. typhimurium chromosome were selected 
by plating on LB-agar containing chloramphenicol and nalidixic acid, +/- kanamicin. 
Integrants contain one intact copy of the gene (ydiV, ahpC, ox flhDC) contiguous with the 
pFUSE construct containing the putative gene promoter fused to lacZYA. sip operon 
expression was evaluated using the strain BJ68, which includes a lacZYA fusion construct 
inserted within and disrupting sipC (Penheiter et al, 1997). Transduction was used to 
transfer the fusion constructs into other S. typhimurium strains when needed. 
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Expression of ydiV, flhDC, ahpC, or the sip operon in strains containing fusion 
constructs was assayed by evaluation of (3-galactosidase activity in whole cell lysates. 
Overnight cultures were diluted 1:100 into 30 ml fresh LB broth in 250 ml beveled flasks 
and grown with agitation at 37°C. At specified time points, 1 ml of culture was harvested 
and centrifuged at room temperature for 2 min at maximum speed in a microfuge. 
Supernatants were removed, and pellets were frozen at -20°C. After all time points had 
been harvested and frozen, pellets were thawed and resuspended in working buffer. 
Lysis of cells, measurement of P-galactosidase activity, and calculations of values were 
performed as described (Miller, 1972). 
Transductions 
To make P22 bacteriophage lysates, 0.5 ml of a stationary phase S. typhimurium 
culture was combined with 2 ml of LBED<j) broth (LB + E salts + dextrose + P22 phage) 
(Maloy et al, 1996). Phage infected cultures were incubated at 37°C with agitation for 6-
16 hours to permit infection and lysis of S. typhimurium. Infected cultures were 
centrifuged for 2 min at maximum speed in a microfuge. Supernatants were transferred 
to clean tubes with two drops of chloroform and vortexed to kill any remaining bacteria. 
For transduction, 10-20 pi donor P22 lysate was mixed with 100-200 pi recipient 
bacteria. Samples were incubated at 37°C for 10-20 min, and then phage infection was 
arrested by addition of 1 ml LB + 10 mM EGTA. Cultures were returned to 37°C and 
incubation was continued for 20 min (for transduction of KanR or AmpR) up to two hours 
(for transduction of CmR). Cultures were plated on LB-agar containing 10 mM EGTA 
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and the appropriate selective antibiotics. Absence of continued phage activity was 
confirmed by plating clones on LB-agar containing Evans-Blue-Uranine (EBU agar). 
Quantitation of c-diGMP 
Synthetic c-diGMP was kindly provided by Dr. Roger Jones of Rutgers 
University, New Jersey (Hsu etal, 1985). 
Samples analyzed for quantitation of endogenous c-diGMP levels were prepared 
as follows. Overnight cultures were diluted 1:100 into 50 ml LB broth + 100 u.g/ml 
carbenicillin in 500 ml flasks. Cultures were grown at 37°C with agitation. After 5.5 hr, 
cultures were spun at 4000 rpm, 4°C for 30 min. Pellets were resuspended in 1 ml 50 
mM Tris, pH 8.0, and sonicated on ice to disrupt cell membranes. Lysates were spun at 
13K, 4°C for 30 min to isolate soluble fractions. Volumes of supernatant containing 1.8 
mg of protein were combined with 1 volume chloroform, 4 volumes methanol, and 3 
volumes of water to extract polar micromolecules. Samples were vortexed and spun at 
13K for 5 min. Aqueous phases were recovered and frozen at -80°C. 
For evaluation of phosphodiesterase activity in lysates, preparation of samples 
was as for quantitation of endogenous c-diGMP with the following modifications. 
Overnight cultures diluted 1:100 were grown for 2.5 hours, at which point 1 mM IPTG 
was added to ECN 145 cultures to induce expression of rYdiV. Cultures were harvested 
2 hours later (total culture time = 4.5 hr.) After sonication, half of the lysate was spun to 
isolate supernatant (soluble fraction), and the other half was saved unseparated to include 
membrane bound proteins (total cell lysates). Volumes of soluble fraction and total cell 
lysate corresponding to 0.5 mg of protein in the soluble fraction were used for enzymatic 
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assays. Samples to be denatured were boiled for 10 min. 50 pmole of c-diGMP was 
added to each sample. Following incubation at 37°C for 10, 30, or 60 min, samples were 
extracted as above, frozen at -80°C, and shipped to Dr. Michael MacCoss at the 
University of Washington for evaluation of c-diGMP content. Dr. MacCoss fractionated 
the extracts using a home built 100 pm capillary column packed with 7 cm of HILIC 
material, producing a flow rate of -500 nl/min. Fractions were subjected to selected 
reaction monitoring (SRM) mass spectrometry as described in the legend for Figure 22. 
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C h a p t e r 3 
M. tuberculosis counter-immune (cim) mutants identified by 
differential screening in immuno-deficient mice 
IFN-y-inducible N O S 2 is an essential component of host defense against Mtb 
(MacMicking et al, 1997). However, it is clear that IFN-y-deficient mice are more 
susceptible to Mtb than NOS2-deficient mice, because time-to-death (MacMicking et al, 
2003; Mogues et al, 2001) and bacterial growth in the tissues (MacMicking et al, 2003) 
after infection are more rapid in the former. These differences indicate that NOS2 is not 
the only anti-mycobacterial mechanism controlled by IFN-y. Recently, MacMicking, et 
al. demonstrated that the IFN-y-inducible GTPase LRG-47 is also an essential component 
of murine defense against Mtb (MacMicking et al, 2003), potentially accounting for the 
difference in susceptibility between NOS2"'" and IFN-y"'" mice. Chemical inhibition of 
NOS2 further exacerbates infection in LRG-47-deficient mice, indicating that these 
mechanisms make independent contributions to host defense. However, the combined 
loss of LRG-47 and NOS2 does not increase susceptibility to the same level observed in 
IFN-y-deficient mice (MacMicking et al, 2003), suggesting further IFN-y-mediated host 
mechanisms for the control of Mtb. Unidentified IFN-y-dependent, NOS2-independent 
mechanisms have also been shown to be important for the control of other macrophage 
pathogens, including Bordetella pertussis (Mahon and Mills, 1999), Mycobacterium 
avium (Gomes et al, 1999), Toxoplasma gondii (Suzuki et al, 2000; Yap and Sher, 
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1999), Leishmani donovani (Murray and Delph-Etienne, 2000), Francisella tularensis 
(Polsinelli et al, 1994), Legionella pneumophila (Heath et al, 1996) and Listeria 
monocytogenes (Leenen et al, 1994). 
To better understand the role of IFN-y during infection with Mtb, we sought to 
identify genes used by Mtb as counter-measures to IFN-y mediated pathways. The 
interplay between the immune response and persistent pathogens like Mtb is a fine-tuned 
balance of host attacks and bacterial counter-measures (Munoz-Elias and McKinney, 
2002). Over thousands of years of co-existence with mammalian hosts, there has 
presumably been strong evolutionary pressure for pathogenic mycobacteria to evolve 
counter-measures against each of the potentially bactericidal elements of the host 
immune response. Host mechanisms against which the bacterium has evolved effective 
counter-measures appear to be of lesser significance during infection with wild type 
strains of Mtb, but are revealed as important immune pressures when the relevant 
bacterial genes are disrupted. One example of this phenomenon is detoxification by 
KatG catalase of the phox respiratory burst, which effectively neutralizes the impact of 
this bactericidal immune mechanism (Ng et al, 2004). 
Here we use a variant of signature-tagged transposon mutagenesis (STM) (Hensel 
et al, 1995) as a screening method to identify Mtb genes that are involved in evading or 
countering IFN-y-dependent, NOS2-independent immune responses. We report the 
identification of four Mtb transposon-induced mutants that are capable of progressive 
replication and rapid lethality in IFN-y-deficient mice but not in NOS2-deficient mice, 
indicating increased susceptibility of the mutants to IFN-y-dependent immune 
mechanisms other than NOS2. Identification of the genes disrupted in these mutants 
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suggests that such diverse processes as phosphate metabolism, polyketide synthesis, and 
cell wall biogenesis may be important for adaptation of Mtb to the in vivo environment as 
influenced by the host immune response. 
Results 
Growth and lethality of Mtb in IFN-y', NOS2', and phox*p91'- NOS2' mice 
Previous infections of phox-deficient mice suggested that host production of ROI 
may play a detectable, albeit minor, role in control of Mtb (Adams et al, 1997; Cooper et 
al, 2000). We considered the possibility that the contributions of IFN-y-activated phox to 
host defense against Mtb might be masked by the dominance of NOS2 in phox-deficient 
mice. To draw forward subtle anti-mycobacterial effects of phox, we compared 
susceptibility of NOS2"'" mice to Mtb with that of mice lacking both NOS2 and phox (Fig. 
6). PhoxEp91-deficiency did not increase the susceptibility of NOS2-deficent mice in 
terms of survival (Fig. 6D) or bacterial growth kinetics in the tissues (Fig. 6A-C). These 
observations suggest the existence of an additional, as-yet unidentified IFN-y-protective 
mechanism(s) that is independent of NOS2, LRG-47, and phox. 
Identification of Mtb counter-immune (cim) mutants by differential screening in 
IFN-y'and NOS2' mice 
The substantial difference in susceptibility of IFN-y"'" and NOS2"'" mice to Mtb 
suggested the possibility of identifying mechanisms of bacterial defense against IFN-y-
dependent, NOS2-independent immune mechanisms by differential screening in mice. 
Our strategy was to passage pools of signature-tagged mutants through NOS2"'" mice and 
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Figure 6. Pathogenesis of Mtb in NOS2"'", phoxgp91"'"NOS2"'", and IFN-y"'" mice. IFN-y"'" 
mice (filled squares), NOS2"'" mice (open circles), and phoxgp91"'"NOS2"'" mice (filled 
triangles) were infected i.v. with -2 x IO5 CFU of wild-type Mtb Erdman. (A-C) Kinetics 
of bacterial growth in the lungs (A), spleens (B), and livers (C) of infected mice (n = 4-5 
per group, except day 21 IFN-y"'", n = 5; day 42 NOS2"'", n=3; day 42 phoxgp91"'"NOS2"'", n 
= 8). *P < 0.05 for comparison of IFN-y"'" mice with NOS2"'" and phoxgp91"'"NOS2"'- mice. 
A representative graph depicting growth of Mtb in the lungs of wild type mice can be 
found in Figure 1 A. (D) Survival of infected mice. Mean time-to-death was 24.5 days for 
IFN-y"'" mice (n = 13), 42.4 days for NOS2"'" mice (n = 13), and 39.4 days for 
phoxgp9l"'"NOS2"'" mice (n = 19). Survival times were significantly different for IFN-y"'" 
mice vs. NOS2"'" mice (P < 0.0001) and IFN-y"'" mice vs. phoxgp91"'"NOS2"'" mice (P < 
0.0001) but not for NOS2"'" mice vs. phoxgp91"'"NOS2"'" mice (P = 0.064). Similar results 
were obtained in a second experiment using Mtb H37Rv. Wild type mice infected with a 
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IFN-y"'" mice in order to identify mutants that were under-represented in the former but 
not the latter. Mice were infected with pools representing 48 independently derived STM 
mutants and sacrificed at -2 wk (IFN-y"'" mice) or -3 wk (NOS2"'" mice) post-infection for 
recovery of bacteria from the lungs. These time-points were selected to permit maximal 
expansion of the bacterial populations in the lungs; by sacrificing animals shortly before 
they would become moribund, the under-representation of attenuated mutants in the 
recovered pools can be maximized. Each pool of mutants was passaged through two 
NOS2"'" mice and two IFN-y"'" mice, and mutants that showed a consistent phenotype in 
both mice of each genotype were selected for further analysis. Here we describe four cim 
mutants identified during initial screening of 2 pools that appear to be defective in 
counter-immune mechanisms specifically directed towards IFN-y-dependent, NOS2-
independent host pathways. 
Identification of genes disrupted in the cim mutants 
The transposon insertion sites (Table V) were identified in each of the four cim 
mutants using inverse PCR (Cox et al, 1999). The first and second mutants were 
disrupted in Rv2958c and Rv0405 (a.k.a. pks6), respectively, neither of which are found 
in operons, and the third mutant was disrupted in Rv0930, which is the final gene in an 
apparent operon. The observed phenotypes of these mutants were therefore unlikely due 
to polar effects of the transposon insertion on neighboring genes. The fourth transposon 
insertion site was located in Rv0072, which appears to be co-transcribed with the 
downstream gene, Rv0073. Rv0072 and Rv0073 have been annotated as putative 































































































































































































































































































of known function in other bacterial species (Braibant et al, 2000). Rv0930 has been 
annotated as part of another putative ABC transporter. Expression of Rv2958c, which is 
homologous to glycosyl transferase genes in other species, was shown previously to 
increase survival of non-pathogenic Mycobacterium smegmatis in macrophages (Miller 
and Shinnick, 2000). pks6, encoding a putative polyketide synthase, was identified in a 
previous STM screen as being essential for full virulence of Mtb in wild-type BALB/c 
mice (Camacho et al, 1999), however, the effect of pks6 deficiency on Mtb replication in 
immuno-deficient mice has not been reported. 
Confirmation of the cim mutants' in vivo phenotypes 
None of the cim mutants displayed a diminished growth rate in vitro (Fig. 1), 
suggesting that their in vivo growth deficiencies were due to loss of functions required for 
Mtb's adaptation to in vivo environmental conditions. The cim mutants' in vivo 
phenotypes were confirmed by infection of wild-type (C57B1/6), IFN-y"'", and NOS2"'" 
mice with the individual strains (Fig. 8). As expected, wild-type Mtb (H37Rv strain) 
demonstrated a marked growth advantage in the lungs of IFN-y"'" and NOS2"'" mice as 
compared to C57B1/6 mice (Fig. 8A). All four of the cim mutants displayed a significant 
growth advantage in IFN-y"'" mice as compared to C57B1/6 mice; however, little or no 
growth advantage was observed in NOS2"'" mice as compared to C57B1/6 mice, thus 
confirming the phenotype that had been selected in the screen (Fig. 8B-E). Additionally, 
all of the cim mutants demonstrated statistically significant deficits in their ability to 












Figure 7. The Mtb cim mutants do not manifest any obvious growth deficiencies in 
vitro. Stationary phase cultures of the indicated Mtb strains were diluted 1:500 in 
fresh medium and incubated at 37°C. Aliquots were withdrawn at the indicated times 
for measurement of the optical density at 600 nm (A) or enumeration of C F U by 
plate culture (B). Symbols: wild-type Mtb H37Rv (filled diamonds); Rv0012 (open 
circles); /?v0405 (open triangles); /?v2958c (open squares), Rv0930 (filled squares). 
At time-points later than 9 days, clumping of the cultures prevented accurate 
measurement of C F U (B). Results are representative of two experiments. 
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Figure 8. Pathogenesis of Mtb cim mutants in mice. Mice were infected i.v. with -0.5-
1.0 x IO6 CFU of wild-type Mtb (A,F) or one of the following Mtb cim mutants: Rv0012 
(B,G), Rv0930 (C, H), flv2958c (D,I), flv0405 (E,J). Symbols: C57B1/6 mice (filled 
triangles), NOS2"'" mice (open circles), and IFN-y"'" mice (filled squares). (A-E) Bacterial 
growth kinetics in the lungs of mice (n = 4 per group). *P < 0.05 for comparisons of 
bacterial loads (CFU) in IFN-y"'" mice vs. C57B1/6 mice at -4 wk post-infection or 
NOS2"'" mice vs. C57B1/6 mice at -6 wk post-infection. Results are representative of two 
experiments. (F-J) Survival of infected mice (n = 4-6 per group). In all cases, survival of 
infected NOS2"'" mice was significantly longer than survival of IFN-y"'" mice infected with 
the same Mtb strain (P < 0.005 for all comparisons). 
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These observations suggest that the cim-encoded functions are essential for progressive 
bacterial growth in the presence, but not the absence, of IFN-y-dependent immune 
mechanisms other than NOS2. This interpretation was further supported by the survival 
kinetics of mice infected with the cim mutants. Time-to-death was similar for IFN-y-
deficient animals infected with wild-type Mtb H37Rv or each of the cim mutants (Table 
V and Fig. 8F-J, solid squares). However, the time-to-death for NOS2-deficient animals 
was markedly delayed when animals were infected with each of the four cim mutants as 
compared to wild-type Mtb (Table V and Fig. 8F-J, open circles). These observations 
indicate that the role of the cim genes in Mtb pathogenesis is contingent on aspects of the 
in vivo environment that are modulated by the host immune response. The most 
straightforward interpretation of these results is that these cim genes encode functions 
that are required for protection against the onslaught of IFN-y-dependent, NOS2-
independent host immune mechanisms; confirmation of this hypothesis will require the 
elucidation of the precise mechanisms by which these cim genes contribute to virulence. 
Discussion 
Long-term persistence in immuno-competent individuals is a hallmark of Mtb 
infection, but little is known about the bacterial mechanisms involved in countering the 
onslaught of the host immune response. Here we describe a genetic strategy to identify 
Mtb genes that are involved in protecting the pathogen against immune mechanisms 
controlled by IFN-y, a key cytokine required for macrophage activation and anti-
mycobacterial defense. IFN-y is known to activate a large number of pathways at the 
level of the macrophage (Ehrt et al, 2001) , but, with few exceptions, the roles of these 
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pathways in anti-mycobacterial defense are unknown. The four cim genes described here 
appear to be involved in adaptation of Mtb to pressures exerted by IFN-y-dependent 
mechanisms other than NOS2, because the corresponding mutants showed little or no 
defect for growth and lethality in IFN-y-deficient mice yet were highly attenuated in 
NOS2-deficient mice. A similar strategy of characterizing virulence in immuno-deficient 
mouse strains was used to demonstrate the role of the Mtb KatG catalase (Ng et al, 2004) 
and the Salmonella Pathogenicity Island-2 (Vazquez-Torres et al, 2000b) in countering 
the host NADPH oxidase; in these cases, attenuation of the mutants was reversed in 
gp91phox"'"mice. 
The cim mutants do not appear to be killed in NOS2-deficient mice, but they are 
incapable of progressive growth in these mice; indeed, the growth profiles of the cim 
mutants are very similar in C57B1/6 and NOS2"'" mice, in sharp contrast to wild-type Mtb, 
which replicates much more extensively in NOS2"'" mice than in C57B1/6 mice (Fig. 8). 
Of interest, none of the cim mutants appeared to be severely attenuated in wild-type 
C57B1/6 mice despite being severely attenuated, compared to wild-type Mtb, in NOS2-
deficient mice (Fig. 8). We anticipated this possibility, which is why we chose to screen 
mutant pools directly in immuno-deficient mice. Several explanations are possible. The 
impact of immune mechanisms that are engaged at later stages of infection, after NOS2 
has already come into play, might be masked by the dominant effect of NOS2. It is also 
possible that alternative pathways that are up-regulated in the absence of NOS2 (Ehrt et 
al, 2001) might exert an anti-bacterial effect only in that context. Direct screening in 
immuno-deficient mice should be particularly useful for identification of Mtb genes that 
permit continued bacterial growth in the face of otherwise bacteriostatic immune 
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mechanisms activated by IFN-y; it is unlikely that such mutants would be identified by 
screening in C57B1/6 mice, due to the masking effect of NOS2. 
One of the cim genes, /?v0405, was previously identified as an Mtb virulence 
factor (Camacho et al, 1999). /?v0405 is annotated as polyketide synthase 6 (pks6), one 
of 16 genes in the Mtb genome that are predicted to encode polyketide synthases (Cole et 
al, 1998), although other polyketide synthases continue to be identified (Saxena et al, 
2003). To date, only two of the Mtb polyketide synthases have been assigned 
biochemical functions: Pks2 (Sirakova et al, 2001) and Pksl5/1 (Constant et al, 2002) 
are involved in the biosynthesis of cell wall sulfolipids and phenolglycolipids, 
respectively. Although the polyketide synthesized by Pks6 has not been identified, a 
number of polyketide metabolites from other organisms —such as FK506, rapamycin, and 
cyclosporine—are potent immunosuppressants (Cardenas et al, 1998). Thus, Pks6 might 
be involved in synthesis of a polyketide(s) product that interferes with the IFN-y-
dependent arm of the anti-mycobacterial immune response, which would explain why 
pks6 is apparently dispensable for bacterial virulence in the absence of IFN-y (Fig. 8). 
j/?v2958c and its Mycobacterium leprae homolog were identified previously in 
screens for genes that enhanced the survival of the non-pathogenic saprophyte 
Mycobacterium smegmatis following phagocytosis by macrophages (Miller and Shinnick, 
2000; Mundayoor and Shinnick, 1994). i?v2958c is annotated as one of several putative 
glycosyl transferases in the Mtb genome (Cole et al, 1998); these enzymes may be 
involved in the glycosylation of cell surface lipids or proteins that interact with host cells. 
Defects in glycosylation of secreted and surface proteins have been shown previously to 
affect the immune response to these Mtb antigens (Schmidt et al, 2003). /?v2958c is 
151 
located within the genomic region that includes pksl5/l. This gene cluster is conserved 
in order and sequence between Mtb and M. leprae, suggesting that these genes may 
function in a common pathway for the production of cell wall phenolglycolipids 
(Constant et al, 2002). 
Rv0072 and Rv0930 are annotated as components of a putative ATP binding 
cassette (ABC) transporters. ABC transporters are large multi-subunit permeases which 
function in eukaryotic cells as exporters and in prokaryotes as both importers and 
exporters (Braibant et al, 2000). ABC transporters consist of two membrane-spanning 
domains (MSDs), and two nucleotide-binding domains (NBDs). Prokaryotic ABC 
importers often include an additional high affinity substrate binding protein (SBP) that 
specifies the cargo of the ABC transporter. 
Rv0012 encodes one of two annotated MSD subunits for a putative glutamine 
transporter. The transposon insertion in Rv0012 may also exert polar effects on the 
downstream gene, Rv0013, which is annotated as encoding the glutamine transporter's 
NBD subunit. Mtb is a glutamine prototroph, and previous studies demonstrated that the 
Mtb glutamine synthetase, GlnAl, is important for survival in macrophages and in guinea 
pigs (Miller and Shinnick, 2000; Tullius et al, 2003), indicating that the phagosomal 
concentration of glutamine is too low to support bacterial metabolism. Thus, it is unclear 
what role glutamine transport might play in Mtb pathogenesis. In other species of 
bacteria, ABC transporters have been implicated in the transduction of information from 
the extracellular milieu, leading to adaptive changes in bacterial gene expression (Decker 
et al, 1999; Lucas et al, 2000; Ruiz and Silhavy, 2003; Valdivia and Falkow, 1997). We 
speculate that the very low levels of glutamine in the macrophage phagosome (Miller and 
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Shinnick, 2000; Tullius et al, 2003) might serve as an environmental cue that is 
transduced by the glutamine transporter to the appropriate cellular response pathways, 
resulting in adaptation of the organism to IFN-y-dependent changes in the intracellular 
environment. 
/?v0930, annotated as pstAl, is predicted to encode an MSD subunit for a putative 
high-affinity inorganic phosphate transporter (Braibant et al, 1994; Braibant et al, 
1996a; Braibant et al, 1996b; Lefevre et al, 1997). /?v0930 is the last open reading frame 
in what appears to be an operon encoding another MSD subunit (/cv0929, a.k.a. pstC2) 
and a SBP subunit (/?v0928, a.k.a. pstS3) of the putative phosphate transporter. A 
homologous locus located -4.2 kb downstream of the pstAl locus is thought to encode a 
second high-affinity phosphate transporter; the order of the genes in the two putative 
operons is conserved although the homology between the corresponding genes is limited 
(25-64%). It is unclear at present why loss of just one of the two phosphate transporters 
would result in such a marked phenotype in vivo. In Escherichia coli, the high-affinity Pst 
transport system is of primary importance when phosphate levels are very low, whereas 
the low-affinity Pit transport system is sufficient when extracellular phosphate is 
abundant (Harris et al, 2001). The Mtb genome contains homologs of both of the E. coli 
pit genes (pitA and pitB), but their role in phosphate transport has not been elucidated in 
Mtb. The Pst system has been implicated in virulence in other pathogens, including 
Streptococcus (Orihuela et al, 2001), Salmonella (Lucas et al, 2000; Valdivia and 
Falkow, 1997), Shigella (Runyen-Janecky and Payne, 2002), and pathogenic E. coli 
(Daigle et al, 1995). Attenuation of Pst system mutants in Salmonella is apparently due 
not only to disrupted phosphate metabolism per se but also to dysregulation of other 
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virulence pathways (Lucas et al, 2000; Valdivia and Falkow, 1997), suggesting that Pst 
functions as a sensor of the intra-phagosomal milieu leading to adaptive changes in 
bacterial gene expression. Our results suggest that the Pst system in Mtb is particularly 
important for bacterial adaptation to environmental changes triggered by IFN-y, but given 
the possibility that this system functions both as a transporter and as a regulator of gene 
expression, further studies will be necessary to elucidate the precise role of the Pst system 
in Mtb virulence. 
The success of Mtb as a persistent pathogen can be attributed to the evolution of 
bacterial genes that act to counter elements of the host immune response. Although a 
number of Mtb virulence factors have been identified, few mutants with in vivo 
phenotypes have been described for which the mechanism of virulence has been clarified. 
Differential STM, the screening of bacterial mutants for differential attenuation in the 
face of varying in vivo stresses, allows for identification of mutants that are susceptible to 
specific pressures, and can be applied to a diverse range of scientific questions. Other 
studies from our laboratory are employing differential STM to pinpoint mycobacterial 
genes that are necessary for resisting other in vivo stresses, including RNI, ROI, and 
chemotherapeutic agents, as well as the set of pressures that occur during persistent 
infection. Although differential STM does not provide defined mechanisms of virulence, 
this method offers greater insight into which host pathways bacterial genes are 
countering. Understanding of the counter-immune mechanisms of Mtb might lead to 
potentially new and interesting anti-mycobacterial therapies. Inhibitors targeting these 
pathways would promote the clearance of infection not by killing the organism directly, 
but by increasing its vulnerability to the onslaught of the host immune response. 
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Technical Comments 
Analysis of methods for preparation of bacterial inocula 
Because Mtb's hydrophobic envelope promotes aggregation, bacterial 
preparations for injection into mice must be treated to eliminate clumps. Presence of 
large aggregates in inocula results in atypical distribution in mouse organs after i.v. 
infection. Because the capillary beds of the lungs are much narrower than the vessels 
comprising the reticulo-endothelial system in the spleen and liver, clumps of bacteria 
preferentially lodge in the lungs, resulting in upwards of 5% of the inocolum seeding this 
organ. Not surprisingly, pathogenesis of Mtb infection proceeds unusually, and mice die 
earlier than anticipated. 
We tested three methods for dispersing aggregates of bacteria: vortexing, 
sonication in a water bath, and probe sonication. An aliquot of frozen H37Rv was 
thawed, separated into three tubes, diluted, and vortexed or sonicated accordingly. Mice 
were injected i.v. with 0.1 ml of bacteria. Organs were harvested at 24 hours after 
infection for determination of bacterial distribution and at 3 weeks after infection for 
evaluation of bacterial viability in vivo (Fig. 9). Probe sonication provided the best 
disruption of clumps, as assessed by the lowest percent of inocula lodging in the lungs 
(Fig. 9A) and the highest number of cfu in the inocula (Fig. 9B). The overall distribution 
of the inocula at 24 hours after infection was not appreciably different among the three 
methods of dispersion (Fig. 9A, B); however, by 3 weeks after infection it was clear that 
probe sonication had damaged the bacteria (Fig. 9C). This damage was insufficient to 
kill the bacteria, as indicated by cfus recovered from plating the inocula; rather, probe 
sonication rendered Mtb more vulnerable to the in vivo environment. We therefore chose 
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Figure 9. Evaluation of methods for preparing M t b inocula prior to i.v. injection. 
Freezer stocks of M t b were thawed, diluted and vortexed and/or sonicated to disperse 
clumps. Methods were analyzed by distribution of the inocula in the lung, liver, and 
spleen at 24 hours after infection (A), total cfu in the inocula prior to injection (B), 
and expansion of the inocula in the lungs at 3 weeks after injection, as compared 
with lung cfu at 24 hours (C). In panels A & C, values represent means of 5 mice 
+/- standard deviations. 
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water bath sonication for subsequent experiments, because it effectively dispersed 
aggregates without damaging the bacteria and with less variability than vortexing alone. 
Infection ofphoxgp9l'NOS2 mice with Mtb 
This is not the first report of Mtb infection of mice deficient in both phox and 
NOS2. A previous report by Jung et al. describes growth of Mtb H37Rv in the organs of 
phoxgp91"'"NOS2"'"rnice after aerosol infection, and indicates that Mtb replicates with 
identical kinetics in the lungs, livers, and spleens of phox8p9l"'"NOS2"'"mice and NOS2"'" 
mice (Jung et al, 2002). The data provided here are consistent with the findings of Jung 
et al, but also provide further characterization of pathogenesis of Mtb in phox6p91"'"NOS2" 
'" mice. Our studies include confirmation of Jung et al.'s results using a different strain of 
Mtb (Erdman), confirmation of Jung et al.'s results by a different route of infection (i.v), 
a direct head-to-head comparison of bacterial cfu in the organs of NOS2"'", phox8p91/" 
NOS2"'" and IFN-y"'" mice, and an examination of survival of the three strains of mice 
post-infection. 
Although considered virulent strains of Mtb, no two "wild type" laboratory strains 
can be assumed to behave the same in vivo or in vitro. Within our laboratory, we 
observed in vitro phenotype differences between the strains Erdman and H37Rv. 
Although all strains of Mtb form aggregates if allowed to grow in liquid culture for 
extended periods, H37Rv demonstrates a particularly marked predisposition for 
developing clumps in liquid culture, presumably due to increased hydrophobicity of the 
H37Rv lipid envelope. When immunodeficient mice were infected i.v. with H37Rv or 
Erdman, IFN-y-deficient mice succumbed sooner than NOS2-deficient mice regardless of 
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the Mtb strain; however, the difference in survival between IFN-y-deficient mice and 
NOS2-deficient mice was less dramatic with H37Rv (Fig. 10), consistent with the 
findings of others (Mogues etal, 2001). Thus, the more pronounced difference in 
survival seen during infection with Erdman provides a larger window in which to see 
potential subtle contributions of phox as evaluated by pathogenesis in phoxgp9I"'"NOS2"'" 
mice and NOS2"'"mice. 
Although aerosol infection is more representative of the natural route of infection 
with Mtb, our interest in using modified STM required us to use the i.v. route for 
infection. Intravenous infection permits inoculation with larger numbers of bacteria, 
because immediate dissemination of bacteria through peripheral organs triggers a 
systemic immune response, which leads to more rapid containment of bacterial growth in 
the lungs, thus prolonging murine survival. With aerosol infection, bacteria do not 
disseminate from the lung to other organs for several weeks, delaying the onset of a 
systemic immune response and resulting in 10 to 100 times more bacterial replication in 
the lungs before immunity forces the bacteria to cease replicating. Thus, if more than 
500-1000 cfu seed the lungs during an aerosol infection, death of the animal may occur 
before immunity can halt bacterial replication. STM requires that ample numbers of 
bacteria be delivered to the host species to ensure that all mutants in a pool are 
represented in the target organ. Our pools contained 48 mutants each, so we wanted at 
least 1000 cfu to seed in the lungs of the mice to ensure that all mutants were represented. 
Because we planned to use STM to identify counter-immune mutants susceptible to IFN-
y-dependent, NOS2-independent host mechanisms, we felt it was important to confirm 
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Figure 10. Pathogenesis of H37Rv and Erdman strains of Mtb in immunodeficient 
mice. Survival of IFN-y'" mice (circles) and NOS2"'" mice (squares) infected i.v. with 
lxlO5 cfu Mtb Erdman (closed symbols) or H37Rv (open symbols). For Erdman, 
infections n = 13, for H37Rv infections, n = 4. 
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Although the study by Jung et al. illustrates that phox does not affect the ability of 
Mtb to proliferate in host tissues, it does not directly examine the virulence of Mtb in 
phoxgp91"'"NOS2"'"mice. Several studies have demonstrated that bacterial growth in vivo 
does not always correlate with virulence, as measured by mouse survival (Manca et al, 
1999; Manca et al, 2001; North et al, 1999; Steyn et al, 2002). Two strains of bacteria 
can grow with the same kinetics in vivo, and yet cause death of mice at different rates, 
demonstrating the role of immune pathology in the disease process of tuberculosis. 
Studies have shown that phox and NOS2 act not only as antimicrobial effectors, but also 
as mediators of other macrophage functions (Ehrt et al, 2001). It is possible that Mtb 
might grow similarly in NOS2"'"and phoxgp91"'"NOS2"'mice, but that phoxgp9'"'"NOS2"'"mice 
might generate more immune pathology in response to infection than their NOS 2"'" 
counterparts. This scenario would not be detected by determination of evaluation of 
bacterial growth in vivo, and would be revealed only by analysis of murine survival after 
infection with Mtb or by examination of the host immune response during infection, 
including evaluation of tissue pathology. Our results indicate that NOS2"'"and phoxgp9l/" 
NOS2"'"mice die with roughly the same kinetics after infection with Mtb, suggesting that 
there is no detectable impact of phox on immune pathology during infection with wild 
type Mtb. 
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C h a p t e r 4 
Identification of a Salmonella typhimurium gene 
that modulates interactions with macrophages and contributes 
to virulence 
Careful regulation of virulence factors and defense mechanisms allows 
Salmonella typhimurium to persist and replicate within the phagosome of the macrophage 
despite the macrophage's arsenal of immune defenses. S. typhimurium has specifically 
evolved to alter macrophage cell functions and take advantage of the phagosomal milieu; 
inside the macrophage, the bacterium is safe from attacks by other immune mechanisms. 
Many of the molecular mechanisms that shape the dynamics between S. typhimurium and 
the macrophage have been well characterized, largely due to the ease of genetic 
manipulation of S. typhimurium. Yet, despite genome sequencing, mutagenesis studies, 
and numerous mutant screens, many S. typhimurium genes with putative enzymatic 
functions remain unexamined, including many of the bacterial effectors translocated into 
host cells by the SPI-1 and SPI-2 TTSSs. Genes providing defense against ROI have 
been studied intensively, yet bacterial resistance to RNI is still poorly understood. 
Moreover, complex regulatory circuits used by bacteria to link the induction and 
repression of multiple pathways during the adaptation to new environments are just now 
beginning to be understood. Here we describe the S. typhimurium gene ydiV, discovered 
as contributing to anti-oxidant defense, but which in fact regulates multiple bacterial 
functions. Analysis of its domain architecture reveals that ydiV appears to belong to a 
161 
family of enzymes found throughout prokaryotes. Modulation of intracellular c-diGMP 
by YdiV, and perhaps by most of these enzymes, may act as a novel signaling alternative 
to the classical phospho-relay 2-component regulatory system. 
Results 
Identification of a novel contributor to S. typhimurium's antioxidant defense 
A modified version of signature-tagged transposon mutagenesis was performed 
using the same library of 960 S. typhimurium STM mutants that was evaluated in the 
original description of STM (Hensel et al, 1995). All 960 mutants were screened for 
attenuation in wild type C57BL/6 mice, as determined by under-representation of STM 
tags recovered from the spleen 3 days after infection. Attenuated mutants were 
reassembled alongside randomly chosen virulent mutants (ratio 1:2) into 3 new pools 
containing 96 mutants each. The new pools were used to infect wild type C57BL/6 mice, 
NOS2"'" mice, phoxgp91/" mice and phoxgp91"'"NOS2"'" mice (all on the C57BL/6 
background), and virulence of individual mutants was evaluated in each strain of mouse. 
Of the original 960 mutants, 31 mutants were found to be under-represented in recovered 
bacteria from all 4 strains of mice (Table VI). Hense/ et al. had previously identified 
thirteen of these mutants as attenuated for growth in vivo during a screen of the same 
STM library in BALB/c mice (Hensel et al, 1995). An additional 7 mutants were found 
to be attenuated in wild type C57BL/6 mice, but restored in virulence in at least one 
strain of immunodeficient mice on the C57BL/6 background (Table VII). 
SPI-2 mutants were among the mutants identified as being attenuated in all 4 
strains of mice tested in our differential STM screen (Table VI); yet, these same SPI-2 
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mutants, which were unable to kill C57BL/6 mice, were found to be restored to virulence 
in phox-deficient mice by Vazquez-Torres et al. (Vazquez-Torres et al, 2000b). This 
apparent discrepancy can be explained by the different methods used to evaluate 
virulence in the two studies. Vazquez-Torres et al. defined virulence as the ability of 
mutants to kill mice. STM determines virulence by the ability of mutants to compete 
with wild type bacteria in a mouse, and thus STM measures the rate of bacterial 
proliferation in vivo. When a 1:1 mixture of a SPI-2 mutant and wild type bacteria was 
used to infect C57BL/6 mice, the SPI-2 mutant was confirmed to be highly attenuated 
(competitive index (C.I.) = 0.0023 +/- 0.004), consistent with both our STM results and the 
survival studies of Vazquez-Torres et al. When the SPI-2 mutant was competed against 
wild type S. typhimurium in phox-deficient mice, the competitive index of the mutant 
increased, but remained less than 0.1 (CI = 0.05 +/- 0.05). SPI-2 mutants are therefore 
partially restored in their ability to proliferate in phox-deficient mice. This partial 
restoration is sufficient for the bacteria to overwhelm Nrampls mice, and thus SPI-2 
mutants appear virulent when virulence is evaluated by murine survival after infection; 
however, mutants with a competitive index of less than 0.5 are identified as under-
represented, and thus attenuated, by STM. The difference in the conclusions from the 
two original studies serves to illustrate the incredible sensitivity of STM to detect 
attenuated mutants. 
Southern blot analysis of DNA from the 7 attenuation reversal (AR) mutants ruled 
out the possibility of multiple transposon insertions in the same mutant (data not shown). 
Additionally, transposon insertions in the AR mutants were transduced into fresh cultures 
of wild type 12023, decreasing the likelihood of additional unmarked mutations. The AR 
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mutants demonstrated no deficit in in vitro proliferation in LB broth under conditions of 
good aeration as compared with wild type S. typhimurium (Table VII). Using mixed 
infection, the 7 AR mutants were assayed to confirm attenuation in wild type mice. None 
of the AR mutants demonstrated dramatic deficits in ability to compete with wild type 
bacteria in vivo; however, two mutants consistently generated C.I.s of less than 0.5: AR5 
and AR6 (table VII). The relative virulence of these two mutants was then evaluated in 
immunodeficient mice. AR6 demonstrated attenuation in immunodeficient that was 
equivalent to the deficit seen in wild type mice (Fig. 1 IA). AR5, however, exhibited no 
deficit in virulence in either phox6p91/" mice or phoxgp91/"NOS2"/ mice despite being 
attenuated in both wild type and NOS2"/_ mice (Fig. 11 A), suggesting that the gene(s) 
disrupted in this mutant mediates resistance to a phox-dependent stress. 
The transposon insertion in AR5 was located in the gene ydiV, which is located in 
the S. typhimurium genome downstream of nlpC, a putative membrane-bound peptidase, 
and 62 nucleotides upstream of ydiU (Fig. 1 IB). Other genes in the vicinity include the 
upstream btu operon, which is thought to be involved in Vitamin B12 transport, and aroH 
which participates in the synthesis of aromatic amino acids. The "y" designation of ydiV, 
ydiU, and ydiE indicates that these genes had not been described or assigned functions at 
the time of S. typhimurium genome annotation. The close proximity of ydiV and ydiU 
suggested that these two genes might be transcribed as an operon, and thus the transposon 
insertion in ydiV would disrupt expression of both ydiV and ydiU. To determine whether 
disruption of expression of ydiU contributed to the phenotype of AR5, a S. typhimurium 
strain was constructed in which most of ydiU was replaced with an antibiotic resistance 
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Figure 11. The ydiV locus in not required for growth of S. typhimurium in mice that 
lack phox, but contributes to virulence in wild type mice. (A) Mixed infection of 
mice with A R mutant. Values are means for 5 mice +/- standard deviation. 
^indicates average of 3 experiments. (B) Insertion site of the S T M transposon in 
the mutant A R 5 . 
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typhimurium and the AydiU strain revealed that ydiU was not required for virulence (Fig. 
12A). Moreover, complementation of AR5 with ydiV expressed from a low copy plasmid 
under the control of its own promoter restored the mutant's ability to compete with wild 
type bacteria in C57BL/6 mice (Fig. 12B). 
Expression of YdiV in late log phase mediates protection against ROI in vitro 
Increased susceptibility to phox in vivo does not necessarily predict a decrease in 
resistance to oxidative stress or to ROI in vitro. SPI-2 mutants that are unable to divert 
phox from the phagosome in macrophages are rapidly killed by ROI in mice and 
macrophages, but they are not more vulnerable than wild type strains of S. typhimurium 
to killing by ROI in vitro (Vazquez-Torres et al, 2000b). Moreover, many genes that are 
required for growth or survival in vivo are not constitutively expressed in vitro, including 
SPI-1 (Daefler, 1999), SPI-2 (Deiwick et al, 1999), and many anti-oxidant defenses 
(Janssen et al, 2003). A chromosomal lacZYA fusion was created at the ydiV locus such 
that both endogenous ydiV and (3-galactosidase would be expressed off of the putative 
promoter region of ydiV. Analysis of the resulting S. typhimurium strain (FWI) indicated 
that ydiV is expressed in LB broth in vitro, with a spike in expression occurring at the 
transition between exponential growth and stationary phase (late log phase) (Fig. 13). 
Immunoblot of bacterial lysates using specific antibody generated against rYdiV 
confirmed levels of YdiV protein in the wild type strain during late log phase that were 
more robust than during stationary phase, as well as a lack of YdiV protein in the ydiV 
mutant (Fig. 14). Expression of YdiV was found to be not merely restored, but also 
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Figure 12. Deficiency in ydiV only accounts for the phenotype of the AR5 mutant. 
(A) In vivo phenotype of AR5, AR6, and AydiU S. typhimurium in C57BL/6 and 
gp9jphox-/- mjce as evaluated by competitive mixed infection with wild type 12023 
S. typhimurium. Values are means for 5 mice +/- standard deviation. (B) Mixed 
infections of C 5 7 B L / 6 mice using wild type S.typhimurium vs. the ydiV mutant or 
wild type vs. the complemented mutant. Each bar represents the competitive index 
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Culture Density (AS0Q) 
Figure 13. YdiV expression is induced during late log phase growth in vitro. An 
overnight culture of wild type S. typhimurium containing aydiV-lacZYA fusion 
was diluted into fresh L B and grown with aeration at 37°C. (A) Graph of units 
of p-galactosidase activity/A^ versus time permits correlation of time after 
dilution with (B) spike in induction of (3-galactosidase activity. The arrow in (B) 
indicates the culture density at which the slope of the line changes (signifying 
induction of the lacZYA fusion), and correlates with the time point (5 hr) 
indicated by the arrow in panel (A). Points represent the average of data from 
two independent experiments, and each experiment provided 2 independent 
evaluations of enzyme activity from each culture. Error bars represent the 
standard deviation for the average of the 4 data points. 
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late log phase stationary phase 
ydiV 100 ng 100 ng ydiV 
12023 mutant comPL LT2 rYdiV rYdiV 12023 mutantcomPL 
*> • Ĥ) •'• ^ f ^ ^ 
Figure 14. Expression of YdiV in different strains of S. typhimurium used in this 
study. Immunoblot of total cell lysates from late log phase cultures or stationary 
phase cultures. Polyclonals antibodies to rYdiV were used. 
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performed with bacterial cultures grown to late log phase (5.5 hour after 1:100 dilution of 
an overnight culture) to achieve optimal expression of YdiV in wild type S. typhimurium, 
and thus maximize the difference between wild type and ydiV mutant phenotypes. 
Wild type S. typhimurium, the ydiV mutant and the complemented mutant were 
assayed for their ability to grow in medium containing various toxic stresses (Fig. 15). 
Although all three strains flourished in LB media, only the wild type and complemented 
mutant strains, but not the ydiV mutant, were able is grow in 2 mM H202 (Fig. 15A). 
Plating of H202- treated cultures to determine cfu revealed that the effects of H202 are 
cidal, not static (Fig. 15B). The protective role of ydi V appears to be specific for ROI, as 
the ydiV mutant did not show increased susceptibility to killing by SDS or NaN02, and 
the mutant was able to recover as well as wild type S. typhimurium from the static effects 
of an acidic environment (Fig. 15C-F) 
Investigation of some of the known S. typhimurium mechanisms for resistance to 
H202 revealed no deficits in the ydiV mutant strain. The OxyR regulon was found to be 
fully induced in the ydiV mutant after exposure to sublethal H202 (Fig. 16), and sublethal 
H202 did not enhance expression of ydi V (data not shown). Levels of MsrA and MsrB 
protein were comparable in wild type and mutant lysates (data not shown). There are at 
least 2 OxyR-independent catalases in S. typhimurium: katE and katN, both of which are 
regulated by the alternative sigma factor RpoS (Robbe-Saule et al, 2001). Transduction 
of the chromosomal ydiV-lacZYA fusion into several mutant and wild type strains of S. 
typhimurium revealed that ydiV was not expressed in the attenuated strain LT2 (Fig. 17), 
and a lack of YdiV protein in LT2 was demonstrated by immunoblot (Fig. 14). Although 
other mutations may also exist in LT2, LT2 is defective in expression of rpoS 
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Figure 15. Deficiency in ydiV results in increased susceptibility to killing by ROI. 
Late log phase cultures of S. typhimurium were diluted 1:100 into the LB 
containing specific stresses and incubated at 37°C, with agitation. (A) and (B), 2 
mM H202; (C) and (D), pH 4.0; (E), SDS; (F), acidified sodium nitrite, pH 5.5. 
Susceptibility was determined by culture density after 24 hour exposure to bolus 
stress as evaluated by A^, except in panel B, in which killing of bacteria was 
evaluated at specified time points after exposure to a bolus dose (2 mM) of H202 by 
diluting and plating cultures. In all panels except B & C: wild type, black bars; 
ydiV mutant, grey bars; complemented mutant, striped bars. Panel B: W = wild 
type, M = ydiV mutant; 0 hours in culture, black bars; 3 hours in culture, stippled 
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Figure 16. Disruption of ydiV does not affect induction of the OxyR regulon by 
sub-lethal hydrogen peroxide. Overnight cultures were diluted 1:100 at time 0 and 
grown with agitation at 37"C. A bolus of 60 pM hydrogen peroxide was added at 
specified times to specified cultures. Closed symbols, wild type bacteria containing 
the ahpC-lacZYA fusion; open symbols, ydiV mutant bacteria (SCN19) containing 
the ahpC-lacZYA fusion. Square, no peroxide; triangles, peroxide added at 2 hr after 
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Time (hr) after Inoculation 
Figure 17. yJ/V is regulated by an unknown mechanism that is absent in the 
S. typhimurium strain LT2. The ydiV-lacZYA fusion was transduced into 
different S. typhimurium strains. Overnight cultures of bacteria were diluted 
1:100 into L B and grown at 37"C with aeration. YdiV expression in 
different "wild type" strains of S. typhimurium (A), a mutant of the SPI-1 master 
regulator hilA (B), and a mutant of the SPI-2 master regulator ssrB (C). 
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(Swords et al, 1997). The lack of expression of ydiV in LT2 raises the possibility that 
ydiV may mediate some of the actions of RpoS, including activation of the RpoS-
dependent catalases. More studies will need to be performed to clarify if induction of 
either KatE or KatN by YdiV explains the mechanism by which ydiV contributes to anti-
oxidant defense. 
YdiV is composed of a single EAL domain 
The nucleotide sequence of ydiV gave no indication that ydiV encoded an enzyme 
with known anti-oxidant activity. Blast searches identified homologs in E. coli and 
several other Gram negative species, but none of these genes had been assigned 
functions. The S. typhimurium Genome Sequencing Center at Washington University in 
St. Louis annotated ydiV as a putative EAL domain based on low homology (E value = 
IO"04 - IO"20) to a consensus domain sequence (Wilson, 2002). EAL domains are 
relatively short (~215 amino acids) with conserved acidic residues spread throughout the 
domain (Galperin et al, 2001). Despite the name, only the glutamate is consistently 
found among EAL domains, whereas the alanine and leucine are much less conserved 
(Fig. 18). The BLAST algorithm cdart (conserved domain architecture retrieval tool) 
confirmed that YdiV appears to be composed entirely of a single EAL domain, with only 
the glutamic acid of the EAL motif conserved in YdiV (Fig. 19A). Alignments of other 
assigned EAL domain proteins with the consensus sequence demonstrated much stronger 
homology; however, because these other sequences had contributed to the derivation of 
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A 
gnllCDDIl 1907. C O G 2 2 0 0 , Rln, F O G : E A L domain [Signal transduction mechanisms] 
CD-Length 256 residues, 91.4'.' aligned 
Score = 91.9 bits (228), Expect = 6e-20 
Query: 12 ELF FLPVMD-ENARLVG|E^^TFAAE AVRMPTLLVAPP V tvi ' - EKLALLKT 70 
Sbjct : 18 SLY iCQP1VDLATGRIVG|EAl|rWRHPDGGLISPGEF1P--LAEETGLI . E _,GPWV ..Lh A 75 
Query: 7 1 
Sb jet: 76 
C HFFIQHK jIABj. LPPAISDLLLLDSELFSRAAl F PFuELA I Nl NYPGLNQ 123 
RQLRTWPRAGPLP.LAVNLSPVQLRSPGLVDLLLRLLARLGLPPHRLVLE I TESALIDDL 135 
Query: 124 GKNNETLAN ,-AMHFPLMLANF A Ei TKAIFDGLFKP ML KI [QQRAEMISFEPFM 182 
Sbjct: 136 DTALALLRQLRELGVRIALDDj. TGYS LSYLKRLPPDILK] RSFVRDLETDARDQAI 195 
Query: 183 HA1VAQISSSCESLMIA 1 •Tl AI.hAFAAF , FSAFC ;Gj-.W-PPVPVSQLIKLVQR 237 
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Figure 19. The YdiV primary amino acid sequence exhibits homology to the E A L 
domain. (A) Alignment by cdart of the YdiV amino acid sequence with the C O G S 
database consensus sequence for E A L domains. Red = conserved, Blue = not 
conserved, Grey = unaligned residues not fully covered by all sequences. 
(B) Alignments of E A L containing proteins to the consensus sequences of C O G S 
(upper left) and Pfam (lower right). The sequences other than ydiV are expected to 
be more similar to the consensus sequences because they contributed to the 
derivation of the consensus sequences. Prepared by collaborator Shaneen Singh. 
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alignment than YdiV (Fig. 19B). Additionally, the short length of the YdiV amino acid 
sequence acts to decrease the significance of the E value produced by BLAST. 
Secondary and tertiary structure prediction programs were used to analyze further 
the architecture of YdiV. For secondary structure analysis, the YdiV sequence was 
compared to that of VieA, one of the proteins used to derive the EAL consensus 
sequence. VieA act as a response regulator in Vibrio cholerae, and participates in the 
activation of cholera toxin expression (Tischler et al, 2002). The YdiV and VieA amino 
acid sequences were each converted by 5 independent prediction algorithms into a-
helices and (3-sheets. The structure predictions were then aligned. Despite low 
homology at the primary sequence, the predicted secondary structures of YdiV and VieA 
mapped almost identically (Fig. 20). Moreover, protein threading programs predicted 
that both YdiV and EAL domain secondary structures would aggregate to form higher 
order structures known as a TIM, or a/(3, barrel, a common protein fold found in as many 
as 10% of known enzymes (Nagano et al, 2002) (Fig. 21 A). Active site residues in TIM 
barrels are generally present at the carboxy termini of (3-strands (Anantharaman et al, 
2003), and the residues in the postulated analogous positions in YdiV are highly 
conserved between YdiV and other EAL domains (Fig. 2IB). 
Cyclic di-GMP: a novel signaling molecule in pathogenic bacteria 
In the plant colonizing bacterium Acetobacter xylinum, also known as 
Gluconacetobacter xylinus, proteins containing one EAL domain and a tandem GGDEF 
domain catalyze the synthesis and catabolism of the small molecule cyclic diguanylate (c-
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Figure 20. Secondary structure predications indicate that YdiV exhibits the same 
architecture as the E A L domain. Five independent secondary structure prediction 
algorithms were used to determine the putative arrangement of a-helices and 
(3-sheets in YdiV and the E A L domain-containing protein VieA. The two uncolored 
rows in the middle of each alignment indicate the amino acid sequences of VieA and 
YdiV. The top 5 rows represent 5 predicted secondary structures for VieA produced 
by 5 different prediction algorithms (PHD, S A M - T 9 9 . SSPro, 3 D - P S S M , and Psipred), 
and the bottom 5 rows represent predicted secondary structures for YdiV produced 
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Figure 21. Residues conserved between E A L domains and YdiV map to postulated 
active site residues in the TIM barrel protein fold. (A) Structure of a T I M barrel. 
including active site residue positions. (B) Location of postulated active site residues 
in YdiV amino acid sequence (top line). Identity/similarity of residues between 
YdiV and 1 0 0 % of E A L domain sequences (Purple). 9 5 % of sequences (Red), and 
9 0 % of sequences (orange). Residues conserved in 9 0 % (light grey) or 95c/c (dark 
grey) of other E A L domain sequences but not in YdiV. Secondary structure 
predictions for YdiV produced by 5 different prediction algorithms are aligned 

























Figure 22. Molecular structure of cyclic diguanylate (c-diGMP) 
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each found in an operon with a phosphodiesterase (PDE) gene, are responsible for 
modulating an intracellular pool of c-diGMP, which in turns activates cellulose synthase 
(Ross et al, 1985; Ross et al, 1987). Although both the EAL and the GGDEF domains 
are present in DGCs and PDEs, studies suggest that the GGDEF domain is responsible 
for c-diGMP cyclase activity. Computational analysis has indicated that the GGDEF 
domain demonstrates homology to adenylyl cyclases, including similarities in secondary 
structure predictions, hydrophobicity patterns, and functionally and structurally important 
residues clustered in conserved motifs (Pei and Grishin, 2001). Moreover, different 
GGDEF-containing genes, including one from E.coli that includes no other associated 
domains, can complement a deficiency in cellulose synthesis in Rhizobium 
leguminosarum, a nitrogen fixing bacteria related to A. xylinum (Ausmees et al, 2001). 
These data not only demonstrate functional complementation, but they also indicate that 
the GGDEF domain serves the same enzymatic function in E. coli as it does in A. xylinum 
and R. leguminosarum. Because GGDEF domains are postulated to act as c-diGMP 
cyclases, EAL domains are assumed to possess PDE activity, by default; however, there 
is currently no direct evidence, biochemical or computational, that supports this 
hypothesis. 
YdiV represented an excellent candidate for evaluating whether EAL domains 
possess PDE activity, as it is composed of just the single domain. If YdiV catalytically 
degrades c-diGMP, we anticipated that the complemented mutant, which overexpresses 
YdiV, would contain lower levels of endogenous c-diGMP than either the wild type or 
the ydiV mutant strain. Soluble lysates of late log phase cultures of each of the three 
strains were extracted with methanol and chloroform to eliminate proteins, and then 
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extracts were fractionated by HPLC. Fractions were subjected to electrospray mass 
spectroscopy, and endogenous levels of c-diGMP were measured by comparison to 
known quantities of synthetic c-diGMP. At least ten times more c-diGMP was detected 
in extracts from ydiV mutant S. typhimurium than in extracts from the over-expressing 
strain (Fig. 23). Moreover, the amount of c-diGMP in extracts from the over-expressing 
strain was indistinguishable from background levels, suggesting that over-expression of 
YdiV leads to elimination of endogenous c-diGMP. Wild type extracts are in the process 
of being evaluated to determine if the ydiV mutant contains significantly more c-diGMP 
than wild type S. typhimurium. These data represent the first evidence that EAL domains 
possess PDE activity; moreover, this is the first evidence implicating c-diGMP in the 
regulation of virulence mechanisms of pathogenic bacteria. 
EAL and GGDEF domains are abundant in the S. typhimurium genome 
According to annotation by the Genome Sequencing Center at Washington 
University in St. Louis, the S. typhimurium genome contains 22 genes with either an EAL 
domain, a GGDEF domain, or both (Table VIII). Seven genes encode both domains, four 
genes include other domains in addition to EAL or GGDEF, but in more than half the 
genes, the EAL or GGDEF domain is the only recognized domain in the gene. However, 
all the genes that encode a sole GGDEF domain also encode a long N-terminal region 
that bears no homology to any domains in the database. In fact, S. typhimurium contains 
no genes that are composed of only a GGDEF domain, whereas 5 of the 18 genes with 
EAL domains are short genes composed entirely of an E.AL domain, such as ydiV. 
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Figure 23. Over-expression of YdiV in S. typhimurium results in depletion of 
endogenous c-diGMP. Chloroform / methanol extracts of bacterial cytosolic fractions 
were analyzed for endogenous c-diGMP content. Methods are paraphrased from a 
description by Michael MacCoss who performed the analysis. (A) Positive ion 
electrospray ionization of synthetic c-diGMP, (M+H)+ ion = 691.1. (B) Spectrum after 
solation of the 691.1 ion in the first quadrupole (QI) of a triple mass spectrometer, 
fragmentation of the 691.1 ion by low energy collisions with Ar gas in Q2, and 
detection of the product ions in Q3. The 540 Ion results from the loss of one guanine. 
(C) Selected reaction monitoring (SRM) mass spectrometry: chromatogram of 900 fmol 
of synthetic c-diGMP with mass spectrometer set to detect only molecules with a 
precursor ion of 691 and product ions of 540. (D) S R M mass spectrometry for ydiV 
mutant extract. The second peak results from c-diGMP chelation of cations. (E) S R M 
mass spectrometry for methanol (as a blank). Peak is carry-over from the previous 
sample due to c-diGMP's ability to bind to the metal syringe. (F) S R M mass 
spectrometry for complemented mutant extract (equal quantity to the amount of ydiV 
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'Assigned to each ORF in the S. typhimurium, in order of arrangement on the chromosome, by 
the Genome Sequencing Center, WUSTL (Washington University in St. Louis) 
2Two of the three independent protein domain databases. EAL domains are designated rtn or 
COG2200 in COG (cluster of orthologous groups), pf00563 in Pfam, and DUF2 or Smart00052 
in SMART (simple module architecture reseach tool). GGDEF domains are designated 
COG2199 in COG, pf0090 in Pfam, and DUF1 or smart00267 in SMART. 
3COG4943 = signal sensor + EAL domain, COG5001 = N-terminal sequence + GGDEF + EAL 
4The C-termini of STM551 (aa 69-100) aligns with low homology to residues 803-834 of a B. 
japonicum gene which is COG5001. The homologous portion compises the C-termini of the B. 
japonicum COG5001 EAL domain. 
5pslt indicates that the gene is found on the virulence plasmid. 
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Only one of these genes had been previously studied: adrA, which appears to be 
the S. typhimurium homolog of A. xylinum's cellulose regulating DGC (Romling et al, 
2000; Zogaj et al, 2001). The only other member of this set described in the literature 
was the E. coli homolog of rtn (STM 2215), which had been identified in a screen for 
mutants with altered adaptation rates to exogenous stress (Hall, 1997). Blast searches 
indicated that GGDEF and EAL domains are widespread among prokaryotes, and are 
often found in tandem with signal sensor domains, such as the PAS or CheY domains 
(Galperin et al, 2001). Most of the genes in the database have never been functionally 
analyzed; however, EAL and GGDEF domain-containing genes in other Gram negative 
bacteria, including Bordertella pertussis (Merkel et al, 1998a), Vibrio parahaemolyticus 
(Boles and McCarter, 2002), and Caulobacter crescentus (Aldridge et al, 2003; Hecht 
and Newton, 1995), appear to act as response regulators, influencing diverse bacterial 
functions, including synthesis of exopolysaccharide, expression of flagella, and 
regulation of virulence genes. 
YdiV and regulation of cellulose synthesis in S. typhimurium 
Endogenously produced c-diGMP has been characterized as a regulator of 
enzymatic activity in only one context: activation of cellulose synthesis in nitrogen-
fixing, plant-colonizing bacteria. Recently, it has been appreciated that pathogeneic 
Gram negative bacteria also produce exopolysaccharides under specific conditions. In 
Vibrio species, synthesis of capsular polysaccharides is mediated by proteins containing 
both an EAL and a GGDEF domain (Boles and McCarter, 2002; Rashid et al, 2003). 
Under certain environmental conditions that promote biofilm formation, S. typhimurium 
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produces an extracellular matrix composed of aggregative fimbriae and cellulose (Zogaj 
et al, 2001). Cellulose synthesis is activated by expression of the gene adrA, which 
encodes a putative transmembrane domain, a MASE2 domain, and a GGDEF domain 
(Romling et al, 2000). In light of the parallels to A. xylinum, it seems likely that AdrA 
activates cellulose synthesis by generating c-diGMP. However, unlike the DGCs and 
PDEs in A. xylinum, adrA does not encode an EAL domain, nor is it in an operon with a 
candidate PDE. 
We considered the possibility that YdiV acts as the PDE that turns off cellulose 
synthesis in S. typhimurium. Zogaj et al described four colony morphotypes resulting 
from growth on Congo Red agar that are produced depending on which elements of the 
extracellular matrix S. typhiumurium expresses: in the absence of matrix, colonies appear 
white; production of cellulose only leads to pink colonies; production of fimbriae only is 
associated with brown colonies; and secretion of both cellulose and fimbriae leads to red 
colonies (Zogaj et al, 2001). If YdiV acts as the PDE complement to AdrA, 
overexpression of YdiV should inhibit cellulose synthesis, and thus result in white or 
brown colonies. Overnight cultures of wild type, ydiV mutant, and hypercomplemented 
S. typhimurium were diluted, plated on Congo Red Agar, and incubated at 30°C or 37°C. 
Colonies from each of the three strains grown at 30°C developed an identical morphotype 
with red colonies (Fig. 24). All strains produced white colonies when grown at 37°C 
(data not shown), consistent with inhibition of biofilm formation at this temperature. 
Thus, YdiV does not appear to act in conjunction with AdrA to regulate cellulose 
synthesis, although comparison with a cellulose-deficient strain of S. typhimurium on 






Figure 24. YdiV does not appear to contribute to the production of cellulose 
by S. typhimurium. Bacterial cultures were spread on LB-agar containing no 
NaCl augmented with 40 pg/ml Congo Red and 10 ug/ml Coomasie Brilliant 
Blue. Red color indicates the presence of polysaccharide. 
to make a definitive conclusion. One of the other 17 E A L domain-containing proteins 
encoded by the S. typhimurium genome may act as the reciprocal phosphodiesterase for 
AdrA. 
YdiV contributes to the regulation of flagellin 
Several Gram negative bacteria use EAL or GGDEF domains to regulate motility 
either by effecting function of flagella (Aldridge et al, 2003; Boles and McCarter, 2002) 
or pili (Huang et al, 2003). We examined whether expression of ydiV influenced the 
motility of S. typhimurium. Swimming motility was assayed by growth through 0.3% 
LB-agar. Over a 4-6 hour period, the ydiV mutant swam slightly further than wild type 
bacteria (Fig. 25). Strikingly, the complemented mutant did not swim at all, even when 
agar plates were left to incubate overnight. When bacteria were inoculated on 0.65% 
agar to evaluate swarming motility (across the surface of the agar, rather than through it) 
(Young et al, 1999b), the results were the same: the ydiV mutant swarmed further than 
wild type S. typhimurium, and the complemented mutant did not swarm (data not shown). 
Observation of bacteria from liquid cultures at lOOx magnification confirmed that the 
complemented mutant was amotile. The extreme phenotype of the complemented mutant 
was consistent with expression of YdiV above wild type levels in this strain. 
To determine whether the defect in motility was due to a functional defect in 
flagella or a lack of synthesis of flagella, protein content in bacterial culture supernatants 
was evaluated by silver stained SDS-PAGE (Fig. 26A). One protein was clearly over-
abundant in supernatant from the ydiV mutant strain, but undetectable in the supernatant 












mutant, late log 
phase 
Figure 25. Over-expression of YdiV inhibits S. typhimurium swimming 
motility. 2 pi of bacterial culture was inoculated into LB media containing 
0.35% agar, no NaCl. Plate was incubated at 37°C for 6 hours. 
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Figure 26. Expression of YdiV is inversely correlated with expression of flagellin. 
(A) Silver stained SDS-PAGE of TCA-precipitated bacterial culture supernatants. W , 
wild type. M , ydiV mutant. C, complemented mutant. L, ladder. (B) Immunoblot 
using anti-flagellin antibody. W , wild type. M, ydiV mutant. C, complemented 
mutant. L, ladder, b, LB broth. 
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protein was consistent with flagellin, the monomer encoded by fliC or/7/5 that 
polymerizes to form flagella. An immunoblot of bacterial supernatant proteins using 
anii-Salmonella flagellin antibody confirmed that flagellin levels were higher in 
supernatants from cultures of the ydiV mutant than in supernatants of wild type cultures, 
and undetectable in supernatants from the complemented mutant (Fig. 26B). 
Additionally, immunoblotting of whole bacterial lysates from the 3 strains demonstrated 
the same expression pattern of flagellin. This indicated that the lack of flagellin in the 
supernatant of the complemented mutant was not due to faulty secretion, but rather due to 
an inability to express flagellin. 
Flagellin expression is controlled by a three-tiered regulatory hierarchy. The first 
tier, known as Class I genes, includes the master regulator genes, flhD and flhC. FlhD 
and FlhC form a transcriptional activator that is required for expression of the Class II 
genes, including the sigma factor fliA. Expression of FliA is required for transcription of 
flagellin (fliC and fljB). To investigate which tier might be affected by YdiV, an flhDC-
lacZYA fusion was constructed and transduced into both wild type and ydiV mutant S. 
typhimurium. Counter-intuitively, the expression of flhDC was mildly repressed in the 
ydiV mutant, even though the mutant over-expresses flagellin (Fig. 27). This lack of 
correlation between flhDC and fliC expression was consistent with a previous report. The 
levels of FlhD and FlhC protein are regulated in S. typhimurium by Clp proteases 
(Tomoyasu et al, 2002). When the genes encoding ClpXP are disrupted, levels of FlhD 
and FlhC protein increase, resulting in increased transcription of fliA, and concomitant 
increase in transcription of flagellin. In the absence of ClpXP, the transcription of flhDC 
decreases slightly, suggesting possible feedback inhibition. Over-abundance of YdiV 
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Figure 27. Enhanced production of flagellin by the ydiV mutant is not due to 
increased expression offlhDC. Wild type (closed symbols) and ydiV mutant 
(open symbols) S. typhimurium strains containing an flhDC-lacZYA fusion were 
grown in flasks (diamonds) or tubes (circles). Cultures grown in flasks received 
more aeration than cultures grown in tubes, which has been demonstrated to 
affect expression of flagellin. 
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may suppress flagellin expression by positively regulating either the activity or 
expression of Clp proteases. 
Rapid Salmonella-induced macrophage death is suppressed by over-expression of YdiV 
The first EAL domain-containing protein to be characterized, bvgR from 
Bordetella pertussis, was identified as a locus involved in the regulation of virulence 
genes. A B. pertussis bvgR mutant demonstrates decreased capacity to colonize the lungs 
after aerosol infection of mice, resulting in longer survival of mice before succumbing to 
infection (Merkel et al, 1998b). In addition to contributing to S. typhimurium's survival 
in vivo by mediating resistance to ROI, we found that YdiV regulates other functions 
associated with pathogen-host interactions. S. typhimurium grown to late log phase 
expresses the SPI-1 effector SipB, which induces rapid death of macrophages (Lundberg 
et al, 1999; Monack et al, 2001). Consistent with these studies, when we infected 
periodate-elicited macrophages with late log phase cultures of S. typhimurium, we 
observed rapid depletion of the macrophage monolayer (Fig. 28A). 
Infection of macrophages with the ydiV mutant greatly enhanced killing of 
macrophages, with lysis of up to 100% of cells within 90 minutes after infection (Fig. 
28A). Remarkably, over-expression of YdiV in the complemented mutant completely 
abolished S. typhimurium's cytotoxic effect. Killing of macrophages by both the wild 
type strain and the ydiV mutant was dependent on growth phase and expression of sipB, 
but independent of SPI-2 (Fig. 29), confirming that we were witnessing the same 
phenomenon of rapid Salmonella-induced macrophage death that had been observed by 
others (Monack et al, 2001). When macrophages were infected with a mixed culture of 
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Figure 28. Expression of YdiV is inversely correlated with S. typhimurium's ability to 
induce rapid macrophage death. (A) 20x magnification of periodate-elicited peritoneal 
macrophages 90 minutes after infection with opsonized, late log phase S. typhimurium. 
(B) Quantitation of macrophage death after infection with opsonized, late log phase S. 
typhimurium as measured by L D H release. Experiment shown is representative of 15 
independent experiments. *Toxicity of the mutant is significantly greater than toxicity 
of wild type S. typhimurium. For this experiment, p<0.01; for compiled data, p<10"6 by 
two-tailed Student's /-Test. 
198 
Figure 29. Rapid Sa/mone//a-induced macrophage death is dependent on bacterial 
growth phase and expression of sipB, but not on secretion by SPI-2. 
(A) Macrophages were infected with late log phase cultures of S. typhimurium 
disrupted in ydiV and/or sipB. (B) Macrophages were infected with late log phase or 
stationary phase cultures of wild type (WT), ydiV mutant (Mut) or complemented 
mutant (Com) S. typhimurium. (C) Macrophages were infected with late log phase 
cultures of S. typhimurium disrupted in ydiV and/or ssaR. ssaR encodes a component 
of the secretion apparatus of SPI-2. AydiV contains a targeted disruption in ydiV, and 
demonstrates the same phenotypes as the ydiV::mTn5 transposon mutant. Values are 
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the ydiV mutant and its complemented strain, the mutant phenotype prevailed and the 
macrophages were killed (Fig. 30A). This demonstrates that the complemented strain 
does not actively inhibit death; rather, it lacks a factor required for cytotoxicity. SipB, 
however, was present in the supernatant of the complemented mutant (Fig. 31 A), 
indicating that SipB is necessary but not sufficient to induce rapid macrophage death. 
Moreover, a sip operon- lacZYA fusion construct, as well as silver-stained SDS-PAGE 
analysis of bacterial culture supernatant proteins, indicated that Sip expression in the ydiV 
mutant was comparable to expression in wild type S. typhimurium (Fig. 3 IB), suggesting 
that enhanced cytotoxicity of the ydiV mutant was not due to excessive secretion of SipB. 
Addition of c-diGMP to mammalian cell lines has been shown to cause disruption 
of normal cell cycling (Amikam et al, 1995; Steinberger et al, 1999). Although there is 
evidence that plants generate c-diGMP as an allosteric regulator of cellulose synthase, 
there are no reports of c-diGMP being synthesized in eukaryotic cells from the animal 
kingdom (Amor et al, 1991). Additionally, other nucleotides, specifically ATP, have 
been demonstrated to induce cell death by binding to P2Z receptors on the surface of 
macrophages (Ferrari et al, 1999a). Because the ydiV mutant contains increased levels 
of c-diGMP, and the complemented mutant, which is unable to kill macrophages, appears 
to be deficient in cytosolic c-diGMP, we entertained the possibility that secreted bacterial 
c-diGMP might be the supplemental factor required for SipB-dependent macrophage 
death. Addition of 50 pM synthetic c-diGMP to uninfected macrophages or macrophages 
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Figure 30. Production of a cytotoxic factor by the ydiV mutant. Late log phase 
cultures of S. typhimurium were used to infect macrophages. (A) Mixed infection with 
1:1 ratio of ydiV mutant: complemented mutant, lx represents the same total M O I as 
infection with one strain (2:1), but only half as much of each individual strain. Mix 2x 
represents twice the total M O I used for infection with one strain (4:1), but the same 
number of bacteria from each individual strain as used for infection with one strain. 
(B) 50 p M c-diGMP was added to uninfected macrophages or macrophages infected 
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Figure 31. Expression of YdiV does not affect expression of SipB. (A) Silver stained 
S D S - P A G E of TCA-precipitated late log phase culture supernatants. Positions of 
molecular weight standards are indicated in kilodaltons. Flagellin is negatively 
stained due to over-abundance in relation to the other secreted proteins. Position of 
SipB was determined by absence of a protein band of the approximate correct 
molecular weight in sipB mutant strains. (B) Expression of the sip operon in 
S. typhimurium SL1344 with or without an intact ydiVgene. BJ68 contains lacZYA 
inserted in sipC. Graph depicts the average of 4 independent experiments. 
Comparison of enzyme activity in the two strains at each time point by 2-tailed 
Student's /-Test indicated no significant differences ( P>0.5 for all time points). 
203 
Expression of flagellin is required for S. typhimurium to induce rapid macrophage 
death 
We further characterized the requirements for Salmonella-induced macrophage 
death to help us better understand ydiV's role in cytotoxicity. Opsonization of S. 
typhimurium was not required for macrophage death; however, it accelerated the process, 
and killing of bacteria by either heat or antibiotics abrogated cytotoxicity. Stimulation of 
periodate-elicited macrophages with IFN-y did not promote macrophage resistance to S. 
typhimurium-induced death. Macrophages from phoxsp91/" mice were also lysed during 
infection with the ydiV mutant but left intact following infection with the complemented 
strain, indicating that macrophage death was not the result of host production of ROI by 
phox (data not shown). Inhibition of actin polmerization in macrophages by treatment 
with either dihydrocytochalasin B (DHCB) or cytochalasin D prevented rapid 
Salmonella-induced macrophage death (Fig. 32A). 
Bacterial flagellin activates macrophages by signaling through TLR5 (Hayashi et 
al, 2001a). We tested the possibility that hyper-secretion of flagellin by the ydiV mutant 
resulted in over-stimulation of macrophages, thus enhancing macrophage death. A 
flagellin null mutant (fliCfljB) was obtained from Alison O'Brien (Schmitt et al, 1996), 
and a ydiV'fliCfljB' triple mutant was constructed by transduction of the ydiV mutation in 
the flagellin null mutant. When added to murine macrophages, neither the flagellin 
mutant nor the ydiVfliCfljB' mutant caused any detectable macrophage death (Fig. 33). 
However, macrophages deficient in MyD88, the adaptor molecule used by TLRs to 
transduce signals, were still susceptible to killing by both wild type and ydiV mutant S. 
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Figure 32. Characterization of macrophage functions required for rapid Salmonella-
induced cytotoxicity. (A) Actin rearrangement is required for rapid macrophage death 
after infection with S. typhimurium. Macrophages were pre-treated with D M S O 
(vehicle control), dihydrocytochalasin B, or cytochalasin D for 30 minutes before 
infection. Toxicity is expessed as % lysis = (Exp LDH)/(maximum L D H release)xl00. 
(B) MyD88-deficient macrophages are susceptible to rapid killing by S. typhimurium. 
Striped bars = wild type macrophages; speckled bars = MyD88-deficient 































Figure 33. Rapid Sa/moneZ/a-induced macrophage death requires expression of the 
genes encoding flagellin, fliC and fljB. Macrophages infected with late log phase 
cultures of 5. typhimurium disrupted in ydiV and/or fliC &fljB. Values are means for 
triplicates +/- standard deviations. Results are representative of two independent 
experiments. 
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Although flagellin did not trigger macrophage death through the actions of 
MyD88 and thus probably not through TLR5, other macrophage receptors might 
recognize flagellin. To determine if the crucial toxic factor absent from cultures of the 
complemented strain was a secreted factor, such as secreted flagellin, gentamicin-treated 
supernatants from macrophages infected with the ydiV mutant and gentamicin-treated 
cultures of the ydiV mutant were added to macrophages with or without infection by the 
complemented mutant. Addition of sterile supernatants did not mediate killing of 
macrophages in the presence or absence of the co-infection (Fig. 34). 
Several studies indicate that when secretion by either the flagellar basal body or 
SPI-1 TTSS is disrupted, secretion by the other system is also dysregulated (Eichelberg 
and Galan, 2000; Iyoda et al, 2001; Komoriya et al, 1999). Analysis of proteins secreted 
by S. typhimurium grown under aeraobic conditions in LB medium revealed that all 
proteins detected were either products of flagellar genes or secreted SPI-1 effector, 
including SipB (Komoriya et al, 1999). Moreover, when individual genes encoding 
flagellar components were mutated, changes occured not only in secretion of the specific 
flagellar gene products, but also in secretion of the SPI-1 effector proteins (Komoriya et 
al, 1999). Thus, mutations in the genes encoding flagellin were reported to dysregulate 
SipB secretion; however, silver-stained SDS-PAGE indicated that fliCfljB' S. 
typhimurium is competent to secrete SipB (Fig. 31), further verifying that SipB is 
necessary but not sufficient for rapid Salmonella-induced macrophage death. 
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Figure 34. Supernatants from ydiV mutant S. typhimurium or from ydiV mutant 
infected macrophages do not contain a soluble factor that induces rapid cell death. 
Wells donating supernatants contained either 200 pi of K R P G only (A, B, C) or 
5xl05 macrophages in 200 pi of K R P G (D, E, F). Late log phase ydiV mutant 
S. typhimurium (IO6 cfu) was added to wells B, C, E, and F, and plates were 
centrifuged at 250xg for 5 min at room temperature. After incubation at 37°C for 30 
min, gentamicin was added to wells A, C, D, and F at a final concentration of 250 
pg/ml. Plates were returned to 37°C for another 30 min, and then 100 pi of 
supernatants were transferred to recipient wells. Prior to receiving supernatants, 
recipient wells containing 5xl05 macrophages in 100 pi of K R P G were infected with 
IO6 cfu of complemented mutant S. typhimurium, centrifuged at 250xg for 5 min at 
room temperature, and incubated at 37°C for 10 min to permit ingestion of bacteria. 
After 10 minutes, 100 ml of donor supernatants were added wells, the time 0 time 
point was harvested, and gentamicin was added to the 90 min time point wells at a 
final concentration of 10 pg/ml. Plates were incubated at 37°C for 90 min, followed 
by harvest of supernatants. 
Sample A = toxicity to macrophages of high dose gentamicin 
Sample B = control for C 
Sample C - tests whether live bacteria secrete a toxic molecule into the media 
Sample D = toxicity to macrophages of high dose gentamicin 
Sample E = LIVE bacteria; tests whether macrophages induce bacteria to secrete 
a toxic factor into the supernatant, or vice versa. Because supernatants are 
transferred from wells that had contained live bacteria and macrophages, L D H is 
transferred and is therefore present at 0 min. 
Sample F = N O live bacteria; tests whether macrophages induce bacteria to secrete 
a toxic factor into the supernatant, or vice versa. The L D H present in these well 
represent L D H transferred from donor wells. However, because gentamicin was 
added before transfer of the supernatant, only dead bacteria were added, and no 
further L D H was released. Thus, the amount of L D H is these wells is the same at 0 
and 90 min. 





































































































































S. typhimurium, an enterobacterium pathogenic for humans and mice, contains c-
diGMP; the level of c-diGMP is controlled by YdiV, a protein comprised of an EAL 
domain; and YdiV controls diverse aspects of the host-pathogen interaction, including 
resistance to H202 in vitro and to phox in mice; motility and synthesis of flagellin; and 
killing of macrophages by a process dependent on SipB, flagellin and additional factor(s). 
Lacking ydiV, S. typhimurium killed macrophages with extraordinary speed and 
efficiency. Secretion of SipB by the YdiV over-expressing complemented mutant, which 
lacks cytotoxicity towards macrophages, indicates that other factors in addition to SipB 
are required for Salmonella-induced macrophage death. 
These are the first results providing evidence that the EAL domain alone may 
possess PDE activity for c-diGMP, and that modulation of c-diGMP contributes to the 
regulation of virulence mechanisms in addition to those that rely on cellulose synthesis. 
YdiV likely encodes a c-diGMP PDE or the catalytic subunit of a c-diGMP PDE whose 
regulatory subunit is encoded by another gene. The potential involvement of YdiV in 
depleting cellular levels of the regulatory molecule c-diGMP helps explain the seemingly 
diverse and apparently unrelated phenotypes observed for the S. typhimurium ydiV 
mutant. The abundance of EAL and GGDEF domains throughout eubacteria, many of 
which are linked to signal sensor domains, suggest that synthesis of c-diGMP acts as a 
mechanism of signal transduction that complements the classical two-component 
regulatory systems (Fig. 35). Rather than regulating phosphorylation of response 
regulators, GGDEF and EAL domains would modulate levels of c-diGMP, which would 
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E A L and G G D E F domains within single genomes, suggests that there are 
microenvironments and/or regulons regulated by c-diGMP within bacteria, as are 
regulated by cAMP in eukaryotic cells (Rich et al, 2001). The EAL domain encoded by 
ydiV represents one of 18 EAL domains present in the S. typhimurium genome; the 
phenotypes of the ydiV mutant illustrate that other EAL domains cannot compensate for 
the absence of YdiV, further supporting the idea that c-diGMP does not freely diffuse 
throughout the cell, but rather acts as a signaling molecule relaying information between 
specific proteins. 
The crystal structure of c-diGMP indicates that 2 c-diGMP molecules stack 
together to form a cage-like dimer held together by a chelated divalent cation, with the 4 
guanine backbones lying parallel to one another (Liaw et al, 1990). Currently, allosteric 
activation of cellulose synthase is the only function described for c-diGMP (Ross et al, 
1990; Ross et al, 1991), although the precise molecular interactions have not been 
determined. Considering that EAL and GGDEF domains are found in genes identified by 
their roles in virulence and motility, it is likely that c-diGMP can act as an activator for 
other proteins besides cellulose synthase. Alternatively, one study demonstrated that 
synthetic cyclic dinucleotides can act as competitive inhibitors of RNA polymerase (Hsu 
and Dennis, 1982), suggesting that direct disruption of transcription could be another 
mechanism by which c-diGMP mediates regulatory effects. 
Salmonella-induced macrophage death 
We were initially surprised to discover that macrophage monolayers were 
depleted after infection with S. typhimurium because previously published experiments 
212 
from our laboratory have demonstrated that macrophages both control and kill 
intracellular S. typhimurium. In these experiments, macrophages incubated with S. 
typhimurium over the course of 5 hours did not demonstrate any signs of cytotoxicity 
(Shiloh et al, 1997; Shiloh et al, 1999). The difference between these earlier 
experiments and our current experiments is the preparation of the inocula: previous 
experiments used early log phase or stationary phase cultures, while current studies were 
performed with late log phase cultures. We chose to grow the inocula to late log phase 
because expression studies had demonstrated peak ydiV expression occurring at this time. 
Our observation that S. typhimurium kills murine macrophages is consistent with 
reports of Salmonella-induced cytotoxicity in the literature. The studies by Galan (Chen 
et al, 1996b; Monack et al, 1996), Falkow (Monack et al, 1996), Baccarini(Lundberg et 
al, 1999), and Zychlinsky (Hersh etal, 1999) all use bacteria grown to late log phase, a 
condition which induces expression of SPI-1. The delayed killing of macrophages by S. 
typhimurium described by Heffron's group resulted from infection of macrophages with 
overnight cultures of bacteria grown to stationary phase (Lindgren et al, 1996). Not 
surprisingly, the influence of bacterial growth phase on interactions between pathogens 
and macrophages has been observed with other species as well. If L. pneumophila is 
grown to post-exponential phase, bacteria-containing phagosomes isolate from the 
endocytic network during macrophage infection. However, if exponential-phase L. 
pneumophila is used to infect macrophages, bacteria end up in phagolysosmes that stain 
positively for LAMP-1 and cathepsin D (Joshi et al, 2001). 
Studies by Baccarini's group (Lundberg etal, 1999) included the most rapid 
demonstration of Salmonella-induced macrophage cytotoxicity published to date: almost 
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complete death of macrophages by 90 minutes post infection with an M O I of 25:1. This 
rapid and efficient cytotoxicity is comparable to the killing we see using ydiV mutant S. 
typhimurium, and more extreme than what we observe with our wild type S. typhimurium. 
The "wild type" strain used in the Lundberg et al. study was LT2, a strain we have shown 
does not express ydiV. Therefore, LT2 is a functional ydiV mutant, providing a possible 
explanation for the rapid and efficient cytotoxicity observed in the study by Lundberg et 
al. 
It is also possible that variability in efficiency of killing and elapsed time until 
maximum death observed in different laboratories can be explained by differences in the 
method of determination of "death". Monack, et al (2001) demonstrate still frames from 
video microscopy indicating that macrophages show changes in morphology by 20 
minutes after infection, and manifest alterations consistent with programmed death 
(including cell shrinkage, vacuolization and membrane blebbing) by 45 minutes after 
infection. The authors used inability to exclude a vital dye to measure death within the 
entire population of macrophages. This assay does not detect macrophages that have 
already died and completely disintegrated, and therefore results in an under-estimation of 
cell death. In fact, all assays that rely upon detection of dying cells (as opposed to a dead 
ones) such as DNA fragment staining, exclusion of vital dyes, and Annexin 5 staining 
will miss cells that have already died and broken apart completely. Baccarini's group 
evaluated cytotoxicity using the same assay used in our studies: LDH release. Evaluation 
of LDH release reflects cumulative death rather than a snapshot of dying cells, and is 
therefore a more reliable indicator of cytotoxicity that occurs very rapidly. 
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Although it appears that the groups of Falkow, Galan, Baccarini, and Zychlinsky 
are all observing the same pathogen-induced cytotoxic phenomenon that we have 
described, there are some details upon which there are still discrepancies. Studies by 
Galan's group indicated that cytochalasin D had no effect on cytotoxicity (Chen et al, 
1996b), whereas our studies and those of Falkow's group (Monack et al, 1996) 
demonstrated that inhibition of actin by cytochalasin D halts Salmonella-induced 
macrophage death. There are several potential explanations for the requirement of actin 
cytoskeleton rearrangement during the process of Salmonella-induced macrophage death. 
Phagocytosis of S. typhimurium may be required; either to trigger signaling cascades in 
the macrophage, or simply to increase the area of contact between the bacterium and the 
macrophage. Likewise, phagocytosis may not be necessary so much as zippering, a 
phenomenon of close membrane communication between the bacterium and the host cell 
that creates a large surface for molecular interactions. In the case of rapid Salmonella-
induced death, which appears to require the translocation of SipB into the cytosol of host 
cells, a large amount of membrane contact may be required for the mobilization of 
sufficient bacterial secretion systems, even if internalization of the bacteria is not 
required. Actin's involvement, however, may not occur during the delivery of the death 
signal; rather, actin may be required for the process of what appears to be catastrophic 
disintegration of the cell. The nature of macrophage death induced by Salmonella has 
been characterized extensively, and, although the process resembles necrosis (Brennan 
and Cookson, 2000; Watson et al, 2000), macrophages are not passive participants: 
inhibition of macrophage caspase-1 prevents death (Hersh et al, 1999). It is possible that 
actin rearrangement may also help mediate this necrosis-like process. 
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It is also unclear whether the activation state of the macrophage influences the 
extent of cytotoxicity. IFN-y-activated RAW264.7 cells are highly susceptible to killing, 
but so are thioglycolate-elicited peritoneal macrophages (partially activated cells) and 
bone marrow macrophages (unactivated cells) (Chen et al, 1996b; Monack et al, 1996). 
As far as we can tell, our studies provide the only head to head comparison of IFN-
y-activated macrophages versus unactivated macrophages, and our results indicated that 
activation did not significantly impact Salmonella-induced macrophage death. However, 
periodate-elicited macrophages, used in our assays, are already relatively activated cells. 
Naive populations, such as resident peritoneal cells or bone marrow macrophages will 
need to be used to accurately evaluate the role of macrophage activation in resistance to 
Salmonella-induced macrophage death. 
Finally, the data concerning the influence of bacterial opsonization on 
cytotoxicity are also inconsistent. Falkow's group found that serum-opsonized bacteria 
are less toxic (Monack et al, 1996). A study using a human macrophage cell line also 
found that opsonized bacteria are less capable of killing macrophages (Forsberg et al, 
2003). We found the opposite to be true: opsonized and non-opsonized S. typhimurium 
both kill, but serum-opsonized bacteria do so more rapidly. 
These inconsistencies between results may be the outcome of the slightly different 
experimental setups employed by the different laboratories. Unactivated bone marrow 
cells, macrophage cell lines, and elicited macrophages are physiologically different cells, 
and are likely to demonstrate a range of susceptibilities to pathogen-induced death. 
Moreover, "wild type" strains of S. typhimurium are not genetically identical. The 
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multiplicity of infection and the length of time allowed for infection also vary 
considerably between the different assays. 
Flagellin and Salmonella-induced macrophage death 
This is the first report demonstrating a role for the expression of flagellin in 
Salmonella-induced macrophage death. Multiple theories can be postulated that account 
for the dual requirements of sipB and fliCI fljB expression for cytotoxicity. The role of 
motility as a factor in S. typhimurium's ability to kill cannot be ruled out. Ideally, a 
mutant with paralyzed flagellin would be tested to address this point; however, mutations 
in the mot genes that control the motor of flagellin lead to dysregulation of expression of 
other flagellar genes, thus confounding interpretation of potential mutant phenotypes 
(Komoriya et al, 1999). Centrifugation of culture plates containing both adherent 
macrophages and free-floating bacteria has been shown to effectively colocalize amotile 
bacteria with the macrophage monolayer (Tomita and Kanegasaki, 1982). From our own 
work, we have observed that, following centrifugation and 10 minutes of phagocytosis, 
the number of bacteria ingested by macrophages was equivalent for wild type bacteria, 
the ydiV mutant, and the complemented mutant (data not shown). Thus, the 
complemented mutant's defect in cytotoxicity is not due to an inability to penetrate the 
macrophage monolayer, despite a lack of flagellin. 
Although MyD88 is not required for Salmonella-induced macrophage death, 
flagellin may convey death signals through another receptor, which couples with SipB 
activity to kill the macrophage. Alternatively, disruption of the genes encoding flagellin 
may alter expression of an unknown molecule that functions with SipB to induce 
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macrophage death. SipB has been shown to form a pore in eukaryotic cell membranes 
(Hayward et al, 2000; Scherer et al, 2000), and this unknown protein might be 
translocated through SipB into the macrophage cytosol where it could induce 
macrophage death. 
Another possibility is that flagella secrete and/or translocate SipB. It has been 
shown for other gram negative enteric bacteria that some virulence factors are secreted by 
the flagellar TTSS apparatus (Young et al, 1999a). Additionally, Lee and Galan recently 
demonstrated that the default pathway for S. typhimurium SPI-1 effectors that cannot 
bind their cognate SPI-1 chaperones is secretion through the flagellar apparatus (Lee and 
Galan, 2004). Wild type SipB may be differentially secreted by two different TTSSs, 
resulting in two different effector functions. When SipB is secreted through the SPI-1 
needle apparatus, it acts as a translocon to facilitate delivery of SPI-1 effectors required 
for invasion; however, SipB may be secreted by the flagellar TTSS, thus inducing 
macrophage death. 
Model for YdiV's contributions to virulence 
We propose that YdiV acts as a PDE for c-diGMP, which in turn acts as an 
activator or repressor for diverse functions including anti-oxidant defense and the 
expression of flagellin. Disruption of ydiV results in accumulation of c-diGMP and 
dysregulation of the YdiV regulon. The in vivo phenotype of the ydiV mutant in this 
study is probably due mostly, if not entirely, to its deficit in anti-oxidant defense, as 
demonstrated by reversal of attenuation of the ydiV mutant in phox-deficient mice. 
Although YdiV plays a key role in mediating Salmonella-induced macrophage death, this 
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function probably does not contribute to the in vivo phenotype of the ydiV mutant. SPI-1 
mutants are not attenuated when infected i.p. (Galan and Curtiss, 1989), suggesting that 
SPI-1 is not required after translocation from the gut into the blood; moreover, caspase-1-
deficient mice demonstrate no difference in susceptibility to S. typhimurium when 
compared to wild type mice after i.p. infection (Monack et al, 2000). Thus, SipB-
dependent macrophage death probably occurs solely in macrophages recruited to Peyer's 
patches. Infection of mice by the oral route might reveal different phenotypes for the 
ydiV mutant and the complemented mutant. The complemented mutant, which cannot 
induce macrophage death, may be unable to cause systemic infection after oral 
inoculation. 
YdiV's regulation of flagellin could affect virulence by a mechanism independent 
of S. typhimurium's ability to kill macrophages. S. typhimurium mutants lacking flagella 
are equally effective at killing mice after oral infection as wild type strains (Lockman and 
Curtiss, 1990). In fact, flhD mutants are slightly more virulent than wild type strains 
when administered orally (Schmitt et al, 2001). The increased virulence of the flhD 
mutant does not appear to be due to enhanced invasion of the gut, but rather due to the 
mutant's increased proliferation in macrophages in the spleen and liver. Yet, flagellin is 
repressed in wild type S. typhimurium after ingestion by macrophages in vitro (Eriksson 
et al., 2003). When S. typhimurium is engineered to constitutively express flagellin, 
virulence is dependent on the specific flagellin monomer that is expressed: FliC-
expressing strains retain virulence, but FljB-expressing strains fail to proliferate in the 
spleen (Ikeda et al., 2001). The role of flagellin in pathogenesis during S. typhimurium 
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infection of mice will require further clarification before w e can postulate that 
dysregulation of flagellin contributes to attenuation of the ydi V mutant. 
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C h a p t e r 5 
Some conclusions about pathogenesis of intracellular bacteria 
The 5 genes identified in this study represent diverse categories of bacterial 
activities: modification of extracellular surface moieties (Rv2955c), production of 
bioactive compounds (pks6), recognition of changes in the environment and/or uptake of 
nutrients (Rv0072, pstAl), and regulation of the concentration of a small intracellular 
signaling molecule (ydiV). At the outset of this study, we had hoped that we might 
elucidate strategies for enhanced survival within the macrophage that were common to 
M. tuberculosis and S. typhimurium. Although no one gene or pathway was detected in 
both differential STM screens, some of the genes identified have homologs in both 
species. 
Rv0405 (pks6) appears to be the only cim gene with no counterpart in S. 
typhimurium. In fact there are no polyketide synthases encoded by 5. typhimurium. 
R\2958c has no close homologs in S. typhimurium, however S. typhimurium does encode 
glycosyl transferases, particularly iroB, which is part of an iron-regulatory operon 
(Hantke et al, 2003), and murG, which involved in peptidoglycan synthesis (van den 
Brink-van der Laan et al, 2003). These genes, however, probably do not represent 
counterparts of Rv2958c in S. typhimurium. In addition to not demonstrating strong 
similarity to these two genes, Rv295<Sc is found on the chromosome in the proximity of 
pksl/15 and is thought to function with Pksl/15 in the synthesis of phenolglycolipids. 
Thus, the exact mechanism by which Rv2958c contributes to M. tuberculosis's ability to 
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counter the effects of IFN-y in vivo is probably not shared by S. typhimurium, which does 
not encode polyketide synthases. 
The high-affinity phosphate and glutamine transporters to which Rv0930 (pstAl) 
and Rv0072 contribute respectively not only have homologs in S. typhimurium, but they 
have also been shown to contribute to pathogenesis of S. typhimurium in vivo (Klose and 
Mekalanos, 1997; Lucas et al, 2000). Interestingly, the studies with S. typhimurium have 
implicated both the glutamine transporter and the Pst phosphate system as being 
important for signaling changes in the environment of the bacterium, rather than 
mediating uptake of nutrients. The in vivo requirement for the two transporters in both S. 
typhimurium and M. tuberculosis suggests that the macrophage phagosome likely 
contains low concentrations of glutamine and phosphate. It is worth noting that a third 
shared nutrient transporter, the MgtC magnesium transporter, was found to be required by 
both S. typhimurium and M. tuberculosis for growth in macrophages and in low 
concentrations of magnesium in vitro (Buchmeier et al, 2000). These results suggest that 
magnesium is limited in the phagosome of the macrophage, and that uptake of 
magnesium by the MgtC transporter is required for growth of both bacteria when 
magnesium is limited. Further studies will be required to determine the true roles of the 
glutamine and phosphate transporters. Perhaps restriction of phosphate and glutamine in 
vivo can effectively starve S. typhimurium and M. tuberculosis, or perhaps the bacteria 
have merely evolved to recognize low concentration of these nutrients as signals to up-
regulate particular virulence factors. 
The M. tuberculosis genome contains EAL and GGDEF domain-containing 
proteins; however, unlike S. typhimurium, M. tuberculosis encodes only two. Rwl354c 
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includes an E A L domain, a G G D E F domain, and a G A F domain, while Rvl357c 
contains only an EAL domain. It is intriguing that the only 2 genes encoding 
EAL/GGDEF domain-containing proteins in the M. tuberculosis genome are found in 
such close proximity to each other (within 5000 nucleotides), suggesting that the gene 
products may function together to regulate c-diGMP. Most of the genes at this locus 
have not been assigned function, including Rv 1354c and Rvl357c. Rvl355 was 
annotated moeY, due to weak similarity to a molybdopterin biosynthesis protein. As our 
understanding of the role of c-diGMP in pathogenic bacteria expands, perhaps we will 
gain insight into the roles of these two M. tuberculosis genes. 
M. tuberculosis and S. typhimurium both possess the ability to maintain chronic 
infections, residing for long periods of time within host macrophages. The interaction, 
therefore, between the bacterium and the host is most likely a constantly changing one, 
evolving as the immune response develops over time. The identification of genes that are 
involved with modulation of bacterial function and are required for countering specific 
components of the host immune response supports the idea that regulatory circuits are a 
critical component of the bacterium's ability to cause chronic infection. The putative and 
demonstrated functions of the 5 gene products detected in these differential STM screens 
point to novel, potentially widespread, bacterial pathways for gauging and responding to 
host immune pressures, whose roles in virulence are not yet fully appreciated. 
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